IntechOpen Book Series will also publish a program of research-driven Thematic Edited Volumes that focus on specific areas and allow for a more in-depth overview of a particular subject.
\\n\\n
IntechOpen Book Series will be launching regularly to offer our authors and editors exciting opportunities to publish their research Open Access. We will begin by relaunching some of our existing Book Series in this innovative book format, and will expand in 2022 into rapidly growing research fields that are driving and advancing society.
With the desire to make book publishing more relevant for the digital age and offer innovative Open Access publishing options, we are thrilled to announce the launch of our new publishing format: IntechOpen Book Series.
\n\n
Designed to cover fast-moving research fields in rapidly expanding areas, our Book Series feature a Topic structure allowing us to present the most relevant sub-disciplines. Book Series are headed by Series Editors, and a team of Topic Editors supported by international Editorial Board members. Topics are always open for submissions, with an Annual Volume published each calendar year.
\n\n
After a robust peer-review process, accepted works are published quickly, thanks to Online First, ensuring research is made available to the scientific community without delay.
\n\n
Our innovative Book Series format brings you:
\n\n
\n\t
Topic Focused Publications - Each topic showcases high impact subject areas
\n\t
Renowned Editorial Expertise - Series Editors, Topic Editors, and a team of international Board Members that permanently support each Book Series
\n\t
Fast Publishing - quick turnaround which is unique for book publishing
\n\t
The benefit of ISSN and ISBN for increased citation and indexing possibilities
\n
\n\n\n\n
IntechOpen Book Series will also publish a program of research-driven Thematic Edited Volumes that focus on specific areas and allow for a more in-depth overview of a particular subject.
\n\n
IntechOpen Book Series will be launching regularly to offer our authors and editors exciting opportunities to publish their research Open Access. We will begin by relaunching some of our existing Book Series in this innovative book format, and will expand in 2022 into rapidly growing research fields that are driving and advancing society.
We invite you to explore our IntechOpen Book Series, find the right publishing program for you and reach your desired audience in record time.
\n\n
Note: Edited in October 2021
\n'}],latestNews:[{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"},{slug:"introducing-intechopen-book-series-a-new-publishing-format-for-oa-books-20210915",title:"Introducing IntechOpen Book Series - A New Publishing Format for OA Books"},{slug:"intechopen-identified-as-one-of-the-most-significant-contributor-to-oa-book-growth-in-doab-20210809",title:"IntechOpen Identified as One of the Most Significant Contributors to OA Book Growth in DOAB"}]},book:{item:{type:"book",id:"599",leadTitle:null,fullTitle:"Applications of Digital Signal Processing",title:"Applications of Digital Signal Processing",subtitle:null,reviewType:"peer-reviewed",abstract:"In this book the reader will find a collection of chapters authored/co-authored by a large number of experts around the world, covering the broad field of digital signal processing. This book intends to provide highlights of the current research in the digital signal processing area, showing the recent advances in this field. This work is mainly destined to researchers in the digital signal processing and related areas but it is also accessible to anyone with a scientific background desiring to have an up-to-date overview of this domain. Each chapter is self-contained and can be read independently of the others. These nineteenth chapters present methodological advances and recent applications of digital signal processing in various domains as communications, filtering, medicine, astronomy, and image processing.",isbn:null,printIsbn:"978-953-307-406-1",pdfIsbn:"978-953-51-5574-4",doi:"10.5772/1111",price:139,priceEur:155,priceUsd:179,slug:"applications-of-digital-signal-processing",numberOfPages:412,isOpenForSubmission:!1,isInWos:1,isInBkci:!1,hash:"0806065a04f7ecc14f1c45a0b0127638",bookSignature:"Christian Cuadrado-Laborde",publishedDate:"November 23rd 2011",coverURL:"https://cdn.intechopen.com/books/images_new/599.jpg",numberOfDownloads:96808,numberOfWosCitations:35,numberOfCrossrefCitations:20,numberOfCrossrefCitationsByBook:0,numberOfDimensionsCitations:36,numberOfDimensionsCitationsByBook:0,hasAltmetrics:1,numberOfTotalCitations:91,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"January 25th 2011",dateEndSecondStepPublish:"February 22nd 2011",dateEndThirdStepPublish:"June 29th 2011",dateEndFourthStepPublish:"July 29th 2011",dateEndFifthStepPublish:"November 26th 2011",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6,7",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"29543",title:"Dr.",name:"Christian",middleName:"A",surname:"Cuadrado-Laborde",slug:"christian-cuadrado-laborde",fullName:"Christian Cuadrado-Laborde",profilePictureURL:"https://mts.intechopen.com/storage/users/29543/images/632_n.jpg",biography:"Christian Cuadrado-Laborde received his Ph.D. degree in physics from La Plata University (UNLP, Argentina, 2005), and his Electric and Electronic Engineer degree from the San Luis University (UNSL, Argentina, 1998). \nThen, he joined to the most important federal research agency in Argentina (CONICET, 2005); where he is actually an Associate Researcher. He is currently also an Associate Professor of the La Plata Catholic University (Argentina). He has served also as an Assistant Professor of the Faculty of Engineering of the UNLP. \nHe was awarded by the Spanish Ministry of Science with a research fellow position to join to the Optical Fiber Laboratory group headed by M. V. Andres of the Valencia University (Spain) during 2008-2009. Since then, he has a fluid collaboration with this research group.\nHe serves also as a reviewer for several well-known journals of the Optical Society of America, the IEEE, Elsevier, SPIE, and the Electromagnetic Academy. \nHe has published several papers in top-tier scientific journals such as Optics Letters, Laser and Photonics Reviews, Optics and Photonics News, etc. His current research interest includes fiber optics applications, photonic processing, and all-fiber lasers.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"National Scientific and Technical Research Council",institutionURL:null,country:{name:"Argentina"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"561",title:"Signal Processing",slug:"computer-science-and-engineering-signal-processing"}],chapters:[{id:"24300",title:"Complex Digital Signal Processing in Telecommunications",doi:"10.5772/26259",slug:"complex-digital-signal-processing-in-telecommunications",totalDownloads:12025,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Zlatka Nikolova, Georgi Iliev, Miglen Ovtcharov and Vladimir Poulkov",downloadPdfUrl:"/chapter/pdf-download/24300",previewPdfUrl:"/chapter/pdf-preview/24300",authors:[{id:"18206",title:"Dr.",name:"Vladimir",surname:"Poulkov",slug:"vladimir-poulkov",fullName:"Vladimir Poulkov"},{id:"21534",title:"Dr.",name:"Georgi",surname:"Iliev",slug:"georgi-iliev",fullName:"Georgi Iliev"},{id:"21536",title:"Associate Prof.",name:"Zlatka",surname:"Valkova-Jarvis",slug:"zlatka-valkova-jarvis",fullName:"Zlatka Valkova-Jarvis"},{id:"71205",title:"MSc.",name:"Miglen",surname:"Ovtcharov",slug:"miglen-ovtcharov",fullName:"Miglen Ovtcharov"}],corrections:null},{id:"24301",title:"Digital Backward Propagation: A Technique to Compensate Fiber Dispersion and Non-Linear Impairments",doi:"10.5772/25410",slug:"digital-backward-propagation-a-technique-to-compensate-fiber-dispersion-and-non-linear-impairments",totalDownloads:4288,totalCrossrefCites:3,totalDimensionsCites:5,hasAltmetrics:1,abstract:null,signatures:"Rameez Asif, Chien-Yu Lin and Bernhard Schmauss",downloadPdfUrl:"/chapter/pdf-download/24301",previewPdfUrl:"/chapter/pdf-preview/24301",authors:[{id:"63229",title:"Dr.",name:"Rameez",surname:"Asif",slug:"rameez-asif",fullName:"Rameez Asif"},{id:"67397",title:"MSc.",name:"Chien-Yu",surname:"Lin",slug:"chien-yu-lin",fullName:"Chien-Yu Lin"},{id:"67398",title:"Prof.",name:"Bernhard",surname:"Schmauss",slug:"bernhard-schmauss",fullName:"Bernhard Schmauss"}],corrections:null},{id:"24302",title:"Multiple-Membership Communities Detection and Its Applications for Mobile Networks",doi:"10.5772/26469",slug:"multiple-membership-communities-detection-and-its-applications-for-mobile-networks",totalDownloads:4076,totalCrossrefCites:4,totalDimensionsCites:4,hasAltmetrics:0,abstract:null,signatures:"Nikolai Nefedov",downloadPdfUrl:"/chapter/pdf-download/24302",previewPdfUrl:"/chapter/pdf-preview/24302",authors:[{id:"66756",title:"Dr.",name:"Nikolai",surname:"Nefedov",slug:"nikolai-nefedov",fullName:"Nikolai Nefedov"}],corrections:null},{id:"24303",title:"Comparative Analysis of Three Digital Signal Processing Techniques for 2D Combination of Echographic Traces Obtained from Ultrasonic Transducers Located at Perpendicular Planes",doi:"10.5772/26949",slug:"comparative-analysis-of-three-digital-signal-processing-techniques-for-2d-combination-of-echographic",totalDownloads:2887,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Miguel A. Rodríguez-Hernández, Antonio Ramos and J. L. San Emeterio",downloadPdfUrl:"/chapter/pdf-download/24303",previewPdfUrl:"/chapter/pdf-preview/24303",authors:[{id:"68375",title:"Dr.",name:"Miguel Angel",surname:"Rodriguez-Hernandez",slug:"miguel-angel-rodriguez-hernandez",fullName:"Miguel Angel Rodriguez-Hernandez"},{id:"116560",title:"Dr.",name:"Antonio",surname:"Ramos",slug:"antonio-ramos",fullName:"Antonio Ramos"},{id:"116562",title:"Dr.",name:"Jose Luis",surname:"San Emeterio",slug:"jose-luis-san-emeterio",fullName:"Jose Luis San Emeterio"}],corrections:null},{id:"24304",title:"In-Situ Supply-Noise Measurement in LSIs with Millivolt Accuracy and Nanosecond-Order Time Resolution",doi:"10.5772/27833",slug:"in-situ-supply-noise-measurement-in-lsis-with-millivolt-accuracy-and-nanosecond-order-time-resolutio",totalDownloads:2999,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Yusuke Kanno",downloadPdfUrl:"/chapter/pdf-download/24304",previewPdfUrl:"/chapter/pdf-preview/24304",authors:[{id:"71763",title:"Dr.",name:"Yusuke",surname:"Kanno",slug:"yusuke-kanno",fullName:"Yusuke Kanno"}],corrections:null},{id:"24305",title:"High-Precision Frequency Measurement Using Digital Signal Processing",doi:"10.5772/25683",slug:"high-precision-frequency-measurement-using-digital-signal-processing",totalDownloads:8799,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Ya Liu, Xiao Hui Li and Wen Li Wang",downloadPdfUrl:"/chapter/pdf-download/24305",previewPdfUrl:"/chapter/pdf-preview/24305",authors:[{id:"64161",title:"Dr.",name:"Ya",surname:"Liu",slug:"ya-liu",fullName:"Ya Liu"},{id:"69034",title:"Dr.",name:"Xiao Hui",surname:"Li",slug:"xiao-hui-li",fullName:"Xiao Hui Li"},{id:"69035",title:"MSc.",name:"Wen Li",surname:"Wang",slug:"wen-li-wang",fullName:"Wen Li Wang"}],corrections:null},{id:"24306",title:"High-Speed VLSI Architecture Based on Massively Parallel Processor Arrays for Real-Time Remote Sensing Applications",doi:"10.5772/26496",slug:"high-speed-vlsi-architecture-based-on-massively-parallel-processor-arrays-for-real-time-remote-sensi",totalDownloads:3597,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"A. Castillo Atoche, J. Estrada Lopez, P. Perez Muñoz and S. Soto Aguilar",downloadPdfUrl:"/chapter/pdf-download/24306",previewPdfUrl:"/chapter/pdf-preview/24306",authors:[{id:"66851",title:"Dr.",name:"Alejandro",surname:"Castillo Atoche",slug:"alejandro-castillo-atoche",fullName:"Alejandro Castillo Atoche"},{id:"119434",title:"MSc.",name:"Johan",surname:"Estrada Lopez",slug:"johan-estrada-lopez",fullName:"Johan Estrada Lopez"},{id:"119435",title:"BSc.",name:"Pedro",surname:"Perez Muñoz",slug:"pedro-perez-munoz",fullName:"Pedro Perez Muñoz"},{id:"119436",title:"BSc.",name:"Sergio",surname:"Soto Aguilar",slug:"sergio-soto-aguilar",fullName:"Sergio Soto Aguilar"}],corrections:null},{id:"24307",title:"A DSP Practical Application: Working on ECG Signal",doi:"10.5772/25499",slug:"a-dsp-practical-application-working-on-ecg-signal",totalDownloads:12932,totalCrossrefCites:0,totalDimensionsCites:2,hasAltmetrics:0,abstract:null,signatures:"Cristian Vidal Silva, Andrew Philominraj and Carolina del Río",downloadPdfUrl:"/chapter/pdf-download/24307",previewPdfUrl:"/chapter/pdf-preview/24307",authors:[{id:"63528",title:"Prof.",name:"Cristian",surname:"Vidal Silva",slug:"cristian-vidal-silva",fullName:"Cristian Vidal Silva"},{id:"70740",title:"Prof.",name:"Carolina",surname:"Del Río",slug:"carolina-del-rio",fullName:"Carolina Del Río"},{id:"119165",title:"Prof.",name:"Andrew Sagayadass",surname:"Philominraj",slug:"andrew-sagayadass-philominraj",fullName:"Andrew Sagayadass Philominraj"}],corrections:null},{id:"24308",title:"Applications of the Orthogonal Matching Pursuit/ Nonlinear Least Squares Algorithm to Compressive Sensing Recovery",doi:"10.5772/25842",slug:"applications-of-the-orthogonal-matching-pursuit-nonlinear-least-squares-algorithm-to-compressive-sen",totalDownloads:3494,totalCrossrefCites:0,totalDimensionsCites:4,hasAltmetrics:0,abstract:null,signatures:"George C. Valley and T. Justin Shaw",downloadPdfUrl:"/chapter/pdf-download/24308",previewPdfUrl:"/chapter/pdf-preview/24308",authors:[{id:"64723",title:"Dr.",name:"George",surname:"Valley",slug:"george-valley",fullName:"George Valley"}],corrections:null},{id:"24309",title:"Min-Max Design of FIR Digital Filters by Semidefinite Programming",doi:"10.5772/25413",slug:"min-max-design-of-fir-digital-filters-by-semidefinite-programming",totalDownloads:3801,totalCrossrefCites:3,totalDimensionsCites:6,hasAltmetrics:0,abstract:null,signatures:"Masaaki Nagahara",downloadPdfUrl:"/chapter/pdf-download/24309",previewPdfUrl:"/chapter/pdf-preview/24309",authors:[{id:"63251",title:"Dr.",name:"Masaaki",surname:"Nagahara",slug:"masaaki-nagahara",fullName:"Masaaki Nagahara"}],corrections:null},{id:"24310",title:"Complex Digital Filter Designs for Audio Processing in Doppler Ultrasound System",doi:"10.5772/25958",slug:"complex-digital-filter-designs-for-audio-processing-in-doppler-ultrasound-system",totalDownloads:4399,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Baba Tatsuro",downloadPdfUrl:"/chapter/pdf-download/24310",previewPdfUrl:"/chapter/pdf-preview/24310",authors:[{id:"65121",title:"Dr.",name:"Baba",surname:"Tatsuro",slug:"baba-tatsuro",fullName:"Baba Tatsuro"}],corrections:null},{id:"24311",title:"Most Efficient Digital Filter Structures: The Potential of Halfband Filters in Digital Signal Processing",doi:"10.5772/26146",slug:"most-efficient-digital-filter-structures-the-potential-of-halfband-filters-in-digital-signal-process",totalDownloads:11900,totalCrossrefCites:0,totalDimensionsCites:3,hasAltmetrics:0,abstract:null,signatures:"Heinz G. Göckler",downloadPdfUrl:"/chapter/pdf-download/24311",previewPdfUrl:"/chapter/pdf-preview/24311",authors:[{id:"65680",title:"Prof.",name:"Heinz G.",surname:"Göckler",slug:"heinz-g.-gockler",fullName:"Heinz G. Göckler"}],corrections:null},{id:"24312",title:"Applications of Interval-Based Simulations to the Analysis and Design of Digital LTI Systems",doi:"10.5772/25882",slug:"applications-of-interval-based-simulations-to-the-analysis-and-design-of-digital-lti-systems",totalDownloads:2666,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Juan A. López, Enrique Sedano, Luis Esteban, Gabriel Caffarena, Angel Fernández-Herrero and Carlos Carreras",downloadPdfUrl:"/chapter/pdf-download/24312",previewPdfUrl:"/chapter/pdf-preview/24312",authors:[{id:"64847",title:"Dr.",name:"Juan Antonio",surname:"López",slug:"juan-antonio-lopez",fullName:"Juan Antonio López"},{id:"71182",title:"Mr.",name:"Enrique",surname:"Sedano",slug:"enrique-sedano",fullName:"Enrique Sedano"},{id:"71184",title:"Dr.",name:"Gabriel",surname:"Caffarena",slug:"gabriel-caffarena",fullName:"Gabriel Caffarena"},{id:"71185",title:"Dr.",name:"Luis",surname:"Esteban-Hernández",slug:"luis-esteban-hernandez",fullName:"Luis Esteban-Hernández"},{id:"71186",title:"Dr.",name:"Carlos",surname:"Carreras",slug:"carlos-carreras",fullName:"Carlos Carreras"},{id:"120215",title:"Dr.",name:"Angel",surname:"Fernandez",slug:"angel-fernandez",fullName:"Angel Fernandez"}],corrections:null},{id:"24313",title:"Digital Camera Identification Based on Original Images",doi:"10.5772/27655",slug:"digital-camera-identification-based-on-original-images",totalDownloads:3327,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Dmitry Rublev, Vladimir Fedorov and Oleg Makarevich",downloadPdfUrl:"/chapter/pdf-download/24313",previewPdfUrl:"/chapter/pdf-preview/24313",authors:[{id:"70989",title:"Dr.",name:"Dmitry",surname:"Rublev",slug:"dmitry-rublev",fullName:"Dmitry Rublev"},{id:"71548",title:"Prof.",name:"Oleg",surname:"Makarevich",slug:"oleg-makarevich",fullName:"Oleg Makarevich"},{id:"71549",title:"Dr.",name:"Vladimir",surname:"Fedorov",slug:"vladimir-fedorov",fullName:"Vladimir Fedorov"}],corrections:null},{id:"24314",title:"An Emotional Talking Head for a Humoristic Chatbot",doi:"10.5772/26558",slug:"an-emotional-talking-head-for-a-humoristic-chatbot",totalDownloads:4375,totalCrossrefCites:5,totalDimensionsCites:5,hasAltmetrics:0,abstract:null,signatures:"Agnese Augello, Orazio Gambino, Vincenzo Cannella, Roberto Pirrone, Salvatore Gaglio and Giovanni Pilato",downloadPdfUrl:"/chapter/pdf-download/24314",previewPdfUrl:"/chapter/pdf-preview/24314",authors:[{id:"67079",title:"Prof.",name:"Salvatore",surname:"Gaglio",slug:"salvatore-gaglio",fullName:"Salvatore Gaglio"},{id:"71511",title:"Prof.",name:"Roberto",surname:"Pirrone",slug:"roberto-pirrone",fullName:"Roberto Pirrone"},{id:"71514",title:"Dr.",name:"Agnese",surname:"Augello",slug:"agnese-augello",fullName:"Agnese Augello"},{id:"71516",title:"Prof.",name:"Giovanni",surname:"Pilato",slug:"giovanni-pilato",fullName:"Giovanni Pilato"},{id:"235644",title:"Ph.D.",name:"Orazio",surname:"Gambino",slug:"orazio-gambino",fullName:"Orazio Gambino"}],corrections:null},{id:"24315",title:"Study of the Reverse Converters for the Large Dynamic Range Four-Moduli Sets",doi:"10.5772/25405",slug:"study-of-the-reverse-converters-for-the-large-dynamic-range-four-moduli-sets",totalDownloads:2999,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Amir Sabbagh Molahosseini and Keivan Navi",downloadPdfUrl:"/chapter/pdf-download/24315",previewPdfUrl:"/chapter/pdf-preview/24315",authors:[{id:"63216",title:"Dr.",name:"Amir",surname:"Sabbagh Molahosseini",slug:"amir-sabbagh-molahosseini",fullName:"Amir Sabbagh Molahosseini"},{id:"64546",title:"Prof.",name:"Keivan",surname:"Navi",slug:"keivan-navi",fullName:"Keivan Navi"}],corrections:null},{id:"24316",title:"Entropic Complexity Measured in Context Switching",doi:"10.5772/25520",slug:"entropic-complexity-measured-in-context-switching",totalDownloads:2867,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:null,signatures:"Paul Pukite and Steven Bankes",downloadPdfUrl:"/chapter/pdf-download/24316",previewPdfUrl:"/chapter/pdf-preview/24316",authors:[{id:"63568",title:"Dr.",name:"Paul",surname:"Pukite",slug:"paul-pukite",fullName:"Paul Pukite"},{id:"71390",title:"Dr.",name:"Steven",surname:"Bankes",slug:"steven-bankes",fullName:"Steven Bankes"}],corrections:null},{id:"24317",title:"A Description of Experimental Design on the Basis of an Orthonormal System",doi:"10.5772/26486",slug:"a-description-of-experimental-design-on-the-basis-of-an-orthonormal-system",totalDownloads:2797,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Yoshifumi Ukita and Toshiyasu Matsushima",downloadPdfUrl:"/chapter/pdf-download/24317",previewPdfUrl:"/chapter/pdf-preview/24317",authors:[{id:"66825",title:"Dr.",name:"Yoshifumi",surname:"Ukita",slug:"yoshifumi-ukita",fullName:"Yoshifumi Ukita"},{id:"71626",title:"Dr.",name:"Toshiyasu",surname:"Matsushima",slug:"toshiyasu-matsushima",fullName:"Toshiyasu Matsushima"}],corrections:null},{id:"24318",title:"An Optimization of 16-Point Discrete Cosine Transform Implemented into a FPGA as a Design for a Spectral First Level Surface Detector Trigger in Extensive Air Shower Experiments",doi:"10.5772/26791",slug:"an-optimization-of-16-point-discrete-cosine-transform-implemented-into-a-fpga-as-a-design-for-a-spec",totalDownloads:2581,totalCrossrefCites:4,totalDimensionsCites:5,hasAltmetrics:0,abstract:null,signatures:"Zbigniew Szadkowski",downloadPdfUrl:"/chapter/pdf-download/24318",previewPdfUrl:"/chapter/pdf-preview/24318",authors:[{id:"67836",title:"Prof.",name:"Zbigniew Piotr",surname:"Szadkowski",slug:"zbigniew-piotr-szadkowski",fullName:"Zbigniew Piotr Szadkowski"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"2992",title:"Current Trends in Short- and Long-period Fiber Gratings",subtitle:null,isOpenForSubmission:!1,hash:"7ea3b8fc542d07312526928ba5bac062",slug:"current-trends-in-short-and-long-period-fiber-gratings",bookSignature:"Christian Cuadrado-Laborde",coverURL:"https://cdn.intechopen.com/books/images_new/2992.jpg",editedByType:"Edited by",editors:[{id:"29543",title:"Dr.",name:"Christian",surname:"Cuadrado-Laborde",slug:"christian-cuadrado-laborde",fullName:"Christian Cuadrado-Laborde"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3184",title:"Recent Advances in Signal Processing",subtitle:null,isOpenForSubmission:!1,hash:"a12827ec504927d4c493d8add2079d8c",slug:"recent-advances-in-signal-processing",bookSignature:"Ashraf A Zaher",coverURL:"https://cdn.intechopen.com/books/images_new/3184.jpg",editedByType:"Edited by",editors:[{id:"1729",title:"Dr.",name:"Ashraf",surname:"Zaher",slug:"ashraf-zaher",fullName:"Ashraf Zaher"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3175",title:"Signal Processing",subtitle:null,isOpenForSubmission:!1,hash:"25238b9acd5326ed3e8b349570f47c0d",slug:"signal-processing",bookSignature:"Sebastian Miron",coverURL:"https://cdn.intechopen.com/books/images_new/3175.jpg",editedByType:"Edited by",editors:[{id:"1053",title:"Dr.",name:"Sebastian",surname:"Miron",slug:"sebastian-miron",fullName:"Sebastian Miron"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4655",title:"Applications of Digital Signal Processing through Practical Approach",subtitle:null,isOpenForSubmission:!1,hash:"b20308efd28e8a487949997c8d673fb8",slug:"applications-of-digital-signal-processing-through-practical-approach",bookSignature:"Sudhakar Radhakrishnan",coverURL:"https://cdn.intechopen.com/books/images_new/4655.jpg",editedByType:"Edited by",editors:[{id:"26327",title:"Dr.",name:"Sudhakar",surname:"Radhakrishnan",slug:"sudhakar-radhakrishnan",fullName:"Sudhakar Radhakrishnan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"65668",slug:"corrigendum-to-clinical-applications-of-mesenchymal-stromal-cells-mscs-in-orthopedic-diseases",title:"Corrigendum to: Clinical Applications of Mesenchymal Stromal Cells (MSCs) in Orthopedic Diseases",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/65668.pdf",downloadPdfUrl:"/chapter/pdf-download/65668",previewPdfUrl:"/chapter/pdf-preview/65668",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/65668",risUrl:"/chapter/ris/65668",chapter:{id:"61187",slug:"clinical-applications-of-mesenchymal-stromal-cells-mscs-in-orthopedic-diseases",signatures:"Jiazhao Yang, Shiyuan Fang, Lei Xu, Li Li, Kai Xie, Jinsen Lu, Hao\nWang, Xujin Wang and Lixin Kan",dateSubmitted:"December 5th 2017",dateReviewed:"March 29th 2018",datePrePublished:"November 5th 2018",datePublished:"January 23rd 2019",book:{id:"6658",title:"Stromal Cells",subtitle:"Structure, Function, and Therapeutic Implications",fullTitle:"Stromal Cells - Structure, Function, and Therapeutic Implications",slug:"stromal-cells-structure-function-and-therapeutic-implications",publishedDate:"January 23rd 2019",bookSignature:"Mani T. Valarmathi",coverURL:"https://cdn.intechopen.com/books/images_new/6658.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"69697",title:"Dr.",name:"Mani T.",middleName:null,surname:"Valarmathi",slug:"mani-t.-valarmathi",fullName:"Mani T. Valarmathi"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"238560",title:"Dr.",name:"Lixin",middleName:null,surname:"Kan",fullName:"Lixin Kan",slug:"lixin-kan",email:"l-kan@northwestern.edu",position:null,institution:null},{id:"245732",title:"Dr.",name:"Yang",middleName:null,surname:"Jiazhao",fullName:"Yang Jiazhao",slug:"yang-jiazhao",email:"yangjiazhao@126.com",position:null,institution:null},{id:"246322",title:"Dr.",name:"Shiyuan",middleName:null,surname:"Shiyuan",fullName:"Shiyuan Shiyuan",slug:"shiyuan-shiyuan",email:"fangshiyuan2008@126.com",position:null,institution:null},{id:"246323",title:"Dr.",name:"Lei",middleName:null,surname:"Xu",fullName:"Lei Xu",slug:"lei-xu",email:"bayinhexl@126.com",position:null,institution:null},{id:"246325",title:"Dr.",name:"Li",middleName:null,surname:"Li",fullName:"Li Li",slug:"li-li",email:"lili@126.com",position:null,institution:null},{id:"246326",title:"Dr.",name:"Kai",middleName:null,surname:"Xie",fullName:"Kai Xie",slug:"kai-xie",email:"xiekai@126.com",position:null,institution:null},{id:"246327",title:"Dr.",name:"Jinsen",middleName:null,surname:"Lu",fullName:"Jinsen Lu",slug:"jinsen-lu",email:"Lujinsen@126.com",position:null,institution:null},{id:"246328",title:"Dr.",name:"Hao",middleName:null,surname:"Wang",fullName:"Hao Wang",slug:"hao-wang",email:"wanghaopiety@vip.qq.com",position:null,institution:null},{id:"246329",title:"Dr.",name:"Xujin",middleName:null,surname:"Wang",fullName:"Xujin Wang",slug:"xujin-wang",email:"Wangxujin@126.com",position:null,institution:null},{id:"399459",title:"Dr.",name:"Shiyuan",middleName:null,surname:"Fang",fullName:"Shiyuan Fang",slug:"shiyuan-fang",email:"dummy+399459@intechopen.com",position:null,institution:null}]}},chapter:{id:"61187",slug:"clinical-applications-of-mesenchymal-stromal-cells-mscs-in-orthopedic-diseases",signatures:"Jiazhao Yang, Shiyuan Fang, Lei Xu, Li Li, Kai Xie, Jinsen Lu, Hao\nWang, Xujin Wang and Lixin Kan",dateSubmitted:"December 5th 2017",dateReviewed:"March 29th 2018",datePrePublished:"November 5th 2018",datePublished:"January 23rd 2019",book:{id:"6658",title:"Stromal Cells",subtitle:"Structure, Function, and Therapeutic Implications",fullTitle:"Stromal Cells - Structure, Function, and Therapeutic Implications",slug:"stromal-cells-structure-function-and-therapeutic-implications",publishedDate:"January 23rd 2019",bookSignature:"Mani T. Valarmathi",coverURL:"https://cdn.intechopen.com/books/images_new/6658.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"69697",title:"Dr.",name:"Mani T.",middleName:null,surname:"Valarmathi",slug:"mani-t.-valarmathi",fullName:"Mani T. Valarmathi"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"238560",title:"Dr.",name:"Lixin",middleName:null,surname:"Kan",fullName:"Lixin Kan",slug:"lixin-kan",email:"l-kan@northwestern.edu",position:null,institution:null},{id:"245732",title:"Dr.",name:"Yang",middleName:null,surname:"Jiazhao",fullName:"Yang Jiazhao",slug:"yang-jiazhao",email:"yangjiazhao@126.com",position:null,institution:null},{id:"246322",title:"Dr.",name:"Shiyuan",middleName:null,surname:"Shiyuan",fullName:"Shiyuan Shiyuan",slug:"shiyuan-shiyuan",email:"fangshiyuan2008@126.com",position:null,institution:null},{id:"246323",title:"Dr.",name:"Lei",middleName:null,surname:"Xu",fullName:"Lei Xu",slug:"lei-xu",email:"bayinhexl@126.com",position:null,institution:null},{id:"246325",title:"Dr.",name:"Li",middleName:null,surname:"Li",fullName:"Li Li",slug:"li-li",email:"lili@126.com",position:null,institution:null},{id:"246326",title:"Dr.",name:"Kai",middleName:null,surname:"Xie",fullName:"Kai Xie",slug:"kai-xie",email:"xiekai@126.com",position:null,institution:null},{id:"246327",title:"Dr.",name:"Jinsen",middleName:null,surname:"Lu",fullName:"Jinsen Lu",slug:"jinsen-lu",email:"Lujinsen@126.com",position:null,institution:null},{id:"246328",title:"Dr.",name:"Hao",middleName:null,surname:"Wang",fullName:"Hao Wang",slug:"hao-wang",email:"wanghaopiety@vip.qq.com",position:null,institution:null},{id:"246329",title:"Dr.",name:"Xujin",middleName:null,surname:"Wang",fullName:"Xujin Wang",slug:"xujin-wang",email:"Wangxujin@126.com",position:null,institution:null},{id:"399459",title:"Dr.",name:"Shiyuan",middleName:null,surname:"Fang",fullName:"Shiyuan Fang",slug:"shiyuan-fang",email:"dummy+399459@intechopen.com",position:null,institution:null}]},book:{id:"6658",title:"Stromal Cells",subtitle:"Structure, Function, and Therapeutic Implications",fullTitle:"Stromal Cells - Structure, Function, and Therapeutic Implications",slug:"stromal-cells-structure-function-and-therapeutic-implications",publishedDate:"January 23rd 2019",bookSignature:"Mani T. Valarmathi",coverURL:"https://cdn.intechopen.com/books/images_new/6658.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"69697",title:"Dr.",name:"Mani T.",middleName:null,surname:"Valarmathi",slug:"mani-t.-valarmathi",fullName:"Mani T. Valarmathi"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"11581",leadTitle:null,title:"A New Era of Consumer Behavior - Beyond the Pandemic",subtitle:null,reviewType:"peer-reviewed",abstract:"
\r\n\tCOVID-19 pandemic has caused shifts in consumer life and consumer behavior all around the world. Consumers face many situations that they have to overcome during the pandemic crises, affecting not only consumers’ current and future lives, but also companies’ business strategies and future survivals as well. Traditional consumer behavior has started to become a threat for the consumers, so their buying behavior has moved to Internet-centered online platforms with the use of technological advancements. This book aims to focus on consumer behavior during pandemic crises situations with the use of e-commerce. The technological advances and consumer expectations during the pandemic and post-pandemic periods lead to some shifts in consumer behavior and business operations as well.
\r\n
\r\n\tThe book also hopes to cover crises management and handling of communication with situational factors which cause sharp transformations on both sides economically, socially, technologically, psychologically, and so on. Theoretical and practical chapters contributing to the mentioned context are highly appreciated and welcomed.
",isbn:"978-1-80356-183-7",printIsbn:"978-1-80356-182-0",pdfIsbn:"978-1-80356-184-4",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,isSalesforceBook:!1,hash:"0f4b358c85333ef0ec1148654c1ff90d",bookSignature:"Dr. Umut Ayman",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11581.jpg",keywords:"Consumer Behavior, Crises Situation, Pandemic, E-commerce, Post-pandemic, COVID-19, Buying Behavior, Digital Marketing, Consumer Engagement, Crises Management, Business Strategy, Behavior Model",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"February 3rd 2022",dateEndSecondStepPublish:"March 3rd 2022",dateEndThirdStepPublish:"May 2nd 2022",dateEndFourthStepPublish:"July 21st 2022",dateEndFifthStepPublish:"September 19th 2022",remainingDaysToSecondStep:"2 months",secondStepPassed:!0,currentStepOfPublishingProcess:4,editedByType:null,kuFlag:!1,biosketch:"Umut Ayman is an academician also working on campaign designs and launches for products/services for various sectors, and is involved in A to Z integrated marketing communication models including luxury consumption, branding, and fashion marketing communication issues. She also provides consultancy services for social responsibility projects.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"210632",title:"Dr.",name:"Umut",middleName:null,surname:"Ayman",slug:"umut-ayman",fullName:"Umut Ayman",profilePictureURL:"https://mts.intechopen.com/storage/users/210632/images/system/210632.jpeg",biography:"Umut Ayman completed her Bachelor’s degree in Business and her MBA in 1999 at the Eastern Mediterranean University (EMU). She completed her Communication and Media studies PhD in 2015 focusing in her thesis on consumption patterns in branded apparel products and consumers’ decision-making styles from a marketing communication perspective. Within the EMU Community Involvement Center, she provides consultancy services for social responsibility projects. She also works on campaign designs and launches for products/services for various sectors, and is involved in A to Z integrated marketing communication models including luxury consumption, branding, and fashion marketing communication issues. She holds introduction lectures on marketing communication, integrated marketing communication, marketing oriented public relations, marketing communication for social responsibility, IMC research methods, fashion marketing communication, branding and brand management, IMC campaign, and senior project courses. She is working as an Assistant Professor and Vice-chair at EMU, Faculty of Communication, Public Relations and Advertisement Department.",institutionString:"Eastern Mediterranean University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Eastern Mediterranean University",institutionURL:null,country:{name:"Cyprus"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"7",title:"Business, Management and Economics",slug:"business-management-and-economics"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"429339",firstName:"Jelena",lastName:"Vrdoljak",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/429339/images/20012_n.jpg",email:"jelena.v@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"9044",title:"Promotion and Marketing Communications",subtitle:null,isOpenForSubmission:!1,hash:"89b0a14e5fbc99691e93e210da34ea27",slug:"promotion-and-marketing-communications",bookSignature:"Umut Ayman and Anıl Kemal Kaya",coverURL:"https://cdn.intechopen.com/books/images_new/9044.jpg",editedByType:"Edited by",editors:[{id:"210632",title:"Dr.",name:"Umut",surname:"Ayman",slug:"umut-ayman",fullName:"Umut Ayman"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"49323",title:"Comparative Study of the Amount of Re-released Hemoglobin from α-Thalassemia and Hereditary Spherocytosis Erythrocytes",doi:"10.5772/60947",slug:"comparative-study-of-the-amount-of-re-released-hemoglobin-from-thalassemia-and-hereditary-spherocyto",body:'
1. Introduction
Erythrocytes, also called red blood cells (RBCs), are the most common type of blood cell. In humans, mature erythrocytes are flexible and oval biconcave disks. They lack cell nucleus and most organelles, in order to accommodate maximum space for hemoglobin (Hb), which has the important oxygen-transporting function. This protein makes up about 96% of the erythrocytes\' dry content (by weight), and around 35% of the total content (including water) [1]. Hb is an assembly of two α-globin family chains (including α and ξ chains) and two β-globin family chains (including β, γ, δ, and ε chains). Each globin subunit has an embedded heme group and each heme group contains an iron atom that can bind one oxygen molecule through iron-induced dipole forces. These subunits are bound to each other by salt bridges, hydrogen bonds, and hydrophobic interactions. Three Hb variants exist in normal adult erythrocytes, that is HbA (α2β2, over 95%), HbF (α2γ2, <1%), and HbA2 (α2δ2, 1.5–3.5%) [2-3].
The erythrocyte membrane plays many roles that aid in regulating erythrocytes’ surface deformability, flexibility, adhesion to other cells, and immune recognition. These functions are highly dependent on the composition of the membrane, which includes 3 layers: the glycocalyx on the exterior, which is rich in carbohydrates; the lipid bilayer, which contains many transmembrane proteins, besides its lipidic main constituents; and the membrane skeleton, a structural network of proteins located on the inner surface of the lipid bilayer. The determinant of normal membrane cohesion is the system of "vertical" linkages between the phospholipid bilayer and membrane skeleton, formed by the interactions of the cytoplasmic domains of various membrane proteins with the spectrin-based skeletal network. Band 3 and Rh-associated glycoprotein (RhAG) provide such links by interacting with ankyrin, which in turn binds to β-spectrin. Protein 4.2 binds to both band 3 and ankyrin and can regulate the avidity of the interaction between band 3 and ankyrin. Glycophorin C, band 3, XK, Rh, and Duffy all bind to protein 4.1R, the third member of the ternary junctional complex with β-spectrin and actin [4].
Thalassemia is an inherited autosomal recessive blood disorder characterized by abnormal formation of Hb, which results in improper oxygen transport and destruction of erythrocytes. Normally, the majority of adult Hb (HbA), is composed of two α- and two β-globin chains, which are arranged into a heterotetramer. The β-globin chain is encoded by a single gene on chromosome 11 [5], and α-globin chain is encoded by two closely linked genes on chromosome 16 [6]. A normal person has two loci encoding the β-chain, and four loci encoding the α-chain. Thalassemia patients have defects in either the α- or β-globin chain. According to which chain is affected, thalassemias are classified into α-thalassemias and β-thalassemia. α-thalassemias result in decreased α-globin production, which result in an excess of β-chains in adults and excess γ-chains in newborns. The excess β-globin chains form unstable tetramers (HbH, β4), which have abnormal oxygen dissociation curves. β-thalassemias are characterized as either βo or β-thalassemia major if formation of any β chains is prevented, the most severe form of β-thalassemia; as either β+ or β thalassemia intermedia if some β-globin chain formation are allowed; or as β-thalassemia minor if β-globin chain production is not terribly compromised [7-8]. In contrast to the β-thalassemias, which are usually caused by point mutations of the β-globin gene, the α-thalassemia syndromes are usually caused by the deletion of one or more α-globin genes and are subclassified according to the number of α-globin genes that are deleted (or mutated): one gene deleted (α+-thalassemia); two genes deleted on the same chromosome or in cis (α0-thalassemia); three genes deleted (HbH disease); or four genes deleted (hydrops fetalis with Hb Bart’s) [8].
Hereditary spherocytosis (HS) is an autosomal dominant erythrocyte membranopathy [9], but does not belong to hereditary hemoglobinopathies. This disorder is caused by mutations in genes relating to membrane proteins. These proteins include spectrin (α and β), ankyrin [10], band 3, protein 4.2 [11], and other erythrocyte membrane proteins that allow for the erythrocytes to change their shapes. The abnormal erythrocytes are sphere-shaped (spherocytosis) rather than being the normal biconcave disk shaped. This difference in shape not only interferes with the ability to be flexible to travel from the arteries to the smaller capillaries, but also makes the erythrocytes more prone to rupture.
Hemoglobin release test (HRT), also called electrophoresis release test (ERT), which is performed by electrophoresing live erythrocytes directly on a starch–agarose mixed gel with intermittent electric current, was established by our lab in 2007 [3,12]. Starch–agarose mixed gel electrophoresis is a routine method used to separate and analyze Hb in our lab since 1980. Hb within the erythrocytes can only be released once during routine starch–agarose mixed gel electrophoresis, which is performed with continuous power supply, and this phenomenon is named as “initial release” now. The difference in mobility of HbA2 between erythrocyte and hemolysate sample (also called HbA2 phenomenon) was found during an “initial release” experiment in 1981 [12]. In 2007, a sudden power outage was encountered during the electrophoresis of erythrocytes, however, the experiment was not abandoned and electrophoresis was continued after the power was restored. To our surprise, another new Hb band was found to be released from the origin, which was named “single-band re-release” as opposed to the “initial release”. When the power outages were simulated more than once, multiple Hb bands would appear between HbA and origin, and this phenomenon was named as multiple-band re-release or ladder-band re-release [13]. Based on these experiments, isotonic and hypotonic HRT and double-dimensional HRT were developed subsequently. Then the re-released Hb was observed in many patients’ erythrocytes, and its amount varied in different patients [14-15]. Some of the patients had increased Hb re-release, such as β-thalassemia, some general surgery patients, cirrhosis, and some gastro enteric tumor patients, but the specific screening experiment had not been done and the exact mechanism of this phenomenon had not been clear. The erythrocyte membrane or cytoskeleton binding Hb was speculated to have relationship with this phenomenon. To further study the mechanism of Hb re-release, the effects of blood type, blood viscosity, different membrane-destroying methods, exogenous hydrogen peroxide, and glutaraldehyde treatments on the amount of re-released Hb were observed subsequently, and the re-released Hb was speculated to have relationship with the abnormality of erythrocyte membrane and Hb. In this study, re-released Hb from two hereditary hemolytic diseases, HS (erythrocyte membrane disorder) and α-thalassemia (Hb disorder), was observed with a variety of HRT experiments.
2. The comparative study of the re-released hemoglobin from α-thalassemia and hereditary spherocytosis erythrocytes
This study had been approved by the local ethics committee, and one HS patient (coming from the first hospital of Baotou Medical College) and one α- thalassemia patient (coming from the third Worker\'s Hospital of Baogang Group) were included. The HS patient, diagnosed as spectrin defect, is a 45-year-old female with hemolytic anemia, jaundice, and splenomegaly. The α- thalassemia patient, diagnosed as Southeast Asian deletion (SEA) by PCR, is a 35-year-old female with hemolytic anemia and splenomegaly. Before collecting their blood, patients were asked to sign the consent information. Venous blood samples were anticoagulated with EDTA, and then routine blood examination, osmotic fragility test and HRT were performed respectively within 24 h. The spherical erythrocytes of HS patient are more than 20% in peripheral blood smear, and the osmotic fragility is increased (max: 0.39% vs 0.40%-0.45%, min: 0.75% vs 0.55%-0.6%). As to the α-thalassemia patient, a large number of target erythrocytes exist in peripheral blood smear and the osmotic fragility is decreased.
Whole blood was divided into two parts, one part was used to prepare blood samples, and the other part was used to prepare RBC samples. Blood samples were prepared by adding the same volume of CCl4 into the anticoagulated blood. After turbulent mixing and centrifuging (12000 rpm for 10 minutes), the upper layer was whole blood hemolysate, the middle layer between hemolysate and CCl4 was whole blood stroma. The other part of whole blood was firstly made into packed RBCs by washing the RBCs with saline for 4-5 times until the supernatant was colorless [3,12,13]. Then the same volume of CCl4 was added into the packed RBCs, and after mixing and centrifuging (3000 rpm for 10 minutes), the upper red solution was RBC hemolysate, and the middle layer between hemolysate and CCl4 was RBC stroma.
The starch–agarose mixed gel was prepared by dissolving 0.24 g of agarose and 1.72 g of starch in 90 mL of TEB buffer (42.1 mmol/L Tris, 1.71 mmol/L EDTA, 6.47 mmol/L boric acid, pH 8.6) [3,12,13]. The solution was heated until the agarose melts, and then the gel was laid on a 17×17 cm glass while hot. After solidification, about 8 µL of samples were applied on the cathodic side of the gel by using 3 MM filter paper. After adding blood samples on the starch–agarose mixed gel, electrophoresis was carried out in borate buffer (0.3 mol/L boracic acid, 0.06 mol/L NaOH, pH9.0) at 5 V/cm for 2 hours, then paused for 15 minutes and ran for 15 minutes by turns. It took about 6 hours for the entire electrophoresis. After electrophoresis, the red bands on the gel were firstly observed directly with eyes, and then the gel was sequentially stained with Ponceau Red (0.1% Ponceau S, 5% glacial acetic acid and 2% glycerol) and Benzidine (0.6 g of benzidine, 25 mL of glacial acetic acid, 10 mL of glycerol, add deionized water to 500 mL, then keep the solution in 75℃ water bath for 1 hour until the benzidine is dissolved completely. Sodium nitroprusside and 30% H2O2 should be added to this solution before use) for 4 hours, respectively. Finally, the gel was rinsed with rinsing solution (5% glacial acetic acid, 2% glycerin) until the background was clear.
Routine one-directional HRT was performed to compare the re-released Hb from normal, α-thalassemia, and HS patients’ blood samples, which were prepared from whole blood, whole blood hemolysate, whole blood stroma, RBCs, RBCs hemolysate, RBCs stroma and plasma respectively. Comparing with the normal control, the re-released Hb from HS and α-thalassemia erythrocytes had opposite changes (Figure 1). In normal control, there was nearly no HbA in the sample of whole blood stroma, but a small amount of HbA in the RBCs stroma; both whole blood and RBCs sample of normal control had re-released Hb; however re-released Hb did not appear in whole blood and RBCs hemolysate samples. As to HS, there was more HbA appearing in RBCs stroma sample, and no re-released Hb appeared in any of the blood samples. On the contrary, the HbA of α-thalassemia whole blood stroma increased significantly, but that of α-thalassemia RBCs stroma was hard to see; in addition, the re-released Hb from whole blood and RBCs sample of α-thalassemia were increased significantly and Hb ladder was formed obviously.
Figure 1.
One dimension HRT of spherocytosis and α-thalassemia blood samples. Samples 1–8 were whole blood hemolysate, whole blood stroma, whole blood, RBCs, RBCs hemolysate, RBCs stroma, plasma, whole blood hemolysate.
To observe the effect of hypotonic treatment on the re-released Hb, isotonic and hypotonic HRT was performed with normal adult, HS patient, and α-thalassemia patient at room temperature or 37℃ for 1 hour. During the experiment, the whole blood or packed RBCs were firstly diluted with H2O in the proportion from 10: 0 to 1: 9 (named as tube 1 to 10, respectively), and then kept at room temperature or 37℃ for 1 hour. Then one-direction HRT was performed as described above. The result of room temperature isotonic and hypotonic HRT showed that the whole blood sample (tube 1) of normal control had slight ladder of re-released Hb, when diluted with H2O (tube 2 to tube 5), the re-released Hb was decreased, but increased from tube 6 to tube 8, and then decreased again from tube 9 (Figure 2). Compared with the normal control, the re-released Hb ladder decreased obviously in the HS patient, but increased significantly in the α-thalassemia patient. (Figure 2).
Figure 2.
Whole blood isotonic and hypotonic HRT results of normal adult, spherocytosis, and α-thalassemia at room temperature. Whole blood was diluted with H2O in the proportion from 10: 0 to 1: 9, respectively (tube 1 to 10), and kept at room temperature for 1 hour.
The result (Figure 3) of 37℃ isotonic and hypotonic HRT was similar with that at room temperature except for the disappearance of re-released Hb ladder from tube 1 of the normal control.
Figure 3.
Whole blood isotonic and hypotonic HRT results of normal adult, spherocytosis, and α-thalassemias at 37℃. Whole blood was diluted with H2O in the proportion from 10: 0 to 1: 9, respectively (tube 1 to 10), and kept at 37℃ for 1 hour.
Double-direction HRT (or diagonal HRT) was performed to observe not only the re-released HbA but also the re-released HbA2. Firstly, one-direction HRT was performed as described above, then the direction of electric field was changed vertical to the original one, and another cycle of HRT was performed. The result showed that there was few re-released HbA in normal whole blood, but the re-released HbA2 was difficult to observe (Figure 4A). Compared with normal, the re-released HbA from HS whole blood was decreased, but that from α-thalassemia whole blood was increased significantly. The amount of HbA2 in α-thalassemia whole blood was less than the normal control obviously, and the re-released HbA2 could not be detected in our experiment (Figure 4B).
Figure 4.
Double-direction HRT of normal adult, spherocytosis, and α-thalassemias blood sample. A was the double-direction HRT of spherocytosis and α-thalassemia whole blood sample; B was the double-direction HRT of the normal whole blood and RBCs sample.
3. Discussion
Both HS and thalassemia belong to hereditary hemolytic disorders, which include hemoglobinopathies, erythrocyte membranopathy, and erythrocyte enzymopathy [16]. HS is the representative erythrocyte membranopathy [17], and thalassemia is the classic hemoglobinopathy [18-20]. In this study, Clinical tests showed that anemia, splenomegaly, and jaundice were the common clinical signs and symptoms of these two patients [16]. Some of the erythrocytes of the HS patient were spherical, but that of α-thalassemia were target-shaped. The osmotic fragility of erythrocytes increased in HS, but decreased in α-thalassemia. The morphology and osmotic fragility changes were caused by the defects of these two disorders. The abnormalities in HS erythrocyte membrane proteins, particularly ankyrin, α- and β-spectrin, band 3 and protein 4.2, result in the loss of membrane surface area relative to intracellular volume, which leads to spherically shaped erythrocytes with decreased deformability and increased fragility. Increased erythrocyte fragility leads to vesiculation and further membrane loss [21], so HS erythrocytes are unable to withstand the introduction of small amounts of free water that occurs when they are placed in increasingly hypotonic saline solutions. As a consequence, HS erythrocytes hemolyze more readily than normal erythrocytes at any saline concentration [17].
The thalassemic erythrocyte membranes exhibit morphological, biochemical, and mechanical abnormalities due to oxidative damage induced by binding of unmatched globin chains to the cytoplasmic surface of the membrane. So both α- and β- thalassemic erythrocytes become renitent and are less deformable than normal erythrocytes. The morphology and mechanical properties of the erythrocytes membrane are controlled by the cytoskeletal network underlying the lipid bilayer. Spectrin is the principal structural element of the erythrocyte cytoskeleton, regulating membrane cytoskeletal functions [22].
The re-released Hb was compared between these two kinds of hereditary hemolytic disorders by HRT. The results showed that comparing with the normal control, the re-released Hb from HS whole blood or erythrocytes was decreased, but increased distinctively from that of α-thalassemic erythrocytes during routine, two-directional, and isotonic and hypotonic HRT. The re-released Hb is speculated to have relationship with membrane-binding Hb, and the abnormal membrane-binding Hb will lead to abnormal Hb re-release. As known, most of the Hb exists in cytoplasm; only small amount of Hb binds with the membrane through interaction with the cytoskeletal proteins or membrane lipids. The abnormality of both membrane and Hb will change the amount of membrane-binding Hb, and will further lead to the variation of re-released Hb during HRT. HRT was established by our lab in 2007, and in the previous studies, the re-released Hb usually increased from some patients’ erythrocytes during HRT, such as β-thalassemia patients, some general surgery patients, cirrhosis, and some gastroenteric tumor patients. In our study, the re-released Hb from α-thalassemic erythrocytes was increased significantly like before [12], but the re-released Hb from HS erythrocytes was decreased a lot. The abnormal membrane-binding Hb was speculated to be the reason.
It is well known that in vivo and under normal physiological conditions, intraerythrocytic hemoglobin may exist in three different forms represented by oxygenated, deoxygenated and partially oxidized Hb. Apart from the first two derivatives whose relative proportions are continuously changing during the oxygenation deoxygenation cycle, met-hemoglobin (MetHb) is normally present at a steady-state level of about 1% [23]. MetHb usually binds with membrane, and the re-released Hb from normal erythrocytes is speculated to be the membrane-binding MetHb. Oxidative damage can lead to the oxidative membrane damage and increased proportion of MetHb. The oxidization of band 3 leads to dissociation of ankyrin from band 3, and then tetrameric MetHb cross-link with the cytoplasmic domain of oxidized band 3 dimer [24]. In addition to MetHb, the abnormal Hb in all kinds of hemoglobinopathies is speculated to be the other main source of re-released Hb. α-thalassemia has the defect in α-globin syntheses, the relative excess of β-globin increases and the abnormal HbH (β4) forms, which can bind with the membrane and lead to the increased Hb re-release.
Hb usually has interaction with spectrin, and the spectrin defect in HS patient interfere the binding of Hb with membrane, so the membrane-binding Hb and re-released Hb decreased obviously. There are five main kinds of erythrocyte skeleton proteins; defect of different cytoskeletal protein might leads to different results.
In conclusion, the change of re-released Hb is only an experimental phenomenon of HRT, and the mechanism of HRT has not been clear very much. In the future, more and more studies are needed to clarify these.
Acknowledgments
This work was supported by grants from Natural Science Foundation of China (81160214), Major Projects of Higher Education Scientific Research in the Inner Mongolia Autonomous Region (NJ09157), Key Science and Technology Research Project of the Ministry of Education, Natural Science Foundation of Inner Mongolia (2010BS1101). We also especially acknowledge all of the people who donated their blood samples for our research.
\n',keywords:"hereditary spherocytosis, α-thalassemia, hemoglobin release test, erythrocyte, hemoglobin",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/49323.pdf",chapterXML:"https://mts.intechopen.com/source/xml/49323.xml",downloadPdfUrl:"/chapter/pdf-download/49323",previewPdfUrl:"/chapter/pdf-preview/49323",totalDownloads:1541,totalViews:152,totalCrossrefCites:1,totalDimensionsCites:1,totalAltmetricsMentions:0,impactScore:1,impactScorePercentile:59,impactScoreQuartile:3,hasAltmetrics:0,dateSubmitted:"November 17th 2014",dateReviewed:"June 1st 2015",datePrePublished:null,datePublished:"November 11th 2015",dateFinished:"October 10th 2015",readingETA:"0",abstract:"Hemoglobin release test (HRT), which is established by our lab, is a new experiment to observe the re-released hemoglobin (Hb) from erythrocytes. In this study, one-dimension HRT, double dimension HRT, and isotonic and hypotonic HRT were performed to observe the re-released Hb from the blood samples of normal adult, hereditary spherocytosis (HS), and α-thalassemia. The results showed that compared with normal adult, the re-released Hb from HS blood sample was decreased significantly; however, the re-released Hb from α-thalassemia blood sample was increased significantly. The mechanism of this phenomenon was speculated to have relation with the abnormal amount of membrane-binding Hb.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/49323",risUrl:"/chapter/ris/49323",book:{id:"4729",slug:"inherited-hemoglobin-disorders"},signatures:"Yan Su, Hongjie Ma, Hongwang Zhang, Lijun Gao, Guorong Jia,\nWenbin Qin and Qitu He",authors:[{id:"174727",title:"Prof.",name:"Yan",middleName:null,surname:"Su",fullName:"Yan Su",slug:"yan-su",email:"synmg@126.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Baotou Medical College",institutionURL:null,country:{name:"China"}}},{id:"177712",title:"Dr.",name:"Wenbin",middleName:null,surname:"Qin",fullName:"Wenbin Qin",slug:"wenbin-qin",email:"qinwenbinbt@sohu.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Baotou Medical College",institutionURL:null,country:{name:"China"}}},{id:"177713",title:"Dr.",name:"Qitu",middleName:null,surname:"He",fullName:"Qitu He",slug:"qitu-he",email:"Heqitu@163.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. The comparative study of the re-released hemoglobin from α-thalassemia and hereditary spherocytosis erythrocytes",level:"1"},{id:"sec_3",title:"3. Discussion",level:"1"},{id:"sec_4",title:"Acknowledgments",level:"1"}],chapterReferences:[{id:"B1",body:'Weed RI, Reed CF, Berg G. Is hemoglobin an essential structural component of human erythrocyte membranes? The Journal of Clinical Investigation. 1963;42:581-588.'},{id:"B2",body:'Ribeil JA, Arlet JB, Dussiot M, Moura IC, Courtois G, Hermine O. Ineffective erythropoiesis in β -thalassemia. Scientific World Journal. 2013;2013:394295. DOI: 10.1155/2013/394295.'},{id:"B3",body:'Su Y, Gao L, Ma Q, Zhou L, Qin L, Han L, Qin W. Interactions of hemoglobin in live red blood cells measured by the electrophoresis release test. Electrophoresis. 2010;31(17):2913-2920. DOI : 10.1002/elps.201000034.'},{id:"B4",body:'Barcellini W, Bianchi P, Fermo E, Imperiali FG, Marcello AP, Vercellati C, Zaninoni A, Zanella A. Hereditary red cell membrane defects: diagnostic and clinical aspects. Blood Transfusion. 2011;9(3):274-277.'},{id:"B5",body:'Schwartz E, Cohen A, Surrey S. Overview of the beta thalassemias: genetic and clinical aspects. Hemoglobin. 1988;12(5-6):551-564.'},{id:"B6",body:'Bernini LF, Harteveld CL. Alpha-thalassaemia. Bailliere’s Clinical Haematology. 1998;11(1):53-90.'},{id:"B7",body:'Clarke GM, Higgins TN. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clinical Chemistry. 2000;46(8 Pt 2):1284-1290.'},{id:"B8",body:'Forget BG, Bunn HF. Classification of the Disorders of Hemoglobin. Cold Spring Harb Perspect Med. 2013;3:a011684. DOI: 10.1101/cshperspect.a011684.'},{id:"B9",body:'Guitton C, Garçon L, Cynober T, Gauthier F, Tchernia G, Delaunay J, Leblanc T, Thuret I, Bader-Meunier B. Hereditary spherocytosis: guidelines for the diagnosis and management in children. Archives de Pediatrie. 2008;15(9):1464-1473. DOI: 10.1016/j.'},{id:"B10",body:'Gallagher PG, Forget BG. Hematologically important mutations: spectrin and ankyrin variants in hereditary spherocytosis. Blood Cells, Molecules and Diseases. 1998;24(4):539-543.'},{id:"B11",body:'Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008;372(9647):1411-1426. DOI:10.1016/S0140-6736(08)61588-3.'},{id:"B12",body:'Su Y, Shao G, Gao L, Zhou L, Qin L, Qin W. RBC electrophoresis with discontinuous power supply - a newly established hemoglobin release test. Electrophoresis. 2009;30(17):3041-3043. DOI: 10.1002/elps.200900176.'},{id:"B13",body:'Su Y, Shen J, Gao L, Tian Z, Tian H, Qin L, Qin W. Molecular Interactions of Re-released proteins in Electrophoresis of Human Erythrocytes. Electrophoresis. 2012;33 (9-10): 1402-1405. DOI: 10.1002/elps.201100644.'},{id:"B14",body:'Qin W. Electrophoresis release of hemoglobin from living red blood cells. Scientia Sinica(Vitae). 2014;41(8):597-607.'},{id:"B15",body:'Li JX, Su Y. Clinical research progress of red cell hemoglobin release test. Progress in Veterinary Medicine. 2014;35(10):104-107.'},{id:"B16",body:'Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. American Academy of Family Physicians. 2004;69(11):2599-2606.'},{id:"B17",body:'Gallagher PG. Abnormalities of the erythrocyte membrane. Pediatric Clinic of North America. 2013;60(6):1349-1362. DOI: 10.1016/j.pcl.2013.09.001.'},{id:"B18",body:'De Franceschi L, Bertoldi M, Matte A, Santos Franco S, Pantaleo A, Ferru E, Turrini F. Oxidative stress and β-thalassemic erythroid cells behind the molecular defect. Oxidative Medicine and Cellular Longevity. 2013;2013:985210. DOI: 10.1155/2013/985210.'},{id:"B19",body:'Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization. 2008;86(6):480-487.'},{id:"B20",body:'Weatherall DJ. The global problem of genetic disease. Annals of Human Biology. 2005;32(2):117-122.'},{id:"B21",body:'Alaarg A, Schiffelers RM, van Solinge WW, van Wijk R. Red blood cell vesiculation in hereditary hemolytic anemia. Frontiers of Physiology. 2013;4(365):1-82. DOI: 10.3389/fphys.'},{id:"B22",body:'Rutaiwan T, Pornpimol M, Prapon W. Status of red cell membrane protein phosphorylation in thalassemia. ScienceAsia-Journal of the Science Society of Thailand. 2002;28: 313-317.'},{id:"B23",body:'Giardina B, Scatena R, Clementi ME, Ramacci MT, Maccari F, Cerroni L, Condò SG. Selective binding of met-hemoglobin to erythrocytic membrane: a possible involvement in red blood cell aging. Advances in Experimental Medicine and Biology. 1991;307:75-84.'},{id:"B24",body:'Arashiki N, Kimata N, Manno S, Mohandas N, Takakuwa Y. Membrane peroxidation and methemoglobin formation are both necessary for band 3 clustering: mechanistic insights into human erythrocyte senescence. Biochemistry. 2013;52(34):5760-5769. DOI: 10.1021/bi400405p.'}],footnotes:[],contributors:[{corresp:null,contributorFullName:"Yan Su",address:null,affiliation:'
Laboratory of Hemoglobin, Baotou Medical College, Baotou, China
Department of Hematology, the First Affiliated Hospital of Baotou Medical College, Baotou, China
'}],corrections:null},book:{id:"4729",type:"book",title:"Inherited Hemoglobin Disorders",subtitle:null,fullTitle:"Inherited Hemoglobin Disorders",slug:"inherited-hemoglobin-disorders",publishedDate:"November 11th 2015",bookSignature:"Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/4729.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:null,printIsbn:"978-953-51-2198-5",pdfIsbn:"978-953-51-7261-1",reviewType:"peer-reviewed",numberOfWosCitations:7,isAvailableForWebshopOrdering:!0,editors:[{id:"97021",title:"Dr.",name:"Anjana",middleName:null,surname:"Munshi",slug:"anjana-munshi",fullName:"Anjana Munshi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1029"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"49236",type:"chapter",title:"Hemoglobinopathy Approach Diagnosis and Treatment Policy",slug:"hemoglobinopathy-approach-diagnosis-and-treatment-policy",totalDownloads:2367,totalCrossrefCites:0,signatures:"Mehrdad Payandeh and Masoud Sadeghi",reviewType:"peer-reviewed",authors:[{id:"75876",title:"Prof.",name:"Mehrdad",middleName:null,surname:"Payandeh",fullName:"Mehrdad Payandeh",slug:"mehrdad-payandeh"}]},{id:"49387",type:"chapter",title:"Thalassemia — From Genotype to Phenotype",slug:"thalassemia-from-genotype-to-phenotype",totalDownloads:4802,totalCrossrefCites:2,signatures:"Ghada Y. El-Kamah and Khalda S. Amr",reviewType:"peer-reviewed",authors:[{id:"58735",title:"Prof.",name:"Ghada",middleName:null,surname:"El-Kamah",fullName:"Ghada El-Kamah",slug:"ghada-el-kamah"},{id:"176872",title:"Prof.",name:"Khalda",middleName:null,surname:"Amr",fullName:"Khalda Amr",slug:"khalda-amr"}]},{id:"49189",type:"chapter",title:"Sickle Cell Disease (SCD)",slug:"sickle-cell-disease-scd-",totalDownloads:2130,totalCrossrefCites:1,signatures:"Ahmed K. Mansour, Sohier Yahia, Rasha El-Ashry, Angi Alwakeel,\nAhmad Darwish and Khalil Alrjjal",reviewType:"peer-reviewed",authors:[{id:"174667",title:"Prof.",name:"Ahmed",middleName:null,surname:"Mansour",fullName:"Ahmed Mansour",slug:"ahmed-mansour"},{id:"175627",title:"Dr.",name:"Ahmad",middleName:null,surname:"Darwish",fullName:"Ahmad Darwish",slug:"ahmad-darwish"},{id:"175628",title:"Prof.",name:"Sohier",middleName:null,surname:"Yahia",fullName:"Sohier Yahia",slug:"sohier-yahia"},{id:"175629",title:"Dr.",name:"Rasha",middleName:null,surname:"El-Ashry",fullName:"Rasha El-Ashry",slug:"rasha-el-ashry"},{id:"175635",title:"Dr.",name:"Angi",middleName:null,surname:"Adel",fullName:"Angi Adel",slug:"angi-adel"}]},{id:"49412",type:"chapter",title:"Interaction between Erythropoiesis and Iron Metabolism in Human β-thalassemia - Recent Advances and New Therapeutic Approaches",slug:"interaction-between-erythropoiesis-and-iron-metabolism-in-human-thalassemia-recent-advances-and-new-",totalDownloads:1973,totalCrossrefCites:2,signatures:"Nadia Maria Sposi",reviewType:"peer-reviewed",authors:[{id:"94598",title:"Dr.",name:"Nadia Maria",middleName:null,surname:"Sposi",fullName:"Nadia Maria Sposi",slug:"nadia-maria-sposi"}]},{id:"48606",type:"chapter",title:"Acute Splenic Sequestration Crisis",slug:"acute-splenic-sequestration-crisis",totalDownloads:2176,totalCrossrefCites:0,signatures:"Jorge Peña Siado and Julian Londono Hernández",reviewType:"peer-reviewed",authors:[{id:"174239",title:"Dr.",name:"Jorge",middleName:null,surname:"Pena Siado",fullName:"Jorge Pena Siado",slug:"jorge-pena-siado"},{id:"175695",title:"Dr.",name:"Julian",middleName:"Esteban",surname:"Londono",fullName:"Julian Londono",slug:"julian-londono"}]},{id:"49323",type:"chapter",title:"Comparative Study of the Amount of Re-released Hemoglobin from α-Thalassemia and Hereditary Spherocytosis Erythrocytes",slug:"comparative-study-of-the-amount-of-re-released-hemoglobin-from-thalassemia-and-hereditary-spherocyto",totalDownloads:1541,totalCrossrefCites:1,signatures:"Yan Su, Hongjie Ma, Hongwang Zhang, Lijun Gao, Guorong Jia,\nWenbin Qin and Qitu He",reviewType:"peer-reviewed",authors:[{id:"174727",title:"Prof.",name:"Yan",middleName:null,surname:"Su",fullName:"Yan Su",slug:"yan-su"},{id:"177712",title:"Dr.",name:"Wenbin",middleName:null,surname:"Qin",fullName:"Wenbin Qin",slug:"wenbin-qin"},{id:"177713",title:"Dr.",name:"Qitu",middleName:null,surname:"He",fullName:"Qitu He",slug:"qitu-he"}]},{id:"49431",type:"chapter",title:"Modifiers of γ-Globin Gene Expression and Treatment of β-Thalassemia",slug:"modifiers-of-globin-gene-expression-and-treatment-of-thalassemia",totalDownloads:2143,totalCrossrefCites:1,signatures:"Anjana Munshi, Sneha Dadeech, M. Sai Babu and Preeti Khetarpal",reviewType:"peer-reviewed",authors:[{id:"97021",title:"Dr.",name:"Anjana",middleName:null,surname:"Munshi",fullName:"Anjana Munshi",slug:"anjana-munshi"}]},{id:"48913",type:"chapter",title:"Novel Therapy Approaches in β-Thalassemia Syndromes — A Role of Genetic Modifiers",slug:"novel-therapy-approaches-in-thalassemia-syndromes-a-role-of-genetic-modifiers",totalDownloads:1688,totalCrossrefCites:0,signatures:"Sonja Pavlovic, Milena Ugrin and Maja Stojiljkovic",reviewType:"peer-reviewed",authors:[{id:"67195",title:"Dr.",name:"Sonja",middleName:null,surname:"Pavlovic",fullName:"Sonja Pavlovic",slug:"sonja-pavlovic"},{id:"174865",title:"Dr.",name:"Milena",middleName:null,surname:"Ugrin",fullName:"Milena Ugrin",slug:"milena-ugrin"},{id:"174866",title:"Dr.",name:"Maja",middleName:null,surname:"Stojiljkovic",fullName:"Maja Stojiljkovic",slug:"maja-stojiljkovic"}]},{id:"48344",type:"chapter",title:"Sickle Cell Disease – Current Treatment and New Therapeutical Approaches",slug:"sickle-cell-disease-current-treatment-and-new-therapeutical-approaches",totalDownloads:2303,totalCrossrefCites:1,signatures:"Thais Regina Ferreira de Melo, Lucas dos Reis Ercolin, Rafael\nConsolin Chelucci, Aylime Castanho Bolognesi Melchior, Carolina\nLanaro, Chung Man Chin and Jean Leandro dos Santos",reviewType:"peer-reviewed",authors:[{id:"94335",title:"Prof.",name:"Jean",middleName:"Leandro Dos",surname:"Santos",fullName:"Jean Santos",slug:"jean-santos"},{id:"95758",title:"Prof.",name:"Man Chin",middleName:null,surname:"Chung",fullName:"Man Chin Chung",slug:"man-chin-chung"},{id:"126447",title:"BSc.",name:"Thais Regina Ferreira",middleName:null,surname:"Melo",fullName:"Thais Regina Ferreira Melo",slug:"thais-regina-ferreira-melo"},{id:"175545",title:"MSc.",name:"Lucas",middleName:null,surname:"Ercolin",fullName:"Lucas Ercolin",slug:"lucas-ercolin"},{id:"175546",title:"Dr.",name:"Rafael",middleName:null,surname:"Chelucci",fullName:"Rafael Chelucci",slug:"rafael-chelucci"},{id:"175547",title:"MSc.",name:"Aylime",middleName:null,surname:"Melchior",fullName:"Aylime Melchior",slug:"aylime-melchior"},{id:"175548",title:"Dr.",name:"Carolina",middleName:null,surname:"Lanaro",fullName:"Carolina Lanaro",slug:"carolina-lanaro"}]}]},relatedBooks:[{type:"book",id:"1722",title:"DNA Sequencing",subtitle:"Methods and Applications",isOpenForSubmission:!1,hash:"388e3ad9966db34d099c45bd8212c45c",slug:"dna-sequencing-methods-and-applications",bookSignature:"Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/1722.jpg",editedByType:"Edited by",editors:[{id:"97021",title:"Dr.",name:"Anjana",surname:"Munshi",slug:"anjana-munshi",fullName:"Anjana Munshi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"35675",title:"DNA Representation",slug:"dna-repersentation",signatures:"Bharti Rajendra Kumar",authors:[{id:"110603",title:"Mr.",name:"Rajendra",middleName:"Kumar",surname:"Bharti",fullName:"Rajendra Bharti",slug:"rajendra-bharti"}]},{id:"35676",title:"Hot Start 7-Deaza-dGTP Improves Sanger Dideoxy Sequencing Data of GC-Rich Targets",slug:"hot-start-7-deaza-dgtp-improves-sanger-dideoxy-sequencing-data-of-gc-rich-targets",signatures:"Sabrina Shore, Elena Hidalgo Ashrafi and Natasha Paul",authors:[{id:"114797",title:"Dr.",name:"Natasha",middleName:null,surname:"Paul",fullName:"Natasha Paul",slug:"natasha-paul"},{id:"117746",title:"MSc.",name:"Sabrina",middleName:null,surname:"Shore",fullName:"Sabrina Shore",slug:"sabrina-shore"},{id:"117747",title:"MSc.",name:"Elena",middleName:null,surname:"Hidalgo Ashrafi",fullName:"Elena Hidalgo Ashrafi",slug:"elena-hidalgo-ashrafi"}]},{id:"35677",title:"Sequencing Technologies and Their Use in Plant Biotechnology and Breeding",slug:"sequencing-technologies-and-their-use-in-plant-biotechnology-and-breeding",signatures:"Victor Llaca",authors:[{id:"114777",title:"Dr.",name:"Victor",middleName:null,surname:"Llaca",fullName:"Victor Llaca",slug:"victor-llaca"}]},{id:"35678",title:"DNA Sequencing and Crop Protection",slug:"dna-sequencing-and-crop-protection",signatures:"Rosemarie Tedeschi",authors:[{id:"117388",title:"Dr.",name:"Rosemarie",middleName:null,surname:"Tedeschi",fullName:"Rosemarie Tedeschi",slug:"rosemarie-tedeschi"}]},{id:"35679",title:"Improvement of Farm Animal Breeding by DNA Sequencing",slug:"improvement-of-farm-animal-breeding-by-dna-sequencing",signatures:"G. Darshan Raj",authors:[{id:"108968",title:"Dr.",name:"Darshanraj",middleName:null,surname:"Gangaraj",fullName:"Darshanraj Gangaraj",slug:"darshanraj-gangaraj"}]},{id:"35680",title:"The Input of DNA Sequences to Animal Systematics: Rodents as Study Cases",slug:"the-input-of-dna-sequences-to-animal-systematics-rodents-as-study-cases",signatures:"Laurent Granjon and Claudine Montgelard",authors:[{id:"115007",title:"Dr.",name:"Laurent",middleName:null,surname:"Granjon",fullName:"Laurent Granjon",slug:"laurent-granjon"},{id:"116623",title:"Dr.",name:"Claudine",middleName:null,surname:"Montgelard",fullName:"Claudine Montgelard",slug:"claudine-montgelard"}]},{id:"35681",title:"The Application of Pooled DNA Sequencing in Disease Association Study",slug:"pooled-dna-sequencing-in-disease-association-study",signatures:"Chang-Yun Lin and Tao Wang",authors:[{id:"110620",title:"Dr.",name:"Tao",middleName:null,surname:"Wang",fullName:"Tao Wang",slug:"tao-wang"},{id:"112669",title:"Dr.",name:"Chang-Yun",middleName:null,surname:"Lin",fullName:"Chang-Yun Lin",slug:"chang-yun-lin"}]},{id:"35682",title:"Nucleic Acid Aptamers as Molecular Tags for Omics Analyses Involving Sequencing",slug:"nucleic-acid-aptamers-as-molecular-tags-for-omics-analyses-involving-sequencing",signatures:"Masayasu Kuwahara and Naoki Sugimoto",authors:[{id:"101077",title:"Prof.",name:"Masayasu",middleName:null,surname:"Kuwahara",fullName:"Masayasu Kuwahara",slug:"masayasu-kuwahara"},{id:"105610",title:"Prof.",name:"Naoki",middleName:null,surname:"Sugimoto",fullName:"Naoki Sugimoto",slug:"naoki-sugimoto"}]}]}],publishedBooks:[{type:"book",id:"1407",title:"Blood Transfusion in Clinical Practice",subtitle:null,isOpenForSubmission:!1,hash:"205a0a02a90deabcd1fcc38b08809e5f",slug:"blood-transfusion-in-clinical-practice",bookSignature:"Puneet Kaur Kochhar",coverURL:"https://cdn.intechopen.com/books/images_new/1407.jpg",editedByType:"Edited by",editors:[{id:"90515",title:"Dr.",name:"Puneet",surname:"Kochhar",slug:"puneet-kochhar",fullName:"Puneet Kochhar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2607",title:"Blood Cell",subtitle:"An Overview of Studies in Hematology",isOpenForSubmission:!1,hash:"7c47fe55b6adb4aaadb74f8e977e46e5",slug:"blood-cell-an-overview-of-studies-in-hematology",bookSignature:"Terry E. Moschandreou",coverURL:"https://cdn.intechopen.com/books/images_new/2607.jpg",editedByType:"Edited by",editors:[{id:"146196",title:"Dr.",name:"Terry E.",surname:"Moschandreou",slug:"terry-e.-moschandreou",fullName:"Terry E. Moschandreou"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3040",title:"Transfusion Medicine Made Easy For Students of Biomedical Science, Allied Medical Sciences and Medicine",subtitle:null,isOpenForSubmission:!1,hash:"c0bebb1b09be83d922e4e6fc7c1086fe",slug:"transfusion-medicine-made-easy-for-students-of-biomedical-science-allied-medical-sciences-and-medicine",bookSignature:"Osaro Erhabor and Teddy Charles Adias",coverURL:"https://cdn.intechopen.com/books/images_new/3040.jpg",editedByType:"Authored by",editors:[{id:"35140",title:"Dr.",name:"Osaro",surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"3",chapterContentType:"chapter",authoredCaption:"Authored by"}},{type:"book",id:"3836",title:"Fibrinolysis and Thrombolysis",subtitle:null,isOpenForSubmission:!1,hash:"85a8a3555ffe9c09b7131f5aea5e21ea",slug:"fibrinolysis-and-thrombolysis",bookSignature:"Krasimir Kolev",coverURL:"https://cdn.intechopen.com/books/images_new/3836.jpg",editedByType:"Edited by",editors:[{id:"19421",title:"Dr.",name:"Krasimir1",surname:"Kolev",slug:"krasimir1-kolev",fullName:"Krasimir1 Kolev"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4729",title:"Inherited Hemoglobin Disorders",subtitle:null,isOpenForSubmission:!1,hash:"5e792fe0fcde9d7015af6be2d60bfec6",slug:"inherited-hemoglobin-disorders",bookSignature:"Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/4729.jpg",editedByType:"Edited by",editors:[{id:"97021",title:"Dr.",name:"Anjana",surname:"Munshi",slug:"anjana-munshi",fullName:"Anjana Munshi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[{type:"book",id:"4729",title:"Inherited Hemoglobin Disorders",subtitle:null,isOpenForSubmission:!1,hash:"5e792fe0fcde9d7015af6be2d60bfec6",slug:"inherited-hemoglobin-disorders",bookSignature:"Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/4729.jpg",editedByType:"Edited by",editors:[{id:"97021",title:"Dr.",name:"Anjana",surname:"Munshi",slug:"anjana-munshi",fullName:"Anjana Munshi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},onlineFirst:{chapter:{type:"chapter",id:"76741",title:"Challenges in Drug Discovery against Tuberculosis",doi:"10.5772/intechopen.97857",slug:"challenges-in-drug-discovery-against-tuberculosis",body:'
1. Introduction
Tuberculosis (TB), one of the most common deadly disease is caused by a bacterium called Mycobacterium tuberculosis. Robert Koch in 1882, isolated the mammalian strain and proved that the Mycobacterium tuberculosis plays a causative role in Tuberculosis. As per the latest WHO report approximately one-fourth of the world’s population are infected with Mycobacterium tuberculosis (Mtb), whereas 5–10% of the total will develop TB disease during their lifetime [1, 2]. The WHO estimated that in 2018, about 10 million people were affected due to TB worldwide and 1.5 million people suffering from the ailment, including 2,51,000 people who additionally had HIV [3, 4]. In the past, TB was a major reason for death around the globe [5, 6]. In industrialized nations, TB is getting slow due to vast development and improvements in drugs and new antibiotics [5, 7].
TB may exist in two forms, active (dynamic) TB and Latent TB. Dynamic tuberculosis is a condition where MTB causes contamination; regularly, in the lungs, albeit numerous frameworks can be included. Dynamic TB is a multiorgan illness brought about by essential disease or as reactivation of inert tuberculosis. As need be, dynamic tuberculosis could be essential tuberculosis or reactivation tuberculosis.
Latent TB happens when an individual has the TB microscopic organisms inside their body, however, the microbes are available in tiny numbers. They are monitored by the body’s safe framework and do not bring on any indications. Individuals with idle TB do not feel wiped out and are not irresistible. They cannot give the TB microscopic organisms to others. Moreover, they will generally have an ordinary chest x-ray and a negative sputum test. It is regularly just realized that somebody has latent TB since they have had a TB test, for example, the TB skin test. There are two kinds of test that can be utilized. These are the TB skin test (TST) and the fresher IGRA blood test. In nations where there is a significant degree of TB, (for example, the high weight TB nations) most individuals may have latent TB.
Fortunately, most of the TB patients have latent infection i.e., bacteria are present in the body but is not causing active disease. Hence at any one time, there are about 10 million people across the world with active tuberculosis infection and that causes deaths in about 10% of them. So, approximately there are 1 million deaths per year due to tuberculosis [8, 9]. The Mycobacteria principally target the lungs, moreover, it has been observed that M. tuberculosis may also reach and affect other parts of the body, such as the kidney, spine, and brain. A few people get tuberculosis ailment long after getting contaminated, even before their immune system can battle against the TB bacteria. Others may get the ailment years after the fact when their immune system gets frail for some other reason [8, 10].
Tuberculosis possesses a genuine risk to human wellbeing and one of the main reasons for significant human demise on the planet. Moreover, the emergence of drug resistance and its relationship with HIV infections have intensified worldwide circumstances. Unfortunately, despite advanced modalities for diagnosis and treatment of TB, people are still suffering a lot. There are specific properties associated with MTB that has presented vast challenges to develop an efficient drug against Tuberculosis [11]. The major obstacles in TB treatment like screening of compounds with anti-tubercular activity, the long duration medication, the lack of predictive animal models, and insufficient information on the physico-synthetic properties required for successful bacterial penetration [12], are being encountered by the pharmaceutical scientist.
The danger of creating dynamic (active) Tuberculosis ascends to 30% in diabetes victims. Usually, 80% - 90% of the patient having an infection of drug-resistant tuberculosis are relieved by taking concentrated anti-toxin treatment [2]. However, treatment by antibiotics is dependent on a load of drug-resistant M. tuberculosis in the patient [13]. Therapy of anti-drug or multidrug-resistant Tuberculosis (MDRTB: impervious to isoniazid and rifampin) is increasingly perplexing and takes nearly 2 years of chemotherapy amalgamation [14, 15]. Thus, progressively viable medicines are necessary to avoid or the emergence of tuberculosis. Treatment of the significant levels of drug-resistant Mycobacterium tuberculosis contamination, which incorporate rifampin-resistant (Rif-TB), MDR-TB, and extensively resistant TB (XDR-TB) requires new medications method and approaches to combat [5, 10]. The development of new methods of treatment is a complex process as anti-tuberculosis drugs are mostly given in combination to inhibit the further emergence of drug-resistant TB [14]. Moreover, dormant TB has also been observed in many people in which TB is not in a dynamic position and do not show any symptoms in a patient [16] whereas dynamic TB happens when the body cannot possess the TB pathogen but at this condition, the bacteria can reproduce and cause wanted symptoms and people with dynamic TB can spread the contamination [9, 15]. In certain condition, some MTB strains are not affected by the treatment method and hard to treat tuberculosis [17, 18].
2. Need of research on new TB vaccine
In recent decades, advanced diagnosis and treatment method of TB has reduced the mortality rate up to significant level but TB still exists in world population causing extensive human suffering, economic burden led to global inequity. There are neonatal BCG vaccines that can prevent infants and young children from severe forms of TB but this vaccine is unable to show its effect in adolescents and adults who are crucial in TB transmission. We need to develop new efficient vaccines which could work in all age group people that may assist to fulfill the WHO end TB strategy that aims to reduce the TB mortality and TB incidences by 95% and 90% respectively worldwide.
Now, WHO is putting much efforts to produce TB vaccines and the Product Development for Vaccines Advisory Committee (PDVAC) is asking to develop a WHO preferred Product Characteristics (PPC) for new TB vaccines. The WHO’s PPC data was established to document the crucial and priority requirements for vaccines which may show better safety and efficacy compared to BCG vaccine which is given to neonates and infants against pulmonary TB in adults, and new TB vaccines.
The major vaccine platforms like whole-cell vaccines, adjuvanted proteins, and recombinant subunit vector vaccines, are being considered in the pipeline of TB vaccine development. Now focus is on TB treatment in adolescents and adults by developing an effective candidate vaccine that may also replace the BCG in early life immunization. Many other aspects are in consideration in vaccine development, such as BCG boosters, reduction of treatment period using immunotherapeutic adjuncts and vaccine to prevent diseases reoccurrence in TB patient.
In recent developments, as per WHO report, there is TB vaccine candidate (M72/AS01E) developed by the pharmaceutical company GlaxoSmithKline, in partnership with AERAS and was observed substantially effective against Tuberculosis disease and these results came out in a Phase IIb trial carried out in Kenya, South Africa and Zambia in patients having latent tuberculosis. This vaccine was found with 50% efficacy over about 3 years of continuous monitoring.
3. Globally situation of tuberculosis
According to the report of WHO, a sum of 1.4 million individuals passed on from TB in 2019 (counting 208,000 individuals with HIV). Around the world, TB is one of the top 10 reasons for death and the main source from a solitary irresistible specialist (above HIV/AIDS). In 2019, an expected 10 million individuals became sick with tuberculosis (TB) around the world. 5.6 million men, 3.2 million ladies and 1.2 million youngsters. In 2019, 1.2 million kids became sick with TB worldwide. The youngster and juvenile TB is frequently ignored by wellbeing suppliers and can be hard to analyze and treat. In 2019, the 30 high TB trouble nations represented 87% of new TB cases. Eight nations represent 66% of the aggregate, with India driving the tally, trailed by Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh and South Africa. Multidrug-safe TB (MDR-TB) stays a general wellbeing emergency and a wellbeing security danger. A worldwide all out of 206 030 individuals with multidrug-or rifampicin-safe TB (MDR/RR-TB) were identified and told in 2019, a 10% expansion from 186 883 out of 2018. Internationally, the TB rate is falling at about 2% each year and somewhere in the range of 2015 and 2019, the combined decrease was 9%. This was not exactly most of the way to the End TB Strategy achievement of a 20% decrease somewhere in the range of 2015 and 2020. An expected 60 million lives were saved through TB analysis and treatment somewhere in the range of 2000 and 2019. Finishing the TB plague by 2030 is among the wellbeing focuses of the United Nations Sustainable Development Goals (SDGs). Tuberculosis generally influences grown-ups in their most gainful years. Nonetheless, all age bunches are in danger. More than 95% of cases and passings are in non-industrial nations. Multidrug-resistant tuberculosis (MDR-TB) is a type of TB brought about by microbes that do not react to isoniazid and rifampicin, the 2 best first-line hostile to TB drugs. MDR-TB is treatable and reparable by utilizing second-line drugs. Nonetheless, second-line treatment choices are restricted and require broad chemotherapy (as long as 2 years of treatment) with meds that are costly and poisonous.
Sometimes, more serious medication opposition can create. TB brought about by microbes that do not react to the best second-line hostile to TB medications can leave patients with no further treatment alternatives.
In 2019, MDR-TB stays a general wellbeing emergency and a wellbeing security danger. A worldwide total of 206 030 individuals with multidrug-or rifampicin-safe TB (MDR/RR-TB) were identified and advised in 2019, a 10% increment from 186 883 out of 2018. About portion of the worldwide weight of MDR-TB is in 3 nations – India, China and the Russian Federation.
Around the world, just 57% of MDR-TB patients are presently effectively treated. In 2020, WHO suggested another more limited (9–11 months) and completely oral routine for patients with MDB-TB. This exploration has shown that patients think that it’s simpler to finish the routine, contrasted and the more drawn-out regimens that last as long as 20 months. Protection from fluoroquinolones ought to be rejected preceding the commencement of treatment with this routine.
As per WHO rules, the discovery of MDR/RR-TB requires the bacteriological affirmation of TB and testing for drug obstruction utilizing quick sub-atomic tests, culture strategies or sequencing advancements. Treatment requires a course of second-line drugs for at any rate 9 months and as long as 20 months, upheld by advising and checking for unfavorable occasions. WHO prescribes extended admittance to every single oral routine. Before the finish of 2019, 89 nations began utilizing more limited MDR-TB regimens and 109 had imported or begun utilizing bedaquiline, with an end goal to improve the viability of MDR-TB treatment.
4. The course of events in Mycobacterium tuberculosis
Mycobacterium tuberculosis basically passes through the 5 stages during its life cycle. At the first stage, the bacteria are inhaled through the air and typically engulfed by alveolar macrophages, further proceed to the symbiosis stage and causing the caseous necrosis in later stages. Eventually spread to other cells and causing rapid spread of diseases. The whole cycle is presented in detail in Figure 1 and as a flow chart in Figure 2. The Mycobacterium gets entry into the lungs and resides in the alveoli of the lungs while it begins its primary infection. If the immune system fails to eliminate it then there are three cases observed with the mycobacterium in the alveoli. The first case could be the elimination phase, in which the immune system completely eliminates the infection. The next one retention phase where the immune system suppresses the infection but the bacteria remain viable and, in this case, the infection is known as Latent Tuberculosis which is the most asymptomatic Tuberculosis. And the third phase may involve Active infection, which makes the mycobacterium capable of evades the immune response and separates the infection in the lung tissue and at this point of active infection it is known as Active Tuberculosis [19, 20, 21].
Figure 1.
Life cycle of Mycobacterium tuberculosis. This presentation is influenced with the figure available at online resource on study of the tuberculosis. (https://sites.google.com/site/mycobacteriumtbstudy/home/life-cycle-of-organism).
Figure 2.
Flow chart presentation of life cycle of Mycobacterium tuberculosis.
M. tuberculosis has 5 stages in its life cycle as mentioned in Figure 2 as flow chart [1, 2, 7, 22].
5. Pathogenesis and transmission of Mycobacterium tuberculosis
If somebody has active lung disease with TB they will cough and, in the cough, there would be infected droplets carrying the bacteria that could be inhaled by somebody else [8, 15]. Once the bacteria is inhaled it goes into the lungs and then it invades the normal mechanism for protecting lungs against bacterial infection which are the alveolar macrophages. It actively seeks out and invades these macrophages because it can prevent the normal macrophage killing mechanism. So, it diverts the normal figure lysosome pathways and that allows it to survive in the macrophage and it can be latent in that macrophage for decades [3]. Also, Macrophages because they move will allow the bacterium to spread bull RAC across the body and this is one of the reasons why sites of immune functions such as the lymph nodes often get infected with Tuberculosis and long-term persistence within the macrophages is led to latent diseases [18]. Besides, there is a certain inflammatory response to this infection which causes a very distinctive histologic appearance called granulomas and that is one of the hallmarks of Tuberculosis infection. Our closest infection is the presence of granulomas in the infected tissue [5, 6]. This transmission process is represented in Figure 3.
Figure 3.
Transmission of Mycobacterium tuberculosis. The representation is influenced with figure available in online resource. (https://www.istockphoto.com/in/vector/tuberculosis-life-cycle-of-mycobacterium-tuberculos-gm1200338165-343779875).
6. Mechanism of drug-resistant TB
This has been observed that various mechanism of drug resistance in M. tuberculosis is involved.
6.1 Presence of cell wall
The basic property leading to passive resistance to antibiotics in M. tuberculosis is because of its impervious cell wall [23]. The hydrophilic layer of arabinogalactan ensures the impervious nature of the cell wall to the surrounding hydrophobic substances. This layer is also present in hydrophobic mycolic acids which significantly prevents the entry of hydrophilic molecules [24]. This impervious nature of the cell wall results in the deposition of antibiotics throughout the cell wall, the accumulated antibiotics near the cell wall are removed steadily by the release of enzyme & with the involvement of several cellular components [25]. It is demonstrated that β-lactams, which act as inhibitors to the inclusion of peptidoglycan (responsible for maintaining the rigidity of the cell wall) into the cell wall, are degraded by the mycobacteria due to the presence of β-lactamases, which are the enzyme responsible for degradation of β-lactam antibiotics. Danilchanka et al. [24], reported the presence of CpnT channel protein in the outer membrane of both M. tuberculosis and M. bovis, which plays a dual role in nutrient absorption and selective sensitivity to antibacterial agents.
6.2 Slow metabolism mechanism
Bacteria that have long-generation time & undergo metabolic processes with a slower rate are estimated to be challenging targets for most of the antibiotics i.e., bacteria that are metabolically active and rapidly replicating act as a good target for antibiotics [26]. However, in M. tuberculosis, it is still unclear whether the long generation time confirms its resistance to drugs. However, it is been reported that the slow growth rate of M. tuberculosis plays a crucial role in drug resistance. For example, antibiotics such as carbapenems lose their activity comparatively at a faster rate than the growth rate of M. tuberculosis [27]. It is seen that certain specific genes which are involved in the production of triacyl-glycerol permit the growth of M. tuberculosis even in oxygen-deprived conditions. Triacylglycerol decline in the metabolic processes of M. tuberculosis.
6.3 Possession of numerous efflux pumps
These protein channels play a vital role in the regulation of normal metabolism and the physiology of the organism such as toxins, signaling molecules through the cell wall, residues, and nutrient transport [28]. Efflux pumps have shown adaptation to drug resistance in M. tuberculosis. Multi-drug efflux pumps serve as an outlet for cell antibiotics and usually pass through both the inner and outer membranes of the cell [29]. Regulatory protein systems are present in Drug-efflux proteins which are responsible for controlling the expression of the efflux pump and thus helps in specializing them for drug resistance roles [28].
6.4 Mutation in genetic materials
It has been shown that the acquisition of antibiotics resistance in M. tuberculosis is the result of spontaneous mutation in several chromosomal genes. This frequent mutation has been found to cause a deliberate alteration to the required interaction between each drug against tuberculosis and its specified target.
M. tuberculosis shows resistance to rifampicin due to mutation in rpoB of RNA polymerase, decelerating its affinity for rifampicin [30]. It has been identified in certain studies that specific codons can cause resistance to rifampicin only with the onset of mutation in them [31, 32]. Resistance to pyrazinamide is due to mutation in the pncA gene [33, 34]. The mutations in pncA gene account for the large number of resistance cases reported in Mycobacterial tuberculosis.
The mode of action of isoniazid resistance is complex and remains unclear, however, most strains of Mtb resistant to isoniazid are associated with a mutation in KatG and inhA [35, 36]. S315T of KatG mutation is more common in isoniazid-resistant strains. Mutation at this phase results in the formation of isoniazid product with a low affinity for isoniazid adduct [37].
Mutations in embB497 and embB406, codon 306 in embB and Polymorphism in embA, embC, are all involved in ethambutol resistance [38]. In 2013, Safi et al. proposed that the mutation in ubiA (Rv3806c) showed a high level of ethambutol resistance [39]. Some investigators have reported that the mutations in tlyA gene play a vital role in the resistance of Viomycin and Capreomycin [40, 41].
7. Extrapulmonary tuberculosis (EPTB)
TB as a rule influences the lungs, however, it can likewise influence different pieces of the body, like the brain, the kidneys, or the spine. An individual with TB can pass on if they do not get treatment. TB influencing any piece of the body other than lung parenchyma including different structure inside the chest like the pleura, pericardium and perihilar lymph hubs, alluded as extra aspiratory tuberculosis. EPTB incorporates tuberculosis meningitis, stomach tuberculosis (for the most part with ascites), skeletal tuberculosis, Pott’s infection (spine), scrofula (lymphadenitis), and genitourinary (renal) tuberculosis. Scattered, or miliary tuberculosis regularly incorporates aspiratory and extrapulmonary locales. It is assessed that extrapulmonary tuberculosis (EPTB) represents 15–25% of all instances of TB. HIV patients, particularly with low CD4 tallies, have higher paces of EPTB. Youngsters are bound to have skeletal TB than grown-ups [42]. Approximately 10% of all TB cases have both pulmonary and extrapulmonary TB, and an additional 20% have EPTB without pulmonary involvement [2, 43].
8. Major limitations and considerations to work with M. Tuberculosis
Mycobacterium tuberculosis is a gradually developing bacteria which must be handled cautiously under exacting containment to minimize the hazard to research centre individual [4]. The bacterium can reproduce inside the macrophage and kill the immune cell. Another limitation presented by the bacteria in the innovative work of new drugs is the idea of its cell wall which is wealthy in lipids and ultimately makes the development of homogenous and single-cell culture and troublesome [2]. M. tuberculosis can evade the immune response and recreate inside macrophages coming about because of several bacterial variables which along these lines can modulate the immune reaction [4, 5]. Although M. tuberculosis is Gram-positive bacteria its cell wall resembles the external membrane of Gram-negative bacteria since it is composed of an asymmetric bi-layer containing particular mycolic acids, along with glyco-lipids, lipo-glycans, and proteins [3, 9]. Therefore, novel drugs with viability and quicker acting mechanism which can most likely work in the shorter-term and along these lines give better outcomes in the treatment are desperately required [7].
9. Possible opinion regarding the challenges of new drug discovery for tuberculosis
Besides, the development of XDR strains of M. tuberculosis, 5.4% of MDR-TB cases are discovered to be XDR-TB (World Health Organization, 2010, Ref. [3]). Multidrug and Extensive Drug-Resistant Tuberculosis: 2010 Global Report on Surveillance and Response (World Health Organization, 2010, Ref. [4]) is testing TB treatment programs in a few nations and even raises the chance of a re-visitation of a circumstance much the same as the pre-anti-microbial TB time [1]. As of now, MDR-TB is treated by a blend of eight to ten medications with treatments enduring up to 18 two years; just four of these medications were really evolved to treat TB5. Such imperfect treatment prompts practically 30% of MDR-TB patients to encounter treatment disappointment [44]. The treatment alternatives for XDR-TB are exceptionally restricted as XDR-TB bacilli are safe not exclusively to isoniazid and rifampicin, yet in addition to fluoroquinolones and injectables, for example, aminoglycosides. Furthermore, there are not kidding results with most MDR-TB and XDR-TB drugs, incorporating nephrotoxicity and ototoxicity with aminoglycosides, hepatotoxicity with ethionamide and dysglycaemia with gatifloxacin [45]. In this manner, the current circumstance requires the prompt distinguishing proof of new frameworks that can address arising opposition and furthermore requests the direct of suitable clinical preliminaries as verifiably not very many clinical examinations have been performed to assess the adequacy of medications in MDR-TB or XDR-TB patient gatherings. Improving the diagnostics with more extensive inclusion of medication vulnerability testing will likewise assist with tending to the high mortality of MDR/XDR-TB and control the development of obstruction.
Critical difficulties exist in TB drug revelation because of the idea of the causative bacterium. The absence of prescient models for compound section into mycobacteria is likewise a restricting variable since the direct trial proof is arduous to get. Creating essential guidelines around compound passage and efflux could help with improving hits from biochemical screens which need entire cell action, just as adjusting the synthetic properties needed for great pharmacokinetic properties [8].
10. Existing and upcoming tuberculosis drug regime
The present routine of medication for drug-sensitive Tuberculosis treatment was set up during the 1980s. This treatment process encompasses four levels of medications, isonicotinic acid hydrazide, rifampin, Ethambutol dihydrochloride and Pyrazinoic acid amide for six months of treatment (Table 1). The essential focus of Tuberculosis drugs is cell wall biogenesis, deoxyribonucleotide replication, ribonucleotide transcription, and protein synthesis [15, 46].
Drug
Drug property
Acting pH
Site of action
Isoniazid (H)
Bactericidal after 24 hrs with a high potency. Kills more than 90% of bacilli in first few days of treatment.
Both alkaline and acidic medium
Both intracellular and extracellular
Rifampicin (R)
Bactericidal within 1 hrs with high potency.
Both alkaline and acidic medium
Both intracellular and extracellular
Pyrazinamide (Z)
Bactericidal with a low potency
Acidic medium
Intracellular bacilli
Ethambutol (E)
Bacteriostatic with a low potency. Minimizes the emergence of drug resistance
Both alkaline and acidic medium
Both intracellular and extracellular
Streptomycin (S)
Bactericidal with a low potency
Alkaline medium
Extracellular bacilli
Table 1.
Current drugs and their property.
Treatment of drug-resistant or multidrug-resistant (MDR) tuberculosis is substantially further unpredictable [8]. The success of the treatment process relies upon the patient record and drug affectability. MDR-Tuberculosis needs therapy for a long time with a combination of 5 other medications. These second-line drugs will in general be progressively costly and incorporate Sirturo, 2-ethylthioisonicotinamide, Seromycin, Moxifloxacino, and Streptomycine, just like cutting edge medications rifampin systemic and Myambutol [5, 46]. For MDR tuberculosis therapy, we need to go through at least 6 months long treatment process including various vaccinations. Some have been observed to show adverse effects like heart electrophysiology dysfunction and ototoxicity [10, 13].
11. Drug combination trials and standardization of TB regimens
The WHO-recommended formulations of anti-TB drugs and fixed-dose combinations (FDCs) of drugs appear in the WHO Model List of Essential Medicines (available at www.who.int/medicines/publications/essentialmedicines/en). The formulations and combinations of anti-TB drugs available in each country should conform to this list.
Normalized treatment implies that all patients in a characterized bunch get a similar treatment routine. Standard regimens have the accompanying benefits over the individualized solution of medications:
errors in remedy – and in this way the danger of advancement of medication opposition – are decreased;
estimating drug needs, buying, circulation and checking are encouraged;
staff preparing is encouraged;
costs are decreased;
maintaining a regular drug supply when patients move to start with one region then onto the next is made simpler;
outcome assessment is helpful and results are tantamount.
12. Pharmaco-kinetic and pharmaco-dynamic contemplations for tuberculosis medications
Pharmacokinetic (PK) and pharmacodynamics (PD) properties of a medicinal drug play a substantial role to propose its feasibility for medicinal purpose In vivo [47, 48]. Along with the PK/PD of any anti-tubercular drugs, medication also considers other factors like comorbid conditions, safety profile, oral bioavailability and metabolic strength [4, 10]. Oral administration is mostly preferred for advanced Tuberculosis medication whereas, oral bioavailability is critical to treat Tuberculosis [4, 46]. Solubility and gastrointestinal permeability are the two major factors that affect oral bioavailability. At present. Generally, the bioavailability of tablets Tuberculosis ranges from 40–90% and new drugs must show such property of bioavailability [2, 7]. The smaller successive dosing of drugs is suggested to improve the adhesion and recommend to have daily doses. An ideal TB medicine must transmit to the lungs, the site of the primary infection, and should have the ability to infiltrate the granuloma to reach, such as intracellular and extracellular bacilli in the centre of hypoxia and undoubtedly necrotic region [9]. Preferably, the adhesion of drugs compounds in the target tissue must be maintained at a chosen site at minimal inhibitory conditions [49, 50]. This approach is used to avoid the phenomenon of drug binding to plasma protein, inhibition of tissue diffusion and improving the half-life of medicine. Lipophilic drugs have a major portion in anti-tubercular drugs. PK/PD and mode of action determines the dose of drugs for the treatment [5, 6].
In terms of drug safety, an ideal drug for Tuberculosis should not show any acute toxicity or long duration for the treatment [47, 51]. Because of the global nature of Tuberculosis therapy, an excellent drug must not show drug–drug interaction with other chemically or biologically active TB drugs within the regime [7, 22].
13. Target identification
With the entire genomic sequence available for Mycobacterium tuberculosis, the potentiality to explore new targets for the development of antibiotic throughout the M. tuberculosis genome became convenient [9, 10]. Novel chemical entities & targets are expected to avoid resistance to existing drugs and therefore improve current treatments. An ideal target for the development of antibiotic must necessarily be in vivo, vulnerable to medicines and drug-effective [6].
Genetic screens trials are the preliminary step in manifesting which genetic products might be targeted at chemotherapy against tuberculosis. Howsoever, all the necessary genes are not equally vulnerable to pharmacological action [20]. Besides, the target should also be available for competitive or chemical inhibition. That is, the target must have the ability to bind with another molecule rather than its substrate [10, 52, 53]. The inhibition or initiation of the protein function with a possible concentration of the low molecular weight compounds results in cellular breakdowns, such as cell death leading to apoptosis or attenuated growth [14, 46]. Besides being susceptible to chemical inhibition, an anti-target screen inhibitor should also produce drug-like compounds with specificity to affect target function in the absence of interference with any host orthologs [5, 54].
14. Current status of tuberculosis drug discovery
Various strategies have been developed by researchers and investigators and they proposed combined drugs for clinical trials after screening. All these drugs have a specific mode of actions but at the same time, they also showed some side effect which is a challenging task for investigators (Table 2). Currently, about 7 new combinations of drugs are under clinical trials. These lead combinations have been recognized by several methods and differential screening [10]. Few screening methodologies are as follows:
GI disturbances, Thrombocytopenia, sideroblastic anemia, Mild arthralgia myalgia etc.
Injectable anti-TB drugs
Streptomycin
burning, crawling, itching, numbness, prickling etc.
Kanamicin
pain or irritation
Amikacin
diarrhea, hearing loss, spinning sensation (vertigo), numbness etc.
Fluroquinol drugs
Ofloxacin
Nausea, diarrhea, constipation, gas, vomiting etc.
Levofloxacin
low blood sugar, headache, hunger, sweating, irritability etc.
Gatifloxacin
red, irritated, itchy, or teary eyes, blurred vision, eye pain etc.
Second line oral drugs
Ethionamide
Nausea, vomiting, diarrhea, abdominal/stomach pain etc.
Prothionamide
depression and hallucinations
Cycloserine
Headache, drowsiness, dizziness, or shaking etc.
p-Aminosalicylic acid
persistent nausea, vomiting and diarrhea etc.
Anti-TB drugs with long term safety
Linezolid
severe diarrhea or diarrhea that is watery or bloody, fungal infections, low platelet counts etc.
Redaquiline
Nausea / Vomiting, Dizziness, Headache, Hemoptysis etc.
Clofazimine
diarrhea, nausea, vomiting, gastrointestinal intolerance etc.
Amoxicillin
severe skin rash, itching, hives, difficulty breathing or swallowing etc.
High dose Isoniazid
increased blood levels of liver enzymes and numbness etc.
Table 2.
Current mode of therapy and therapeutic drugs for tuberculosis.
14.1 SQ109
A combinatorial library entirely based on 1,2-ethylenediamines such as Ethambutol was examined on two high-throughput in-vitro analysis. The first evaluation involves dilution of bouillon to calculate minimal inhibitory concentration (MIC) contrary to Mycobacterium tuberculosis [55]. The subsequent measurement is based on iniBAC promoter, inhibition of cell wall and bioluminescent assays for high-throughput screening [56]. SQ109 was determined on this screen. But the mode of action and efficacy of SQ109 differ widely from ethambutol [57, 58]. SQ109 is bactericidal in nature and works by targeting a transmembrane transport protein MmpL3 which is responsible for transmitting trehalose monomicolate during cell wall synthesis [59, 60]. It acts against extracellular as well as intracellular bacilli and works on acute and chronic mouse models of tuberculosis infection [61]. SQ109 improved the pharmacological efficacy of the present four available first-line drugs against tuberculosis and represents synergy with Sirturo. It is presently under phase 2 clinical studies [5, 15].
14.2 Q203
It is an amide compound of imidazopyridine and was recognized by the whole-cell screening of infected macrophages [17]. Q203 prevents ATP synthesis via causing an interruption in the electron transport chain and thus also inhibits the cytochrome bc1 complex involved in the electron transport mechanism. Q203 possess an exceptional Pharmacokinetic profile and prevents bacterial replication [2, 20].
14.3 TBA-7371
A member of a series of 1,4-azaindole which was recognized by a strategy of transformation of scaffolds preceded by a program of optimization of lead of a compound imidazopyridine [62]. TBA-7371 inhibits DprE1 non-covalently, a decaprenyl phosphoryl-β-Dribose2′-epimerase, in cell wall Arabian biosynthetic pathway. TBA-7371 is bactericidal and is working against both acute and chronic mouse models of tuberculosis infection. It is under phase 1 clinical studies [3, 46, 57].
14.4 OPC-167832
It is a derivative of 3,4-dihydrocarostyril. OPC-167832 is bactericidal and works by targeting DprE1, leading to the prevention of mycobacterial infection. It represents improved performance when in combination with delamide. Presently it falls under the category of phase 1 clinical studies [10, 15].
14.5 GSK-070
It targets leucyl-tRNA synthetase and is an oxaborole derivative. Oxaborols block leucyl-t-RNA synthesis and ultimately results in blocking protein synthesis by constructing an adduct with t-RNA. It is active against both acute and chronic tuberculosis infection [10, 63].
14.6 PBTZ-169 & BTZ-043
They belong to benzothiazinones and were diagnosed from a broth dilution evaluation in vitro for the detection of antibacterial and antifungal activities. Benzothiazinones basically prevents the formation of arabinose involved in the biosynthesis of cell wall by covalently targeting DprE1. Both PBTZ-169 and BTZ-043 are bactericidal thus prevents bacterial replication and multidrug-resistant tuberculosis infection. They represent almost equal potency against isoniazid and rifampin in the mouse models of recurrent tuberculosis infection. PBTZ-169 is under phase 1 scientific studies [7, 9, 63].
15. Risk factors associated with tuberculosis treatments
Recent emigration makes Tuberculosis very likely to reactivate. Vitamin D deficiency has the same effect because vitamin D is an immune modulator and deficiency of that weakens the immune system, thus protecting against tuberculosis [3, 9]. Another factor, HIV infection, which is present in 8% of patient cases of tuberculosis and this problem of HIV allowing TB to be reactive and become a problem is actually before the patient has become heavily immune-suppressed [64]. Smoking, diabetes and the elderly are all examples where the immune system has been weakened to a degree and allows the potential infection to take hold and cause a problem [22, 63]. Homelessness drug abuse, alcoholism and other immune suppression steroids after transplantation to mention corrosive tumor necrosis factor treatment, all make an individual more likely to reactivate latent disease, like tuberculosis [6]. The antibiotics being used for the TB treatment have also shown some of the side effects and the present major challenge to researchers to overcome these drawbacks of antibiotics (Table 2).
16. Recent developments in diagnostic approaches for tuberculosis
It is not easy to conduct a clinal diagnosis of tuberculosis very frequently as confirmed diagnosis requires culturing the bacteria M. tuberculosis in a sample from the patient [5] and which is very slow-growing. For lung diseases, we take morning sputum for culture purpose and microscopic studies. We also have to do Biopsies of the affected tissues, because that will provide us with a sample for culture and also for looking histologically for the characteristic presence of granulomas [53]. Mycobacterial culture confirms the presence of mycobacterium in given samples by microscopy analysis, and we may also draw the resistance profile i.e., whether the present strain belongs to the sensitive M. tuberculosis group or has resistance to some drugs that can be used to treat it. The major obstacles in culture MTB are that it is slow-growing bacteria and may take 3–4 weeks in liquid culture media [51]. The acid-fast bacilli of mycobacterial infection are detected by the microscopy analysis whereas latent tuberculosis disease is identified by immunological responses to tuberculosis antigens, i.e., i) Heaf test / Montoux: cofounded by BCG ii) Interferon Gamma Release Assays (IGRA) [48, 49]. There are some tools developed recently for the detection of drug-resistant MTB that facilitates early detection too, such GeneXpert, line prob. assay, LAMP assay etc.
16.1 GeneXpert
GeneXpert can detect mutations that cause resistance against Rifampicin. The test is a molecular TB test that detects the DNA of Mycobacterium tuberculosis. It uses a sputum sample and thus provides result in less than 2 hours. It can also detect the genetic mutations which are associated with drug Rifampicin resistance [65]. WHO recommended that this test should be used as the primitive diagnosis test in individuals suspected of having Multi-drug resistant TB, or HIV associated TB.
16.2 Line probe assay (LPA)
This technique also helps to detects mutations causing resistance against Rifampicin. Moreover, this assay can also detect mutations related to drug isoniazid [66]. The line probe assay (LPA), is typically based on strip technology and thus is used in the diagnosis of TB. It also detects RIF as well as Isoniazid (INH) resistance caused due to mutations in rpoβ, and both inhA and katG genes.
WHO has recommended the TB-LAMP (loop-mediated isothermal amplification) test that requires minimal laboratory infrastructure and has been evaluated as an alternative to sputum smear microscopy, which remains the most widespread test used in resource-limited environments. TB-LAMP is a unique temperature-independent way to amplify the DNA of tuberculosis patients. It is a manual test that takes less than one hour and results can be visualized with the naked eye under UV light. The potent TB-LAMP instrument can be used at the level of the peripheral health center where microscopy is often performed. (https://www.who.int/tb/features_archive/TB_LAMP/en/).
17. Available treatment
At present treatment of tuberculosis requires more than one antibiotic with prolonged combination therapies to eradicate the infection and prevent resistance [58] and the standard therapy may include 4 antibiotics i.e., Isoniazid & Rifampicin (most effective drugs and these are given for six months and thus these two helps in killing the bacteria), Pyrazinamide & Ethambutol (given for first two months only) [67, 68]. During treatment antibiotics are required for a long period, the minimum treatment period is six months and if the patient is having CNS or bone disease it often goes on for at least 12 months [69]. The patient is asked to take four drugs for two months and then followed by two drugs for four months, and the actual dose given to the patient is decided by their body weight such as if a patient is lower than 50 kg, they get a lower dose while if the patient is above 50 kg, they get a higher dose [13].
Corticosteroids are given to patients with CNS or pericardial disease because this reduces the further chances of having long term brain damage. All the cases need to be monitored and notified so that there can be a screening process of the patient’s close contacts as well [14, 17].
18. Conclusion
M. tuberculosis is a difficult pathogen to combat and the frontline drugs currently in use are between 40 and 60 years of age. There is an urgent need of novel tuberculosis drugs, but the time to identify, develop and ultimately advance new drug regimens on the market has been extremely slow in the past decade. Organic biochemistry remains to be performed to know the mechanism of activity, to empower lead advancement, and to ensure in vivo effectiveness [20]. Current efforts to develop drugs against tuberculosis are not enough to end the global tuberculosis epidemic. Due to the diversification and complexity of the infection for M tuberculosis, no model can completely define the in-vivo conditions in which mycobacteria are found in Tuberculosis patients and there is no sole standard detection condition for generating successful compounds for tuberculosis drug development. Recent efforts have focused on the development of whole-cell screening trials because objective-based biochemical screens of inhibitors over the past two decades have not provided new tuberculosis drugs [68]. There are significant challenges in the discovery of anti-tuberculosis drugs due to the nature of the causative bacteria. The lack of predictive models for the entry of compounds into mycobacteria is also a limiting factor. Several additional barriers in the development of tuberculosis drugs include: there are no well-established (PK)– (PD) paradigms, lack of validation and human-like pathology of animal models currently available for drug discovery, lack of clinical laboratories suitable for clinical trials, and the lack of adequate research funds. The biggest challenge in the development of anti-tuberculosis drugs is to reduce the duration of treatment for patients with drug-sensitive tuberculosis [18]. Noval drugs are needed to achieve this and overcome drug resistance. In addition, it should be possible to use new drugs for patients with HIV/AIDS co-infection. The present condition of tuberculosis drug development is far better than what was seen past 10–15 years ago. Howsoever, the development is still lacking behind because of the significant challenges in the drug discovery against drug-resistant tuberculosis and the shorter duration of the treatment required for tuberculosis prevention [12, 13].
We need to identify essential Tuberculosis targets based on better knowledge of the disease pathogen and physiology, develop sharp screening trials, and prepare compounds specifically designed to provide better clues for antibacterial activities [11]. Recent granuloma models are based on a single cell type to imitate the aggregate complex that is formed. Biomedical engineering methods can produce further diversified but still organized multicellular structures that clearly defines the organization of human granulomas. The challenge is that the need is urgent, but the process of discovery and development requires an excessive number of resources and time. The search for more effective vaccines should continue to provide long-term solutions to tuberculosis. At the same time, the development of drugs and regimes must be accelerated with a clearer approach [1, 9].
Acknowledgments
Dr. Manish Dwivedi thanks to DST-INSPIRE Faculty award.
Conflict of interest
The authors declare no conflict of interest.
\n',keywords:"Mycobacterium tuberculosis, drug, challenges, bacterial targets",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/76741.pdf",chapterXML:"https://mts.intechopen.com/source/xml/76741.xml",downloadPdfUrl:"/chapter/pdf-download/76741",previewPdfUrl:"/chapter/pdf-preview/76741",totalDownloads:243,totalViews:0,totalCrossrefCites:0,dateSubmitted:"October 23rd 2020",dateReviewed:"April 23rd 2021",datePrePublished:"May 13th 2021",datePublished:"September 15th 2021",dateFinished:"May 13th 2021",readingETA:"0",abstract:"Tuberculosis (TB) is one of the deadly diseases in the present era caused by Mycobacterium tuberculosis. Principally, this bacterium attacks the lungs, however, MTB Has been observed affecting any part of the human body including the kidney, spine, and brain. Drug-resistant progression and other associated properties of MTB become a major hurdle in drug discovery to fight against tuberculosis. Moreover, some of the challenging situations such as the low range of chemical agents, the time-consuming process of drug development, the shortage of predictive animal models, and inadequate information of the physicochemical evidence required for effective bacterial penetration, are additional hindrances for the pharmaceutical scientist. In the current chapter, we focus on challenges encountered during drug discovery and need to be overcome as M. tuberculosis has a substantial barrier in its lipid-containing cell wall to inhibit the influx of drugs which is the initial requirement of the drug to show its therapeutic effect. There is also an immediate need for efficient vaccine development which may show its effect on adolescents and adults along with infants. Investigation on key bacterial targets has been troublesome, in light of the vulnerability around the microenvironments found in vivo and subsequently, the importance of exceptional metabolic pathways. The manuscript is prepared after the extensive literature survey to explore the vigorous approaches in novel drug designing and in proposing potent drug targets. The re-engineering and repositioning of prominent antitubercular drugs are required to attain viable control.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/76741",risUrl:"/chapter/ris/76741",signatures:"Manish Dwivedi and Priya Giri",book:{id:"10542",type:"book",title:"Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex",subtitle:null,fullTitle:"Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex",slug:"molecular-epidemiology-study-of-mycobacterium-tuberculosis-complex",publishedDate:"September 15th 2021",bookSignature:"Yogendra Shah",coverURL:"https://cdn.intechopen.com/books/images_new/10542.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83968-100-4",printIsbn:"978-1-83968-099-1",pdfIsbn:"978-1-83968-101-1",isAvailableForWebshopOrdering:!0,editors:[{id:"278914",title:"Ph.D.",name:"Yogendra",middleName:null,surname:"Shah",slug:"yogendra-shah",fullName:"Yogendra Shah"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"337061",title:"Assistant Prof.",name:"Manish",middleName:null,surname:"Dwivedi",fullName:"Manish Dwivedi",slug:"manish-dwivedi",email:"manishdwivedi777@gmail.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"337625",title:"Ms.",name:"Priya",middleName:null,surname:"Giri",fullName:"Priya Giri",slug:"priya-giri",email:"priyagiri201@gmail.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Need of research on new TB vaccine",level:"1"},{id:"sec_3",title:"3. Globally situation of tuberculosis",level:"1"},{id:"sec_4",title:"4. The course of events in Mycobacterium tuberculosis",level:"1"},{id:"sec_5",title:"5. Pathogenesis and transmission of Mycobacterium tuberculosis",level:"1"},{id:"sec_6",title:"6. Mechanism of drug-resistant TB",level:"1"},{id:"sec_6_2",title:"6.1 Presence of cell wall",level:"2"},{id:"sec_7_2",title:"6.2 Slow metabolism mechanism",level:"2"},{id:"sec_8_2",title:"6.3 Possession of numerous efflux pumps",level:"2"},{id:"sec_9_2",title:"6.4 Mutation in genetic materials",level:"2"},{id:"sec_11",title:"7. Extrapulmonary tuberculosis (EPTB)",level:"1"},{id:"sec_12",title:"8. Major limitations and considerations to work with M. Tuberculosis",level:"1"},{id:"sec_13",title:"9. Possible opinion regarding the challenges of new drug discovery for tuberculosis",level:"1"},{id:"sec_14",title:"10. Existing and upcoming tuberculosis drug regime",level:"1"},{id:"sec_15",title:"11. Drug combination trials and standardization of TB regimens",level:"1"},{id:"sec_16",title:"12. Pharmaco-kinetic and pharmaco-dynamic contemplations for tuberculosis medications",level:"1"},{id:"sec_17",title:"13. Target identification",level:"1"},{id:"sec_18",title:"14. Current status of tuberculosis drug discovery",level:"1"},{id:"sec_18_2",title:"14.1 SQ109",level:"2"},{id:"sec_19_2",title:"14.2 Q203",level:"2"},{id:"sec_20_2",title:"14.3 TBA-7371",level:"2"},{id:"sec_21_2",title:"14.4 OPC-167832",level:"2"},{id:"sec_22_2",title:"14.5 GSK-070",level:"2"},{id:"sec_23_2",title:"14.6 PBTZ-169 & BTZ-043",level:"2"},{id:"sec_25",title:"15. Risk factors associated with tuberculosis treatments",level:"1"},{id:"sec_26",title:"16. Recent developments in diagnostic approaches for tuberculosis",level:"1"},{id:"sec_26_2",title:"16.1 GeneXpert",level:"2"},{id:"sec_27_2",title:"16.2 Line probe assay (LPA)",level:"2"},{id:"sec_28_2",title:"16.3 Loop-mediated isothermal amplification (LAMP) assay",level:"2"},{id:"sec_30",title:"17. Available treatment",level:"1"},{id:"sec_31",title:"18. Conclusion",level:"1"},{id:"sec_32",title:"Acknowledgments",level:"1"},{id:"sec_35",title:"Conflict of interest",level:"1"}],chapterReferences:[{id:"B1",body:'Koul A, Arnoult E, Lounis N, et al. The challenge of new drug discovery for tuberculosis. Nature. 2011 Jan 27;469(7331):483-490. DOI: 10.1038/nature09657'},{id:"B2",body:'CDC “Tuberculosis Fact Sheets”, Centers for Disease Control and Prevention, 2014; https://www.cdc.gov/tb/publications/ factsheets/general/ltbiandactivetb.htm accessed: 22 December 2017.'},{id:"B3",body:'World Health Organization. Multidrug and Extensively Drug-resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO; 2010.'},{id:"B4",body:'WHO “Multidrug-Resistant Tuberculosis (MDR-TB) 2016 Update”, World Health Organization, 2016; http://www.who.int/tb/ challenges/mdr/mdr_tb_factsheet.pdf accessed: 29 September 2017.'},{id:"B5",body:'Sarathy, J. P.; Zuccotto, F.; Hsinpin, H.; Sandberg, L.; Via, L. E.; Marriner, G. A.; Masquelin, T.; Wyatt, P.; Ray, P.; Dartois, V. Prediction of Drug Penetration in Tuberculosis Lesions. ACS Infect. Dis. 2016, 12;2(8):552-63.'},{id:"B6",body:'Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015 Feb;14(2):111-129.'},{id:"B7",body:'Pai, M.; Behr, M. A.; Dowdy, D.; Dheda, K.; Divangahi, M.; Boehme, C. C.; Ginsberg, A.; Swaminathan, S.; Spigelman, M.; Getahun, H.; et al. Tuberculosis. Nat. Rev. Dis. Primers 2016, 2, 16076.'},{id:"B8",body:'Kumar, A., Chettiar, S., & Parish, T. (2016). Current challenges in drug discovery for tuberculosis. Expert Opinion on Drug Discovery, 12(1), 1-4.'},{id:"B9",body:'Early JV, Casey A, Martinez-Grau MA, et al. Oxadiazoles have butyrate-specific conditional activity against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2016Jun;60(6):3608-3616.'},{id:"B10",body:'Yuan, T., & Sampson, N. S. (2018). Hit generation in TB drug discovery: From genome to granuloma. Chemical Reviews, 118(4), 1887-1916.'},{id:"B11",body:'Rybniker, J.; Chen, J. M.; Sala, C.; Hartkoorn, R. C.; Vocat, A.; Benjak, A.; Boy-Rottger, S.; Zhang, M.; Szekely, R.; Greff, Z.; et al. Anticytolytic screen identifies inhibitors of mycobacterial virulence protein secretion. Cell Host Microbe 2014, 16, 538−548.'},{id:"B12",body:'Abrahams GL, Kumar A, Savvi S, et al. Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening. Chem Biol. 2012 Jul 27;19(7):844-854.'},{id:"B13",body:'Mdluli K, Kaneko T, Upton A. Tuberculosis drug discovery and emerging targets. Ann N Y Acad Sci. 2014 Sep;1323:56-75.'},{id:"B14",body:'Tonge, P. J. Drug−target kinetics in drug discovery. ACS Chem. Neurosci. 2018'},{id:"B15",body:'Sala C, Dhar N, Hartkoorn RC, et al. Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2010 Oct;54(10):4150-4158.'},{id:"B16",body:'Gold, B.; Nathan, C. Targeting phenotypically tolerant Mycobacterium tuberculosis. Microbiol. Spectr. 2017, 5, 0031−2016.'},{id:"B17",body:'Rao SP, Lakshminarayana SB, Kondreddi RR, Herve M, Camacho LR, Bifani P, Kalapala SK, Jiricek J, Ma NL, Tan BH, Ng SH, Nanjundappa M, Ravindran S, Seah PG, Thayalan P, Lim SH, Lee BH, Goh A, Barnes WS, Chen Z, Gagaring K, Chatterjee AK, Pethe K, Kuhen K, Walker J, Feng G, Babu S, Zhang L, Blasco F, Beer D, Weaver M, Dartois V, Glynne R, Dick T, Smith PW, Diagana TT, Manjunatha UH. Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis. Sci Transl Med. 2013 Dec 4;5(214):214ra168.'},{id:"B18",body:'Sledz, P.; Silvestre, H. L.; Hung, A. W.; Ciulli, A.; Blundell, T. L.; Abell, C. Optimization of the Interligand Overhauser Effect for Fragment Linking: Application to Inhibitor Discovery against Mycobacterium tuberculosis Pantothenate Synthetase. J. Am. Chem. Soc. 2010, 7;132(13):4544-5.'},{id:"B19",body:'Cooper AM. Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 2009;27, 393-422.'},{id:"B20",body:'Cragg GM, Newman DJ. Natural products: A continuing source of novel drug leads. BiochimBiophys Acta. 2013 Jun;1830(6):3670-3695.'},{id:"B21",body:'Protopopova, M.; Hanrahan, C.; Nikonenko, B.; Samala, R.; Chen, P.; Gearhart, J.; Einck, L.; Nacy, C. A. Identification of a new Antitubercular drug candidate, SQ109, from a combinatorial library of 1, 2-Ethylenediamines. J. Antimicrob. Chemother. 2005;56(5):968-974.'},{id:"B22",body:'Hoagland, D. T.; Liu, J.; Lee, R. B.; Lee, R. E. New Agents for the Treatment of Drug-Resistant Mycobacterium tuberculosis. Adv. Drug Delivery Rev. 2016;1;102:55-72.'},{id:"B23",body:'Maitra A, Munshi T, Healy J, Martin LT, Vollmer W, et al. (2019) Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen. FEMS Microbiol Rev 43(5): 548-575.'},{id:"B24",body:'Danilchanka O, Pires D, Anes E, Niederweis (2015) The Mycobacterium tuberculosis Outer Membrane Channel Protein CpnT Confers Susceptibility to Toxic Molecules. Antimicrob Agents Chemother 59(4): 2328-2336.'},{id:"B25",body:'Chiaradia L, Lefebvre J, Marcoux J, Burlet Schiltz O, Etienne G, et al. (2017) Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane. Scientific Reports 7(1): 12807.'},{id:"B26",body:'Pandey AK, Sassetti C M (2008) Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci USA 105(11): 4376- 4380.'},{id:"B27",body:'Baek SH, Li A H, Sassetti CM (2011) Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol 9(5): e1001065.'},{id:"B28",body:'Nguyen L (2016) Antibiotic resistance mechanisms in M. tuberculosis: An update. Arch Toxicol 90(7): 1585-1604.'},{id:"B29",body:'Knutson KL, Hmama Z, Herrera Velit P, Rochford R, Reiner NE (2014) Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes: Role of the Src homology 2 containing tyrosine phosphatase 1. Journal of Biological Chemistry 273(1): 645-652.'},{id:"B30",body:'Damtie D, Woldeyohannes D, Mathewos B (2014) Review on molecular mechanism of first line antibiotic resistance in Mycobacterium tuberculosis. Mycobact Dis 4(6): 174.'},{id:"B31",body:'Somoskovi A, Parsons LM, Salfinger M (2001) The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir Res 2(3): 164-168.'},{id:"B32",body:'Heep M, Rieger U, Beck D, Lehn N (2000) Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both helicobacter pylori and Mycobacterium tuberculosis. Antimicrob Agents Chemother 44(4): 1075-1077.'},{id:"B33",body:'Tahir MK, Nayyer M, Sheed KA, Tanwir AM, Iqbal SM, et al. (2019) Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. BMC Infect Dis 19(1): 116.'},{id:"B34",body:'Huy NQ , Lucie C, Hoa T, Hung NV, Lan N, et al. (2017) Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates. Emerg Microbes Infect 6(10): e86.'},{id:"B35",body:'Hazbón MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, et al. (2006) Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 50(8): 2640-2649.'},{id:"B36",body:'Seifert M, Catanzaro D, Catanzaro A, Rodwell TC (2015) Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: A systematic review. PloS one 10(3): e0119628.'},{id:"B37",body:'Bollela VR, Namburete EI, Feliciano CS, Macheque D, Harrison LH, et al. (2016) Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis. Int J Tuberc Lung Dis 20(8): 1099-1104.'},{id:"B38",body:'Plinke C, Cox HS, Zarkua N, Karimovich HA, Braker A, et al. (2010) embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. J Antimicrob Chemother 65(7):1359-1367.'},{id:"B39",body:'Tulyaprawat O, Chaiprasert A, Chongtrakool P, Suwannakarn K, Ngamskulrungroj P (2019) Association of ubiA mutations and high-level of ethambutol resistance among Mycobacterium tuberculosis Thai clinical isolates. Tuberculosis 114: 42-46.'},{id:"B40",body:'Johansen SK, Maus CE, Plikaytis BB, Douthwaite S (2006) Capreomycin binds across the ribosomal subunit interface using tlyA -encoded 2’-O-methylations in 16S and 23S rRNAs. Molecular Cell 23: 173-182.'},{id:"B41",body:'Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, et al. (2012) Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: A systematic review. PLoS One 7(3): e33275.'},{id:"B42",body:'N. Jean Haulman, ... Charles M. Nolan, in The Travel and Tropical Medicine Manual (Fourth Edition), 2008, 391-406.'},{id:"B43",body:'Masahiro Narita, Christopher Spitters, in The Travel and Tropical Medicine Manual (Fifth Edition), 2017.'},{id:"B44",body:'Mitnick, C. et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N. Engl. J. Med. 348, 119-128 (2003)'},{id:"B45",body:'Ma, Z., Lienhardt, C., McIlleron, H., Nunn, A. J. & Wang, X. Global tuberculosis drug development pipeline: The need and the reality. Lancet 375, 2100-2109 (2010).'},{id:"B46",body:'Payne DJ, Gwynn MN, Holmes DJ, et al. Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat Rev Drug Discov.2007 Jan;6(1):29-40.'},{id:"B47",body:'Sacksteder, K. A.; Protopopova, M.; Barry, C. E.; Andries, K.; Nacy, C. A. Discovery and development of SQ109: A new Antitubercular drug with a novel mechanism of action. Future Microbiol. 2012; 7(7):823-837.'},{id:"B48",body:'Ioerger, T. R.; O’Malley, T.; Liao, R.; Guinn, K. M.; Hickey, M. J.; Mohaideen, N.; Murphy, K. C.; Boshoff, H. I.; Mizrahi, V.; Rubin, E. J. Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One 2013; 23;8(9):e75245.'},{id:"B49",body:'Tobin, D. M.; Ramakrishnan, L. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell. Microbiol. 2008 ;10(5):1027-1039.'},{id:"B50",body:'50Piton, J.; Foo, C. S.Y.; Cole, S. T. Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors. Drug Discovery Today 2017;22(3):526-533.'},{id:"B51",body:'Pienaar, E.; Sarathy, J.; Prideaux, B.; Dietzold, J.; Dartois, V.; Kirschner, D. E.; Linderman, J. J. Comparing efficacies of moxifloxacin, levofloxacin and Gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach. PLoS Comput. Biol. 2017; 17;13(8):e1005650.'},{id:"B52",body:'Angelo Iacobino, Giovanni Piccaro, Federico Giannoni, Alessandro Mustazzolu, Lanfranco Fattorini. Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH. Antimicrobial Agents and Chemotherapy 2017; 23;61(3):e02296-16.'},{id:"B53",body:'Raju Mukherjee, Anup Chandra Pal, Mousumi Banerjee. Enabling faster go/No-go decisions through secondary screens in anti-mycobacterial drug discovery. Tuberculosis 2017 ;106:44-52.'},{id:"B54",body:'Zheng, X.; Av-Gay, Y. New era of Tb drug discovery and its impact on disease management. Curr. Treat. Options Infect. Dis. 2016; 8,299-310.'},{id:"B55",body:'Moreira, W.; Ngan, G. J.; Low, J. L.; Poulsen, A.; Chia, B. C.; Ang, M. J.; Yap, A.; Fulwood, J.; Lakshmanan, U.; Lim, J. Target Mechanism-Based Whole-Cell Screening Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria. mBio 2015, 6, e00253−00215.'},{id:"B56",body:'Palmer, A. C.; Kishony, R. Opposing effects of target overexpression reveal drug mechanisms. Nat. Commun. 2014, 5, 4296.'},{id:"B57",body:'Sorrentino, F.; del Rio, R. G.; Zheng, X.; Matilla, J. P.; Gomez, P. T.; Hoyos, M. M.; Herran, M. E. P.; Losana, A. M.; Av-Gay, Y. Development of an intracellular screen for new compounds able to inhibit Mycobacterium tuberculosis growth in human macrophages. Antimicrob. Agents Chemother. 2015 Oct 26;60(1):640-645.'},{id:"B58",body:'Wang, F.; Sambandan, D.; Halder, R.; Wang, J.; Batt, S. M.; Weinrick, B.; Ahmad, I.; Yang, P.; Zhang, Y.; Kim, J. Identification of a small molecule with activity against drug-resistant and persistent tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110, E2510−E2517'},{id:"B59",body:'Hung, A. W.; Silvestre, H. L.; Wen, S.; Ciulli, A.; Blundell, T. L.; Abell, C. Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase. Angew. Chem., Int. Ed. 2009, 48, 8452− 8456.'},{id:"B60",body:'Bonnett, S. A.; Ollinger, J.; Chandrasekera, S.; Florio, S.; O’Malley, T.; Files, M.; Jee, J.-A.; Ahn, J.; Casey, A.; Ovechkina, Y. A Target-Based Whole Cell Screen Approach to Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase. ACS Infect. Dis. 2016; 9;2(12):893-902.'},{id:"B61",body:'Pavelka, M. S., Jr.; Chen, B.; Kelley, C. L.; Collins, F. M.; Jacobs, W. R., Jr Vaccine efficacy of a lysine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 2003; 71(7):4190-4192.'},{id:"B62",body:'Xie, Z.; Siddiqi, N.; Rubin, E. J. Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 2005, 49, 4778−4780.'},{id:"B63",body:'Cadena, A. M.; Fortune, S. M.; Flynn, J. L. Heterogeneity in tuberculosis. Nat. Rev. Immunol. 2017;17(11):691-702.'},{id:"B64",body:'Christophe T, Ewann F, Jeon HK, Cechetto J, Brodin P. High-content imaging of Mycobacterium tuberculosis-infected macrophages: An in vitro model for tuberculosis drug discovery. Future Med Chem. 2010 Aug;2(8):1283-1293.'},{id:"B65",body:'Two hour detection of MTB and resistance to rifampicin”, Cepheid International, 2011 (www.cepheidinternational.com).'},{id:"B66",body:'Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-López EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010 Jan;48(1):229-237.'},{id:"B67",body:'DeBarber, A. E.; Mdluli, K.; Bosman, M.; Bekker, L.-G.; Barry, C. E. Ethionamide Activation and Sensitivity in Multidrug-Resistant Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 2000; 15;97(17):9677-82.'},{id:"B68",body:'Tousif S, Ahmad S, Bhalla K, Moodley P, Das G (2015) Challenges of tuberculosis treatment with DOTS: An immune impairment perspective. J Cell Sci Ther 6: 223.'},{id:"B69",body:'Boshoff, H. I.; Myers, T. G.; Copp, B. R.; McNeil, M. R.; Wilson, M. A.; Barry, C. E., 3rd The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: Novel Insights into Drug Mechanisms of Action. J. Biol. Chem. 2004, 279, 40174−40184.'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Manish Dwivedi",address:"mdwivedi@lko.amity.edu",affiliation:'
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow, India
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow, India
'}],corrections:null},book:{id:"10542",type:"book",title:"Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex",subtitle:null,fullTitle:"Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex",slug:"molecular-epidemiology-study-of-mycobacterium-tuberculosis-complex",publishedDate:"September 15th 2021",bookSignature:"Yogendra Shah",coverURL:"https://cdn.intechopen.com/books/images_new/10542.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83968-100-4",printIsbn:"978-1-83968-099-1",pdfIsbn:"978-1-83968-101-1",isAvailableForWebshopOrdering:!0,editors:[{id:"278914",title:"Ph.D.",name:"Yogendra",middleName:null,surname:"Shah",slug:"yogendra-shah",fullName:"Yogendra Shah"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"18378",title:"Emeritus Prof.",name:"Satoru",middleName:null,surname:"Okamoto",email:"okamoto@cis.shimane-u.ac.jp",fullName:"Satoru Okamoto",slug:"satoru-okamoto",position:null,biography:"Dr. Satoru Okamoto is currently a Professor in the Interdisciplinary Graduate School of Science and Engineering at Shimane University, Japan since 1995. He pursued his degree in M.Sc. in 1977 and Ph. D in mechanical engineering in 1980 from Osaka University. Then, he worked as a researcher in the Research & Development Department at Ishikawajima-Harima Heavy Industries Co., Ltd (IHI). At IHI, he worked as a researcher of aircraft engines and gas turbines, and had also designed compressors and fans of jet engines. Prof. Okamoto has served as Editorial Board Member for leading energy journals and Chairperson of the 10th International Symposium on Advanced Science and Technology in Experimental Mechanics (10th ISEM \\'15-Matsue). In addition, he has published over 150 journal and conference publications, as well as 4 book chapter-authors for his researching performance.",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/18378/images/1657_n.jpg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"1",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:{name:"Shimane University",institutionURL:null,country:{name:"Japan"}}},booksEdited:[{id:"114",type:"book",slug:"wind-tunnels",title:"Wind Tunnels",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/114.jpg",abstract:"Although great advances in computational methods have been made in recent years, wind tunnel tests remain essential for obtaining the full range of data required to guide detailed design decisions for various practical engineering problems.\nThis book collects original and innovative research studies on recent applications in wind tunnel tests, exhibiting various investigation directions and providing a bird’s eye view on this broad subject area. It is composed of seven chapters that have been grouped in two major parts. The first part of the book (chapters 1–4) deals with wind tunnel technologies and devices. The second part (chapters 5–7) deals with the latest applications of wind tunnel testing. \nThe text is addressed not only to researchers but also to professional engineers, engineering lecturers, and students seeking to gain better understanding of the current status of wind tunnels. Through its seven chapters, the reader will have an access to a wide range of works related to wind tunnel testing.",editors:[{id:"18378",title:"Emeritus Prof.",name:"Satoru",surname:"Okamoto",slug:"satoru-okamoto",fullName:"Satoru Okamoto"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",title:"Edited Volume"}}],chaptersAuthored:[{id:"13564",title:"Experimental Study of Flow-Induced Vibrations and Scattering of Roof Tiles by Wind Tunnel Testing",slug:"experimental-study-of-flow-induced-vibrations-and-scattering-of-roof-tiles-by-wind-tunnel-testing",abstract:null,signatures:"Satoru Okamoto",authors:[{id:"18378",title:"Emeritus Prof.",name:"Satoru",surname:"Okamoto",fullName:"Satoru Okamoto",slug:"satoru-okamoto",email:"okamoto@cis.shimane-u.ac.jp"}],book:{id:"114",title:"Wind Tunnels",slug:"wind-tunnels",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"19357",title:"Dr.",name:"Xuechao",surname:"Duan",slug:"xuechao-duan",fullName:"Xuechao Duan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"19389",title:"Dr.",name:"Yuanying",surname:"Qiu",slug:"yuanying-qiu",fullName:"Yuanying Qiu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Xidian University",institutionURL:null,country:{name:"China"}}},{id:"19487",title:"Dr.",name:"Jonathan",surname:"Merrison",slug:"jonathan-merrison",fullName:"Jonathan Merrison",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"21493",title:"Dr.",name:"Ben Zion",surname:"Sandler",slug:"ben-zion-sandler",fullName:"Ben Zion Sandler",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"22276",title:"Dr.",name:"Marco",surname:"Marini",slug:"marco-marini",fullName:"Marco Marini",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"22445",title:"Dr.",name:"Xin",surname:"Liu",slug:"xin-liu",fullName:"Xin Liu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"22711",title:"Ms.",name:"Sara",surname:"Di Benedetto",slug:"sara-di-benedetto",fullName:"Sara Di Benedetto",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"55707",title:"Prof.",name:"V.",surname:"Portman",slug:"v.-portman",fullName:"V. Portman",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"55709",title:"Dr.",name:"V.",surname:"Chapsky",slug:"v.-chapsky",fullName:"V. Chapsky",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"55711",title:"Prof.",name:"I.",surname:"Zilberman",slug:"i.-zilberman",fullName:"I. Zilberman",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"open-access-funding-institutions-list",title:"List of Institutions by Country",intro:"
If you are associated with any of the institutions in our list below, you can apply to receive OA publication funds by following the instructions provided in the links.
",metaTitle:"List of Institutions by Country",metaDescription:"If you are associated with any of the institutions in our list below, you can apply to receive OA publication funds by following the instructions provided in the links. However, if your research is financed through any of the below-mentioned funders, please consult their Open Access policies or grant ‘terms and conditions’ to explore ways to cover your publication costs (also accessible by clicking on the link in their title).",metaKeywords:null,canonicalURL:"open-access-funding-institutions-list",contentRaw:'[{"type":"htmlEditorComponent","content":"
Corresponding authors will receive a 25% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters. A 20% discount for publishing a long-form monographs, 25% for compacts and 23% for short-form monographs.
\\n\\n
CSIC affiliated authors can also take advantage of a central Open Access fund (amounting to 10,000 EUR) to cover up to 50% of the rest of the OAPF until it expires. Effective for chapters accepted from January 1, 2020.
Corresponding authors will receive a 25% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters. A 20% discount for publishing a long-form monographs, 25% for compacts and 23% for short-form monographs.
Corresponding authors will receive a 25% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters. A 20% discount for publishing a long-form monographs, 25% for compacts and 23% for short-form monographs.
Corresponding authors will receive a 25% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters. A 20% discount for publishing a long-form monographs, 25% for compacts and 23% for short-form monographs.
The Claremont Colleges are pledging funds via the Knowledge Unlatched program to ensure academics can publish Open Access content more easily.
\\n\\n
Corresponding authors will receive a 15% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters or monograph publications. To use the discount you will need to verify your institutional email address. These discounts are valid from 2020 to 2022.
The University of Massachusetts, Amherst is pledging funds via the Knowledge Unlatched program to ensure academics can publish Open Access content more easily.
\\n\\n
Corresponding authors will receive a 10% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters or monograph publications. To use the discount you will need to verify your institutional email address. These discounts are valid from 2020 to 2022.
The University of Surrey is pledging funds via the Knowledge Unlatched program to ensure academics can publish Open Access content more easily.
\\n\\n
Corresponding authors will receive a 10% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters or monograph publications. To use the discount you will need to verify your institutional email address. These discounts are valid from 2020 to 2022.
\\n\\n
\\n\\t
Virginia Polytechnic Institute and State University
Corresponding authors will receive a 25% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters. A 20% discount for publishing a long-form monographs, 25% for compacts and 23% for short-form monographs.
\n\n
CSIC affiliated authors can also take advantage of a central Open Access fund (amounting to 10,000 EUR) to cover up to 50% of the rest of the OAPF until it expires. Effective for chapters accepted from January 1, 2020.
Corresponding authors will receive a 25% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters. A 20% discount for publishing a long-form monographs, 25% for compacts and 23% for short-form monographs.
Corresponding authors will receive a 25% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters. A 20% discount for publishing a long-form monographs, 25% for compacts and 23% for short-form monographs.
Corresponding authors will receive a 25% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters. A 20% discount for publishing a long-form monographs, 25% for compacts and 23% for short-form monographs.
The Claremont Colleges are pledging funds via the Knowledge Unlatched program to ensure academics can publish Open Access content more easily.
\n\n
Corresponding authors will receive a 15% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters or monograph publications. To use the discount you will need to verify your institutional email address. These discounts are valid from 2020 to 2022.
The University of Massachusetts, Amherst is pledging funds via the Knowledge Unlatched program to ensure academics can publish Open Access content more easily.
\n\n
Corresponding authors will receive a 10% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters or monograph publications. To use the discount you will need to verify your institutional email address. These discounts are valid from 2020 to 2022.
The University of Surrey is pledging funds via the Knowledge Unlatched program to ensure academics can publish Open Access content more easily.
\n\n
Corresponding authors will receive a 10% discount on their Open Access Publication Fees (OAPF) for Open Access book chapters or monograph publications. To use the discount you will need to verify your institutional email address. These discounts are valid from 2020 to 2022.
\n\n
\n\t
Virginia Polytechnic Institute and State University
Important: You must be a member or grantee of the above listed institutions in order to apply for their Open Access publication funds.
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"58592",title:"Dr.",name:"Arun",middleName:null,surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/58592/images/1664_n.jpg",biography:"Arun K. Shanker is serving as a Principal Scientist (Plant Physiology) with the Indian Council of Agricultural Research (ICAR) at the Central Research Institute for Dryland Agriculture in Hyderabad, India. He is working with the ICAR as a full time researcher since 1993 and has since earned his Advanced degree in Crop Physiology while in service. He has been awarded the prestigious Member of the Royal Society of Chemistry (MRSC), by the Royal Society of Chemistry, London in 2015. Presently he is working on systems biology approach to study the mechanism of abiotic stress tolerance in crops. His main focus now is to unravel the mechanism of drought and heat stress response in plants to tackle climate change related threats in agriculture.",institutionString:null,institution:{name:"Indian Council of Agricultural Research",country:{name:"India"}}},{id:"4782",title:"Prof.",name:"Bishnu",middleName:"P",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/4782/images/system/4782.jpg",biography:"Bishnu P. Pal is Professor of Physics at Mahindra École\nCentrale Hyderabad India since July 1st 2014 after retirement\nas Professor of Physics from IIT Delhi; Ph.D.’1975 from IIT\nDelhi; Fellow of OSA and SPIE; Senior Member IEEE;\nHonorary Foreign Member Royal Norwegian Society for\nScience and Arts; Member OSA Board of Directors (2009-\n11); Distinguished Lecturer IEEE Photonics Society (2005-\n07).",institutionString:null,institution:{name:"Indian Institute of Technology Delhi",country:{name:"India"}}},{id:"69653",title:"Dr.",name:"Chusak",middleName:null,surname:"Limsakul",slug:"chusak-limsakul",fullName:"Chusak Limsakul",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Prince of Songkla University",country:{name:"Thailand"}}},{id:"23804",title:"Dr.",name:"Hamzah",middleName:null,surname:"Arof",slug:"hamzah-arof",fullName:"Hamzah Arof",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/23804/images/5492_n.jpg",biography:"Hamzah Arof received his BSc from Michigan State University, and PhD from the University of Wales. Both degrees were in electrical engineering. His current research interests include signal processing and photonics. Currently he is affiliated with the Department of Electrical Engineering, University of Malaya, Malaysia.",institutionString:null,institution:{name:"University of Malaya",country:{name:"Malaysia"}}},{id:"41989",title:"Prof.",name:"He",middleName:null,surname:"Tian",slug:"he-tian",fullName:"He Tian",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"East China University of Science and Technology",country:{name:"China"}}},{id:"33351",title:null,name:"Hendra",middleName:null,surname:"Hermawan",slug:"hendra-hermawan",fullName:"Hendra Hermawan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/33351/images/168_n.jpg",biography:null,institutionString:null,institution:{name:"Institut Teknologi Bandung",country:{name:"Indonesia"}}},{id:"11981",title:"Prof.",name:"Hiroshi",middleName:null,surname:"Ishiguro",slug:"hiroshi-ishiguro",fullName:"Hiroshi Ishiguro",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRglaQAC/Profile_Picture_1626411846553",biography:"Hiroshi Ishiguro is an award-winning roboticist and innovator. As the Director of the Intelligent Robotics Laboratory, which is part of the Department of Systems Innovation in the Graduate School of Engineering Science at Osaka University, Japan, Ishiguro concentrates on making robots that are similar as possible to humans to understand the human species. A notable project of his laboratory is the Actroid, a humanoid robot with a lifelike appearance and observable behavior such as facial movements. (Sources: http://www.geminoid.jp/en/index.html, https://en.wikipedia.org/wiki/Hiroshi_Ishiguro)",institutionString:null,institution:{name:"Osaka University",country:{name:"Japan"}}},{id:"45747",title:"Dr.",name:"Hsin-I",middleName:null,surname:"Chang",slug:"hsin-i-chang",fullName:"Hsin-I Chang",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"National Chiayi University",country:{name:"Taiwan"}}},{id:"61581",title:"Dr.",name:"Joy Rizki Pangestu",middleName:null,surname:"Djuansjah",slug:"joy-rizki-pangestu-djuansjah",fullName:"Joy Rizki Pangestu Djuansjah",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/61581/images/237_n.jpg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"94249",title:"Prof.",name:"Junji",middleName:null,surname:"Kido",slug:"junji-kido",fullName:"Junji Kido",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Yamagata University",country:{name:"Japan"}}},{id:"12009",title:"Dr.",name:"Ki Young",middleName:null,surname:"Kim",slug:"ki-young-kim",fullName:"Ki Young Kim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12009/images/system/12009.jpg",biography:"Http://m80.knu.ac.kr/~doors",institutionString:null,institution:{name:"National Cheng Kung University",country:{name:"Taiwan"}}},{id:"132595",title:"Prof.",name:"Long",middleName:null,surname:"Wang",slug:"long-wang",fullName:"Long Wang",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Peking University",country:{name:"China"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6581},{group:"region",caption:"Middle and South America",value:2,count:5888},{group:"region",caption:"Africa",value:3,count:2381},{group:"region",caption:"Asia",value:4,count:12507},{group:"region",caption:"Australia and Oceania",value:5,count:1006},{group:"region",caption:"Europe",value:6,count:17529}],offset:12,limit:12,total:12507},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{topicId:"11"},books:[{type:"book",id:"11168",title:"Sulfur Industry",subtitle:null,isOpenForSubmission:!0,hash:"39d4f4522a9f465bfe15ec2d85ef8861",slug:null,bookSignature:"Dr. Enos Wamalwa Wambu and Dr. Esther Nthiga",coverURL:"https://cdn.intechopen.com/books/images_new/11168.jpg",editedByType:null,editors:[{id:"187655",title:"Dr.",name:"Enos",surname:"Wambu",slug:"enos-wambu",fullName:"Enos Wambu"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11449",title:"Telehealth / Telemedicine – The Far-Reaching Medicine for Everyone and Everywhere",subtitle:null,isOpenForSubmission:!0,hash:"71545975025beddf27aa2931e0af5408",slug:null,bookSignature:"Dr. Tang-Chuan Wang",coverURL:"https://cdn.intechopen.com/books/images_new/11449.jpg",editedByType:null,editors:[{id:"201262",title:"Dr.",name:"Tang-Chuan",surname:"Wang",slug:"tang-chuan-wang",fullName:"Tang-Chuan Wang"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11451",title:"Molecular Docking - Recent Advances",subtitle:null,isOpenForSubmission:!0,hash:"8c918a1973786c7059752b28601f1329",slug:null,bookSignature:"Dr. Erman Salih Istifli",coverURL:"https://cdn.intechopen.com/books/images_new/11451.jpg",editedByType:null,editors:[{id:"179007",title:"Dr.",name:"Erman Salih",surname:"Istifli",slug:"erman-salih-istifli",fullName:"Erman Salih Istifli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11452",title:"Cryopreservation - Applications and Challenges",subtitle:null,isOpenForSubmission:!0,hash:"a6c3fd4384ff7deeab32fc82722c60e0",slug:null,bookSignature:"Dr. Marian Quain",coverURL:"https://cdn.intechopen.com/books/images_new/11452.jpg",editedByType:null,editors:[{id:"300385",title:"Dr.",name:"Marian",surname:"Quain",slug:"marian-quain",fullName:"Marian Quain"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11453",title:"Biomimetics - Bridging the Gap",subtitle:null,isOpenForSubmission:!0,hash:"173e62fa4d7bf5508cec3bdd8e3cb32d",slug:null,bookSignature:"Prof. Ziyad S. Haidar",coverURL:"https://cdn.intechopen.com/books/images_new/11453.jpg",editedByType:null,editors:[{id:"222709",title:"Prof.",name:"Ziyad S.",surname:"Haidar",slug:"ziyad-s.-haidar",fullName:"Ziyad S. Haidar"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11506",title:"Antenna Arrays",subtitle:null,isOpenForSubmission:!0,hash:"1b378e33d6f6e73721ee0dacbbb89aa1",slug:null,bookSignature:"Prof. Hussain Al-Rizzo, Dr. Nijas Kunju and Dr. Aldebaro Klautau",coverURL:"https://cdn.intechopen.com/books/images_new/11506.jpg",editedByType:null,editors:[{id:"153384",title:"Prof.",name:"Hussain",surname:"Al-Rizzo",slug:"hussain-al-rizzo",fullName:"Hussain Al-Rizzo"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11507",title:"New Generation of Sustainable Smart Cities",subtitle:null,isOpenForSubmission:!0,hash:"dc693757b86ab8742367a38cda6cb622",slug:null,bookSignature:"Prof. Amjad Almusaed and Prof. Asaad Almssad",coverURL:"https://cdn.intechopen.com/books/images_new/11507.jpg",editedByType:null,editors:[{id:"446856",title:"Prof.",name:"Amjad",surname:"Almusaed",slug:"amjad-almusaed",fullName:"Amjad Almusaed"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11509",title:"Wireless Power Transfer - Perspectives and Application",subtitle:null,isOpenForSubmission:!0,hash:"f188555eee4211fc24b6cca361983149",slug:null,bookSignature:"Dr. Kim Ho Yeap",coverURL:"https://cdn.intechopen.com/books/images_new/11509.jpg",editedByType:null,editors:[{id:"126825",title:"Dr.",name:"Kim Ho",surname:"Yeap",slug:"kim-ho-yeap",fullName:"Kim Ho Yeap"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11510",title:"New Trends in Electric Machines - Technology and Applications",subtitle:null,isOpenForSubmission:!0,hash:"f57b5e35a1bf18acd4fd0d41fe59f49c",slug:null,bookSignature:"Dr. Miguel Delgado Prieto, Dr. José Alfonso Antonino-Daviu and Dr. Roque A. Osornio-Rios",coverURL:"https://cdn.intechopen.com/books/images_new/11510.jpg",editedByType:null,editors:[{id:"234568",title:"Dr.",name:"Miguel",surname:"Delgado Prieto",slug:"miguel-delgado-prieto",fullName:"Miguel Delgado Prieto"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11512",title:"Photodetectors - Recent Advances, New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"01d4be8e37c9bf12fd8dcb67c135b29b",slug:null,bookSignature:"Prof. Kuan W. A. Chee",coverURL:"https://cdn.intechopen.com/books/images_new/11512.jpg",editedByType:null,editors:[{id:"206271",title:"Prof.",name:"Kuan",surname:"Chee",slug:"kuan-chee",fullName:"Kuan Chee"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11513",title:"Gas Sensors",subtitle:null,isOpenForSubmission:!0,hash:"8eeb7ab232fa8d5c723b61e0da251857",slug:null,bookSignature:"Dr. Soumen Dhara and Dr. Gorachand Dutta",coverURL:"https://cdn.intechopen.com/books/images_new/11513.jpg",editedByType:null,editors:[{id:"196334",title:"Dr.",name:"Soumen",surname:"Dhara",slug:"soumen-dhara",fullName:"Soumen Dhara"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11514",title:"Vision Sensors - Recent Advances",subtitle:null,isOpenForSubmission:!0,hash:"6da8427ef3062c142b4e9650a5fed534",slug:null,bookSignature:"Dr. Francisco J. Gallegos-Funes",coverURL:"https://cdn.intechopen.com/books/images_new/11514.jpg",editedByType:null,editors:[{id:"2868",title:"Dr.",name:"Francisco",surname:"Gallegos-Funes",slug:"francisco-gallegos-funes",fullName:"Francisco Gallegos-Funes"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:41},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:11},{group:"topic",caption:"Business, Management and Economics",value:7,count:6},{group:"topic",caption:"Chemistry",value:8,count:20},{group:"topic",caption:"Computer and Information Science",value:9,count:20},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:15},{group:"topic",caption:"Engineering",value:11,count:60},{group:"topic",caption:"Environmental Sciences",value:12,count:8},{group:"topic",caption:"Immunology and Microbiology",value:13,count:9},{group:"topic",caption:"Materials Science",value:14,count:27},{group:"topic",caption:"Mathematics",value:15,count:9},{group:"topic",caption:"Medicine",value:16,count:122},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:9},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:6},{group:"topic",caption:"Physics",value:20,count:11},{group:"topic",caption:"Psychology",value:21,count:10},{group:"topic",caption:"Robotics",value:22,count:4},{group:"topic",caption:"Social Sciences",value:23,count:9},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:4}],offset:12,limit:12,total:103},popularBooks:{featuredBooks:[{type:"book",id:"10584",title:"Engineered Wood Products for Construction",subtitle:null,isOpenForSubmission:!1,hash:"421757c56a3735986055250821275a51",slug:"engineered-wood-products-for-construction",bookSignature:"Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",editors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10222",title:"Demyelination Disorders",subtitle:null,isOpenForSubmission:!1,hash:"b6c26ceccacdde70c41c587361bd5558",slug:"demyelination-disorders",bookSignature:"Stavros J. Baloyannis, Fabian H. Rossi and Welwin Liu",coverURL:"https://cdn.intechopen.com/books/images_new/10222.jpg",editors:[{id:"156098",title:"Emeritus Prof.",name:"Stavros J.",middleName:"J.",surname:"Baloyannis",slug:"stavros-j.-baloyannis",fullName:"Stavros J. Baloyannis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9544",title:"Global Trade in the Emerging Business Environment",subtitle:null,isOpenForSubmission:!1,hash:"fb8cb09b9599246add78d508a98273d5",slug:"global-trade-in-the-emerging-business-environment",bookSignature:"Muhammad Mohiuddin, Jingbin Wang , Md. Samim Al Azad and Selim Ahmed",coverURL:"https://cdn.intechopen.com/books/images_new/9544.jpg",editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10979",title:"Parenting",subtitle:"Challenges of Child Rearing in a Changing Society",isOpenForSubmission:!1,hash:"6f345ebcf4fd61e73643c69063a12c7b",slug:"parenting-challenges-of-child-rearing-in-a-changing-society",bookSignature:"Sayyed Ali Samadi",coverURL:"https://cdn.intechopen.com/books/images_new/10979.jpg",editors:[{id:"52145",title:"Dr.",name:"Sayyed Ali",middleName:null,surname:"Samadi",slug:"sayyed-ali-samadi",fullName:"Sayyed Ali Samadi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9808",title:"Contemporary Topics in Patient Safety",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"fb6371607c2c6c02c6a2af8892765aba",slug:"contemporary-topics-in-patient-safety-volume-1",bookSignature:"Stanislaw P. Stawicki and Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/9808.jpg",editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10681",title:"Biodegradation Technology of Organic and Inorganic Pollutants",subtitle:null,isOpenForSubmission:!1,hash:"9a6e10e02788092872fd249436898e97",slug:"biodegradation-technology-of-organic-and-inorganic-pollutants",bookSignature:"Kassio Ferreira Mendes, Rodrigo Nogueira de Sousa and Kamila Cabral Mielke",coverURL:"https://cdn.intechopen.com/books/images_new/10681.jpg",editors:[{id:"197720",title:"Ph.D.",name:"Kassio",middleName:null,surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10764",title:"Antenna Systems",subtitle:null,isOpenForSubmission:!1,hash:"2fbf1c7a5d92723f08198fc9b526a8ad",slug:"antenna-systems",bookSignature:"Hussain Al-Rizzo and Said Abushamleh",coverURL:"https://cdn.intechopen.com/books/images_new/10764.jpg",editors:[{id:"153384",title:"Prof.",name:"Hussain",middleName:null,surname:"Al-Rizzo",slug:"hussain-al-rizzo",fullName:"Hussain Al-Rizzo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10668",title:"Sustainability of Concrete With Synthetic and Recycled Aggregates",subtitle:null,isOpenForSubmission:!1,hash:"55856c6a8bc3a5b21dae5a1af09a56b6",slug:"sustainability-of-concrete-with-synthetic-and-recycled-aggregates",bookSignature:"Hosam M. Saleh",coverURL:"https://cdn.intechopen.com/books/images_new/10668.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam",middleName:null,surname:"Saleh",slug:"hosam-saleh",fullName:"Hosam Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,isOpenForSubmission:!1,hash:"176adcf090fdd1f93cb8ce3146e79ca1",slug:"reactive-oxygen-species",bookSignature:"Rizwan Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9032",title:"Corporate Social Responsibility",subtitle:null,isOpenForSubmission:!1,hash:"f609bf3251d7cc7bae0099a4374adfc3",slug:"corporate-social-responsibility",bookSignature:"Beatrice Orlando",coverURL:"https://cdn.intechopen.com/books/images_new/9032.jpg",editors:[{id:"232969",title:"Prof.",name:"Beatrice",middleName:null,surname:"Orlando",slug:"beatrice-orlando",fullName:"Beatrice Orlando"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10351",title:"Enhanced Liposuction",subtitle:"New Perspectives and Techniques",isOpenForSubmission:!1,hash:"f08ed6de16da357614586c5b58ed4dfa",slug:"enhanced-liposuction-new-perspectives-and-techniques",bookSignature:"Diane Irvine Duncan",coverURL:"https://cdn.intechopen.com/books/images_new/10351.jpg",editors:[{id:"279869",title:"Dr.",name:"Diane Irvine",middleName:null,surname:"Duncan",slug:"diane-irvine-duncan",fullName:"Diane Irvine Duncan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10779",title:"21st Century Nanostructured Materials",subtitle:"Physics, Chemistry, Classification, and Emerging Applications in Industry, Biomedicine, and Agriculture",isOpenForSubmission:!1,hash:"72c67f97f9bef68200df115b5fd79884",slug:"21st-century-nanostructured-materials-physics-chemistry-classification-and-emerging-applications-in-industry-biomedicine-and-agriculture",bookSignature:"Phuong V. Pham",coverURL:"https://cdn.intechopen.com/books/images_new/10779.jpg",editors:[{id:"236073",title:"Dr.",name:"Phuong",middleName:"Viet",surname:"Pham",slug:"phuong-pham",fullName:"Phuong Pham"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4386},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10584",title:"Engineered Wood Products for Construction",subtitle:null,isOpenForSubmission:!1,hash:"421757c56a3735986055250821275a51",slug:"engineered-wood-products-for-construction",bookSignature:"Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",publishedDate:"April 28th 2022",numberOfDownloads:3665,editors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10222",title:"Demyelination Disorders",subtitle:null,isOpenForSubmission:!1,hash:"b6c26ceccacdde70c41c587361bd5558",slug:"demyelination-disorders",bookSignature:"Stavros J. Baloyannis, Fabian H. Rossi and Welwin Liu",coverURL:"https://cdn.intechopen.com/books/images_new/10222.jpg",publishedDate:"May 4th 2022",numberOfDownloads:1713,editors:[{id:"156098",title:"Emeritus Prof.",name:"Stavros J.",middleName:"J.",surname:"Baloyannis",slug:"stavros-j.-baloyannis",fullName:"Stavros J. Baloyannis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9544",title:"Global Trade in the Emerging Business Environment",subtitle:null,isOpenForSubmission:!1,hash:"fb8cb09b9599246add78d508a98273d5",slug:"global-trade-in-the-emerging-business-environment",bookSignature:"Muhammad Mohiuddin, Jingbin Wang , Md. Samim Al Azad and Selim Ahmed",coverURL:"https://cdn.intechopen.com/books/images_new/9544.jpg",publishedDate:"April 28th 2022",numberOfDownloads:2481,editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10979",title:"Parenting",subtitle:"Challenges of Child Rearing in a Changing Society",isOpenForSubmission:!1,hash:"6f345ebcf4fd61e73643c69063a12c7b",slug:"parenting-challenges-of-child-rearing-in-a-changing-society",bookSignature:"Sayyed Ali Samadi",coverURL:"https://cdn.intechopen.com/books/images_new/10979.jpg",publishedDate:"May 4th 2022",numberOfDownloads:1107,editors:[{id:"52145",title:"Dr.",name:"Sayyed Ali",middleName:null,surname:"Samadi",slug:"sayyed-ali-samadi",fullName:"Sayyed Ali Samadi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9808",title:"Contemporary Topics in Patient Safety",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"fb6371607c2c6c02c6a2af8892765aba",slug:"contemporary-topics-in-patient-safety-volume-1",bookSignature:"Stanislaw P. Stawicki and Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/9808.jpg",publishedDate:"April 20th 2022",numberOfDownloads:3307,editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10681",title:"Biodegradation Technology of Organic and Inorganic Pollutants",subtitle:null,isOpenForSubmission:!1,hash:"9a6e10e02788092872fd249436898e97",slug:"biodegradation-technology-of-organic-and-inorganic-pollutants",bookSignature:"Kassio Ferreira Mendes, Rodrigo Nogueira de Sousa and Kamila Cabral Mielke",coverURL:"https://cdn.intechopen.com/books/images_new/10681.jpg",publishedDate:"April 20th 2022",numberOfDownloads:3266,editors:[{id:"197720",title:"Ph.D.",name:"Kassio",middleName:null,surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10764",title:"Antenna Systems",subtitle:null,isOpenForSubmission:!1,hash:"2fbf1c7a5d92723f08198fc9b526a8ad",slug:"antenna-systems",bookSignature:"Hussain Al-Rizzo and Said Abushamleh",coverURL:"https://cdn.intechopen.com/books/images_new/10764.jpg",publishedDate:"April 28th 2022",numberOfDownloads:1868,editors:[{id:"153384",title:"Prof.",name:"Hussain",middleName:null,surname:"Al-Rizzo",slug:"hussain-al-rizzo",fullName:"Hussain Al-Rizzo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10668",title:"Sustainability of Concrete With Synthetic and Recycled Aggregates",subtitle:null,isOpenForSubmission:!1,hash:"55856c6a8bc3a5b21dae5a1af09a56b6",slug:"sustainability-of-concrete-with-synthetic-and-recycled-aggregates",bookSignature:"Hosam M. Saleh",coverURL:"https://cdn.intechopen.com/books/images_new/10668.jpg",publishedDate:"May 4th 2022",numberOfDownloads:856,editors:[{id:"144691",title:"Prof.",name:"Hosam",middleName:null,surname:"Saleh",slug:"hosam-saleh",fullName:"Hosam Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,isOpenForSubmission:!1,hash:"176adcf090fdd1f93cb8ce3146e79ca1",slug:"reactive-oxygen-species",bookSignature:"Rizwan Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",publishedDate:"April 28th 2022",numberOfDownloads:1704,editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9032",title:"Corporate Social Responsibility",subtitle:null,isOpenForSubmission:!1,hash:"f609bf3251d7cc7bae0099a4374adfc3",slug:"corporate-social-responsibility",bookSignature:"Beatrice Orlando",coverURL:"https://cdn.intechopen.com/books/images_new/9032.jpg",publishedDate:"March 16th 2022",numberOfDownloads:7489,editors:[{id:"232969",title:"Prof.",name:"Beatrice",middleName:null,surname:"Orlando",slug:"beatrice-orlando",fullName:"Beatrice Orlando"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"8737",title:"Rabies Virus at the Beginning of 21st Century",subtitle:null,isOpenForSubmission:!1,hash:"49cce3f548da548c718c865feb343509",slug:"rabies-virus-at-the-beginning-of-21st-century",bookSignature:"Sergey Tkachev",coverURL:"https://cdn.intechopen.com/books/images_new/8737.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"61139",title:"Dr.",name:"Sergey",middleName:null,surname:"Tkachev",slug:"sergey-tkachev",fullName:"Sergey Tkachev"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10861",title:"Furan Derivatives",subtitle:"Recent Advances and Applications",isOpenForSubmission:!1,hash:"fdfc39cecd82f91b0effac994f75c877",slug:"furan-derivatives-recent-advances-and-applications",bookSignature:"Anish Khan, Mohammed Muzibur Rahman, M. Ramesh, Salman Ahmad Khan and Abdullah Mohammed Ahmed Asiri",coverURL:"https://cdn.intechopen.com/books/images_new/10861.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"293058",title:"Dr.",name:"Anish",middleName:null,surname:"Khan",slug:"anish-khan",fullName:"Anish Khan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10356",title:"Natural Medicinal Plants",subtitle:null,isOpenForSubmission:!1,hash:"943e56ccaaf19ff696d25aa638ae37d6",slug:"natural-medicinal-plants",bookSignature:"Hany A. El-Shemy",coverURL:"https://cdn.intechopen.com/books/images_new/10356.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"54719",title:"Prof.",name:"Hany",middleName:null,surname:"El-Shemy",slug:"hany-el-shemy",fullName:"Hany El-Shemy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10870",title:"Ultrasound Imaging",subtitle:"Current Topics",isOpenForSubmission:!1,hash:"2f0bc3733ab226d67fa73759ef0e12ad",slug:"ultrasound-imaging-current-topics",bookSignature:"Felix Okechukwu Erondu",coverURL:"https://cdn.intechopen.com/books/images_new/10870.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"68312",title:"Prof.",name:"Felix",middleName:null,surname:"Okechukwu Erondu",slug:"felix-okechukwu-erondu",fullName:"Felix Okechukwu Erondu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11392",title:"Leadership in a Changing World",subtitle:"A Multidimensional Perspective",isOpenForSubmission:!1,hash:"86a6d33cf601587e591064ce92effc02",slug:"leadership-in-a-changing-world-a-multidimensional-perspective",bookSignature:"Muhammad Mohiuddin, Bilal Khalid, Md. Samim Al Azad and Slimane Ed-dafali",coverURL:"https://cdn.intechopen.com/books/images_new/11392.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10400",title:"The Application of Ant Colony Optimization",subtitle:null,isOpenForSubmission:!1,hash:"f4fdfd07ee1ab99fb7c740d6d0c144c6",slug:"the-application-of-ant-colony-optimization",bookSignature:"Ali Soofastaei",coverURL:"https://cdn.intechopen.com/books/images_new/10400.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"257455",title:"Dr.",name:"Ali",middleName:null,surname:"Soofastaei",slug:"ali-soofastaei",fullName:"Ali Soofastaei"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10915",title:"Leadership",subtitle:"New Insights",isOpenForSubmission:!1,hash:"0d72e79892f2a020cee66a52d09de5a4",slug:"leadership-new-insights",bookSignature:"Mário Franco",coverURL:"https://cdn.intechopen.com/books/images_new/10915.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"105529",title:"Dr.",name:"Mário",middleName:null,surname:"Franco",slug:"mario-franco",fullName:"Mário Franco"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10683",title:"Technological Innovations and Advances in Hydropower Engineering",subtitle:null,isOpenForSubmission:!1,hash:"7ce7ad8768bd2cad155470fe1fd883f4",slug:"technological-innovations-and-advances-in-hydropower-engineering",bookSignature:"Yizi Shang, Ling Shang and Xiaofei Li",coverURL:"https://cdn.intechopen.com/books/images_new/10683.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"349630",title:"Dr.",name:"Yizi",middleName:null,surname:"Shang",slug:"yizi-shang",fullName:"Yizi Shang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7102",title:"Pneumonia",subtitle:null,isOpenForSubmission:!1,hash:"9fd70142814192dcec58a176749f1b60",slug:"pneumonia",bookSignature:"Nima Rezaei",coverURL:"https://cdn.intechopen.com/books/images_new/7102.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9670",title:"Current Trends in Wheat Research",subtitle:null,isOpenForSubmission:!1,hash:"89d795987f1747a76eee532700d2093d",slug:"current-trends-in-wheat-research",bookSignature:"Mahmood-ur-Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9670.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"185476",title:"Dr.",name:"Mahmood-ur-Rahman",middleName:null,surname:"Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-ur-Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"1121",title:"Mechanobiology",slug:"mechanobiology",parent:{id:"197",title:"Physical Medicine and Rehabilitation",slug:"physical-medicine-and-rehabilitation"},numberOfBooks:1,numberOfSeries:0,numberOfAuthorsAndEditors:46,numberOfWosCitations:79,numberOfCrossrefCitations:36,numberOfDimensionsCitations:114,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"1121",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"291",title:"Theoretical Biomechanics",subtitle:null,isOpenForSubmission:!1,hash:"2aa3a76485400839fc28dfab42fbddc2",slug:"theoretical-biomechanics",bookSignature:"Vaclav Klika",coverURL:"https://cdn.intechopen.com/books/images_new/291.jpg",editedByType:"Edited by",editors:[{id:"8254",title:"Dr.",name:"Vaclav",middleName:null,surname:"Klika",slug:"vaclav-klika",fullName:"Vaclav Klika"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:1,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"22189",doi:"10.5772/19975",title:"Biomechanics and Modeling of Skeletal Soft Tissues",slug:"biomechanics-and-modeling-of-skeletal-soft-tissues",totalDownloads:8050,totalCrossrefCites:2,totalDimensionsCites:22,abstract:null,book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"Rami K. Korhonen and Simo Saarakkala",authors:[{id:"22848",title:"PhD.",name:"Simo",middleName:null,surname:"Saarakkala",slug:"simo-saarakkala",fullName:"Simo Saarakkala"},{id:"55617",title:"Dr.",name:"Rami K",middleName:null,surname:"Korhonen",slug:"rami-k-korhonen",fullName:"Rami K Korhonen"}]},{id:"22197",doi:"10.5772/22266",title:"Induced Acceleration Analysis of Three-Dimensional Multi-Joint Movements and Its Application to Sports Movements",slug:"induced-acceleration-analysis-of-three-dimensional-multi-joint-movements-and-its-application-to-spor",totalDownloads:4051,totalCrossrefCites:8,totalDimensionsCites:15,abstract:null,book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"Masaya Hirashima",authors:[{id:"46998",title:"Dr.",name:"Masaya",middleName:null,surname:"Hirashima",slug:"masaya-hirashima",fullName:"Masaya Hirashima"}]},{id:"22198",doi:"10.5772/23751",title:"Stability During Arboreal Locomotion",slug:"stability-during-arboreal-locomotion",totalDownloads:3032,totalCrossrefCites:1,totalDimensionsCites:14,abstract:null,book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"Andrew R. Lammers and Ulrich Zurcher",authors:[{id:"13957",title:"Dr.",name:"Ulrich",middleName:null,surname:"Zurcher",slug:"ulrich-zurcher",fullName:"Ulrich Zurcher"},{id:"53541",title:"Dr.",name:"Andrew",middleName:null,surname:"Lammers",slug:"andrew-lammers",fullName:"Andrew Lammers"}]},{id:"22193",doi:"10.5772/19977",title:"Towards a Realistic and Self-Contained Biomechanical Model of the Hand",slug:"towards-a-realistic-and-self-contained-biomechanical-model-of-the-hand",totalDownloads:3289,totalCrossrefCites:3,totalDimensionsCites:14,abstract:null,book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"Joaquín L. Sancho-Bru, Antonio Pérez-González, Marta C. Mora, Beatriz E. León, Margarita Vergara, José L. Iserte, Pablo J. Rodríguez-Cervantes and Antonio Morales",authors:[{id:"1899",title:"Ms.",name:"Marta Covadonga",middleName:null,surname:"Mora Aguilar",slug:"marta-covadonga-mora-aguilar",fullName:"Marta Covadonga Mora Aguilar"},{id:"36994",title:"Ph.D.",name:"Joaquín Luis",middleName:null,surname:"Sancho-Bru",slug:"joaquin-luis-sancho-bru",fullName:"Joaquín Luis Sancho-Bru"},{id:"54818",title:"Prof.",name:"Antonio",middleName:null,surname:"Pérez-González",slug:"antonio-perez-gonzalez",fullName:"Antonio Pérez-González"},{id:"54819",title:"Ms.",name:"Beatriz",middleName:null,surname:"Leon",slug:"beatriz-leon",fullName:"Beatriz Leon"},{id:"54820",title:"Ms.",name:"Margarita",middleName:null,surname:"Vergara",slug:"margarita-vergara",fullName:"Margarita Vergara"},{id:"54821",title:"Dr.",name:"José L.",middleName:null,surname:"Iserte-Vilar",slug:"jose-l.-iserte-vilar",fullName:"José L. Iserte-Vilar"},{id:"54822",title:"Prof.",name:"Pablo-Jesús",middleName:null,surname:"Rodríguez-Cervantes",slug:"pablo-jesus-rodriguez-cervantes",fullName:"Pablo-Jesús Rodríguez-Cervantes"},{id:"90429",title:"Prof.",name:"Antonio",middleName:null,surname:"Morales",slug:"antonio-morales",fullName:"Antonio Morales"}]},{id:"22187",doi:"10.5772/22382",title:"Functional Data Analysis for Biomechanics",slug:"functional-data-analysis-for-biomechanics",totalDownloads:4046,totalCrossrefCites:6,totalDimensionsCites:10,abstract:null,book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"Elizabeth Crane, David Childers, Geoffrey Gerstner and Edward Rothman",authors:[{id:"35150",title:"Dr.",name:"Geoffrey",middleName:null,surname:"Gerstner",slug:"geoffrey-gerstner",fullName:"Geoffrey Gerstner"},{id:"47533",title:"Dr.",name:"Elizabeth",middleName:null,surname:"Crane",slug:"elizabeth-crane",fullName:"Elizabeth Crane"},{id:"55257",title:"Mr.",name:"David",middleName:null,surname:"Childers",slug:"david-childers",fullName:"David Childers"},{id:"55258",title:"Dr.",name:"Edward",middleName:null,surname:"Rothman",slug:"edward-rothman",fullName:"Edward Rothman"}]}],mostDownloadedChaptersLast30Days:[{id:"22197",title:"Induced Acceleration Analysis of Three-Dimensional Multi-Joint Movements and Its Application to Sports Movements",slug:"induced-acceleration-analysis-of-three-dimensional-multi-joint-movements-and-its-application-to-spor",totalDownloads:4051,totalCrossrefCites:8,totalDimensionsCites:15,abstract:null,book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"Masaya Hirashima",authors:[{id:"46998",title:"Dr.",name:"Masaya",middleName:null,surname:"Hirashima",slug:"masaya-hirashima",fullName:"Masaya Hirashima"}]},{id:"22201",title:"Biomechanics of the Neck",slug:"biomechanics-of-the-neck",totalDownloads:3656,totalCrossrefCites:0,totalDimensionsCites:0,abstract:null,book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"Haibin Chen, Liying Zhang, Zhengguo Wang, King H. Yang and Albert I. King",authors:[{id:"45161",title:"Dr.",name:"Haibin",middleName:null,surname:"Chen",slug:"haibin-chen",fullName:"Haibin Chen"},{id:"116883",title:"Prof.",name:"Zhengguo",middleName:null,surname:"Wang",slug:"zhengguo-wang",fullName:"Zhengguo Wang"},{id:"116884",title:"Dr.",name:"Liying",middleName:null,surname:"Zhang",slug:"liying-zhang",fullName:"Liying Zhang"},{id:"116885",title:"Prof.",name:"King H",middleName:null,surname:"Yang",slug:"king-h-yang",fullName:"King H Yang"},{id:"116888",title:"Prof.",name:"Albert I",middleName:null,surname:"King",slug:"albert-i-king",fullName:"Albert I King"}]},{id:"22200",title:"The Biomechanics of the Anterior Cruciate Ligament and Its Reconstruction",slug:"the-biomechanics-of-the-anterior-cruciate-ligament-and-its-reconstruction",totalDownloads:4182,totalCrossrefCites:1,totalDimensionsCites:2,abstract:"There is a vast amount of literature available discussing the movements of the knee joint and the function of the ligaments controlling these movements. (Brantigan & Voshell, 1941)",book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"Christopher D. S. Jones and Paul N. Grimshaw",authors:[{id:"36851",title:"Dr.",name:"Paul",middleName:null,surname:"Grimshaw",slug:"paul-grimshaw",fullName:"Paul Grimshaw"},{id:"41198",title:"Dr.",name:"Chris",middleName:null,surname:"Jones",slug:"chris-jones",fullName:"Chris Jones"}]},{id:"22185",title:"Mechanobiology of Fracture Healing: Basic Principles and Applications in Orthodontics and Orthopaedics",slug:"mechanobiology-of-fracture-healing-basic-principles-and-applications-in-orthodontics-and-orthopaedic",totalDownloads:3664,totalCrossrefCites:4,totalDimensionsCites:9,abstract:null,book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"Antonio Boccaccio and Carmine Pappalettere",authors:[{id:"34921",title:"Dr.",name:"Antonio",middleName:null,surname:"Boccaccio",slug:"antonio-boccaccio",fullName:"Antonio Boccaccio"},{id:"53207",title:"Prof.",name:"Carmine",middleName:null,surname:"Pappalettere",slug:"carmine-pappalettere",fullName:"Carmine Pappalettere"}]},{id:"22188",title:"Biomechanical Computer Models",slug:"biomechanical-computer-models",totalDownloads:4987,totalCrossrefCites:0,totalDimensionsCites:2,abstract:null,book:{id:"291",slug:"theoretical-biomechanics",title:"Theoretical Biomechanics",fullTitle:"Theoretical Biomechanics"},signatures:"K. Engel, R. Herpers and U. Hartmann",authors:[{id:"53870",title:"Prof.",name:"Ulrich",middleName:null,surname:"Hartmann",slug:"ulrich-hartmann",fullName:"Ulrich Hartmann"},{id:"59507",title:"Mr.",name:"Karsten",middleName:null,surname:"Engel",slug:"karsten-engel",fullName:"Karsten Engel"},{id:"59508",title:"Prof.",name:"Rainer",middleName:null,surname:"Herpers",slug:"rainer-herpers",fullName:"Rainer Herpers"}]}],onlineFirstChaptersFilter:{topicId:"1121",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:8,numberOfPublishedChapters:87,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:98,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:27,numberOfPublishedChapters:285,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:139,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:0,numberOfUpcomingTopics:2,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!1},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:105,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:9,numberOfPublishedChapters:101,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:11,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:0,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!1},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:null,scope:"
\r\n\tTransforming our World: the 2030 Agenda for Sustainable Development endorsed by United Nations and 193 Member States, came into effect on Jan 1, 2016, to guide decision making and actions to the year 2030 and beyond. Central to this Agenda are 17 Goals, 169 associated targets and over 230 indicators that are reviewed annually. The vision envisaged in the implementation of the SDGs is centered on the five Ps: People, Planet, Prosperity, Peace and Partnership. This call for renewed focused efforts ensure we have a safe and healthy planet for current and future generations.
\r\n
\r\n\t
\r\n
\r\n\tThis Series focuses on covering research and applied research involving the five Ps through the following topics:
\r\n
\r\n\t
\r\n
\r\n\t1. Sustainable Economy and Fair Society that relates to SDG 1 on No Poverty, SDG 2 on Zero Hunger, SDG 8 on Decent Work and Economic Growth, SDG 10 on Reduced Inequalities, SDG 12 on Responsible Consumption and Production, and SDG 17 Partnership for the Goals
\r\n
\r\n\t
\r\n
\r\n\t2. Health and Wellbeing focusing on SDG 3 on Good Health and Wellbeing and SDG 6 on Clean Water and Sanitation
\r\n
\r\n\t
\r\n
\r\n\t3. Inclusivity and Social Equality involving SDG 4 on Quality Education, SDG 5 on Gender Equality, and SDG 16 on Peace, Justice and Strong Institutions
\r\n
\r\n\t
\r\n
\r\n\t4. Climate Change and Environmental Sustainability comprising SDG 13 on Climate Action, SDG 14 on Life Below Water, and SDG 15 on Life on Land
\r\n
\r\n\t
\r\n
\r\n\t5. Urban Planning and Environmental Management embracing SDG 7 on Affordable Clean Energy, SDG 9 on Industry, Innovation and Infrastructure, and SDG 11 on Sustainable Cities and Communities.
\r\n
\r\n\t
\r\n
\r\n\tThe series also seeks to support the use of cross cutting SDGs, as many of the goals listed above, targets and indicators are all interconnected to impact our lives and the decisions we make on a daily basis, making them impossible to tie to a single topic.
",coverUrl:"https://cdn.intechopen.com/series/covers/24.jpg",latestPublicationDate:"April 24th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:0,editor:{id:"262440",title:"Prof.",name:"Usha",middleName:null,surname:"Iyer-Raniga",slug:"usha-iyer-raniga",fullName:"Usha Iyer-Raniga",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRYSXQA4/Profile_Picture_2022-02-28T13:55:36.jpeg",biography:"Usha Iyer-Raniga is a professor in the School of Property and Construction Management at RMIT University. Usha co-leads the One Planet Network’s Sustainable Buildings and Construction Programme (SBC), a United Nations 10 Year Framework of Programmes on Sustainable Consumption and Production (UN 10FYP SCP) aligned with Sustainable Development Goal 12. The work also directly impacts SDG 11 on Sustainable Cities and Communities. She completed her undergraduate degree as an architect before obtaining her Masters degree from Canada and her Doctorate in Australia. Usha has been a keynote speaker as well as an invited speaker at national and international conferences, seminars and workshops. Her teaching experience includes teaching in Asian countries. She has advised Austrade, APEC, national, state and local governments. She serves as a reviewer and a member of the scientific committee for national and international refereed journals and refereed conferences. She is on the editorial board for refereed journals and has worked on Special Issues. Usha has served and continues to serve on the Boards of several not-for-profit organisations and she has also served as panel judge for a number of awards including the Premiers Sustainability Award in Victoria and the International Green Gown Awards. Usha has published over 100 publications, including research and consulting reports. Her publications cover a wide range of scientific and technical research publications that include edited books, book chapters, refereed journals, refereed conference papers and reports for local, state and federal government clients. She has also produced podcasts for various organisations and participated in media interviews. She has received state, national and international funding worth over USD $25 million. Usha has been awarded the Quarterly Franklin Membership by London Journals Press (UK). Her biography has been included in the Marquis Who's Who in the World® 2018, 2016 (33rd Edition), along with approximately 55,000 of the most accomplished men and women from around the world, including luminaries as U.N. Secretary-General Ban Ki-moon. In 2017, Usha was awarded the Marquis Who’s Who Lifetime Achiever Award.",institutionString:null,institution:{name:"RMIT University",institutionURL:null,country:{name:"Australia"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:5,paginationItems:[{id:"91",title:"Sustainable Economy and Fair Society",coverUrl:"https://cdn.intechopen.com/series_topics/covers/91.jpg",isOpenForSubmission:!0,editor:{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo",profilePictureURL:"https://mts.intechopen.com/storage/users/181603/images/system/181603.jpg",biography:"Antonella Petrillo is a Professor at the Department of Engineering of the University of Naples “Parthenope”, Italy. She received her Ph.D. in Mechanical Engineering from the University of Cassino. Her research interests include multi-criteria decision analysis, industrial plant, logistics, manufacturing and safety. She serves as an Associate Editor for the International Journal of the Analytic Hierarchy Process. She is a member of AHP Academy and a member of several editorial boards. She has over 160 Scientific Publications in International Journals and Conferences and she is the author of 5 books on Innovation and Decision Making in Industrial Applications and Engineering.",institutionString:null,institution:{name:"Parthenope University of Naples",institutionURL:null,country:{name:"Italy"}}},editorTwo:null,editorThree:null},{id:"92",title:"Health and Wellbeing",coverUrl:"https://cdn.intechopen.com/series_topics/covers/92.jpg",isOpenForSubmission:!0,editor:{id:"348225",title:"Prof.",name:"Ann",middleName:null,surname:"Hemingway",slug:"ann-hemingway",fullName:"Ann Hemingway",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035LZFoQAO/Profile_Picture_2022-04-11T14:55:40.jpg",biography:"Professor Hemingway is a public health researcher, Bournemouth University, undertaking international and UK research focused on reducing inequalities in health outcomes for marginalised and excluded populations and more recently focused on equine assisted interventions.",institutionString:null,institution:{name:"Bournemouth University",institutionURL:null,country:{name:"United Kingdom"}}},editorTwo:null,editorThree:null},{id:"93",title:"Inclusivity and Social Equity",coverUrl:"https://cdn.intechopen.com/series_topics/covers/93.jpg",isOpenForSubmission:!0,editor:{id:"210060",title:"Prof. Dr.",name:"Ebba",middleName:null,surname:"Ossiannilsson",slug:"ebba-ossiannilsson",fullName:"Ebba Ossiannilsson",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6LkBQAU/Profile_Picture_2022-02-28T13:31:48.png",biography:'Professor Dr. Ebba Ossiannilsson is an independent researcher, expert, consultant, quality auditor and influencer in the fields of open, flexible online and distance learning (OFDL) and the "new normal". Her focus is on quality, innovation, leadership, and personalised learning. She works primarily at the strategic and policy levels, both nationally and internationally, and with key international organisations. She is committed to promoting and improving OFDL in the context of SDG4 and the future of education. Ossiannilsson has more than 20 years of experience in her current field, but more than 40 years in the education sector. She works as a reviewer and expert for the European Commission and collaborates with the Joint Research Centre for Quality in Open Education. Ossiannilsson also collaborates with ITCILO and ICoBC (International Council on Badges and Credentials). She is a member of the ICDE Board of Directors and has previously served on the boards of EDEN and EUCEN. Ossiannilsson is a quality expert and reviewer for ICDE, EDEN and the EADTU. She chairs the ICDE OER Advocacy Committee and is a member of the ICDE Quality Network. She is regularly invited as a keynote speaker at conferences. She is a guest editor for several special issues and a member of the editorial board of several scientific journals. She has published more than 200 articles and is currently working on book projects in the field of OFDL. Ossiannilsson is a visiting professor at several international universities and was recently appointed Professor and Research Fellow at Victoria University of Wellington, NZ. Ossiannilsson has been awarded the following fellowships: EDEN Fellows, EDEN Council of Fellows, and Open Education Europe. She is a ICDE OER Ambassador, Open Education Europe Ambassador, GIZ Ambassador for Quality in Digital Learning, and part of the Globe-Community of Digital Learning and Champion of SPARC Europe. On a national level, she is a quality developer at the Swedish Institute for Standards (SIS) and for ISO. She is a member of the Digital Skills and Jobs Coalition Sweden and Vice President of the Swedish Association for Distance Education. She is currently working on a government initiative on quality in distance education at the National Council for Higher Education. She holds a Ph.D. from the University of Oulu, Finland.',institutionString:"Swedish Association for Distance Education, Sweden",institution:null},editorTwo:null,editorThree:null},{id:"94",title:"Climate Change and Environmental Sustainability",coverUrl:"https://cdn.intechopen.com/series_topics/covers/94.jpg",isOpenForSubmission:!1,editor:null,editorTwo:null,editorThree:null},{id:"95",title:"Urban Planning and Environmental Management",coverUrl:"https://cdn.intechopen.com/series_topics/covers/95.jpg",isOpenForSubmission:!0,editor:{id:"181079",title:"Dr.",name:"Christoph",middleName:null,surname:"Lüthi",slug:"christoph-luthi",fullName:"Christoph Lüthi",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRHSqQAO/Profile_Picture_2022-04-12T15:51:33.png",biography:"Dr. Christoph Lüthi is an urban infrastructure planner with over 25 years of experience in planning and design of urban infrastructure in middle and low-income countries. He holds a Master’s Degree in Urban Development Planning from the University College of London (UCL), and a Ph.D. in Urban Planning & Engineering from TU Berlin. He has conducted applied research on urban planning and infrastructure issues in over 20 countries in Africa and Asia. In 2005 he joined Eawag-Sandec as Leader of the Strategic Environmental Sanitation Planning Group. Since 2015 he heads the research department Sanitation, Water and Solid Waste for Development (Sandec) at the Swiss Federal Institute of Aquatic Research and Technology (Eawag).",institutionString:"Swiss Federal Institute of Aquatic Science and Technology, Switzerland",institution:null},editorTwo:{id:"290571",title:"Dr.",name:"Rui Alexandre",middleName:null,surname:"Castanho",slug:"rui-alexandre-castanho",fullName:"Rui Alexandre Castanho",profilePictureURL:"https://mts.intechopen.com/storage/users/290571/images/system/290571.jpg",biography:"Rui Alexandre Castanho has a master\\'s degree in Planning, Audit, and Control in Urban Green Spaces and an international Ph.D. in Sustainable Planning in Borderlands. Currently, he is a professor at WSB University, Poland, and a visiting professor at the University of Johannesburg, South Africa. Dr. Castanho is a post-doc researcher on the GREAT Project, University of Azores, Ponta Delgada, Portugal. He collaborates with the Environmental Resources Analysis Research Group (ARAM), University of Extremadura (UEx), Spain; VALORIZA - Research Center for the Enhancement of Endogenous Resources, Polytechnic Institute of Portalegre (IPP), Portugal; Centre for Tourism Research, Development and Innovation (CITUR), Madeira, Portugal; and AQUAGEO Research Group, University of Campinas (UNICAMP), Brazil.",institutionString:"University of Johannesburg, South Africa and WSB University, Poland",institution:{name:"University of Johannesburg",institutionURL:null,country:{name:"South Africa"}}},editorThree:null}]},overviewPageOFChapters:{paginationCount:9,paginationItems:[{id:"81493",title:"Rust Disease Classification Using Deep Learning Based Algorithm: The Case of Wheat",doi:"10.5772/intechopen.104426",signatures:"Shivani Sood, Harjeet Singh and Suruchi Jindal",slug:"rust-disease-classification-using-deep-learning-based-algorithm-the-case-of-wheat",totalDownloads:35,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"81428",title:"Observatory of Sustainable Development in Postgraduate Study Programs in Baja California",doi:"10.5772/intechopen.104641",signatures:"Rodolfo Martinez-Gutierrez, Maria Marcela Solis-Quinteros, Maria Esther Ibarra-Estrada and Angel Ernesto Jimenez-Bernardino",slug:"observatory-of-sustainable-development-in-postgraduate-study-programs-in-baja-california",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Globalization and Sustainability - Recent Advances, New Perspectives and Emerging Issues",coverURL:"https://cdn.intechopen.com/books/images_new/11476.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"81235",title:"Global Food System Transformation for Resilience",doi:"10.5772/intechopen.102749",signatures:"Jasper Okoro Godwin Elechi, Ikechukwu U. Nwiyi and Cornelius Smah Adamu",slug:"global-food-system-transformation-for-resilience",totalDownloads:30,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"80749",title:"Analysis of the Nexus Between Coping Strategies and Resilience to Food Insecurity Shocks: The Case of Rural Households in Boricha Woreda, Sidama National Regional State, Ethiopia",doi:"10.5772/intechopen.102613",signatures:"Adane Atara Debessa, Degefa Tolossa and Berhanu Denu",slug:"analysis-of-the-nexus-between-coping-strategies-and-resilience-to-food-insecurity-shocks-the-case-of",totalDownloads:45,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}}]},overviewPagePublishedBooks:{paginationCount:0,paginationItems:[]},openForSubmissionBooks:{paginationCount:5,paginationItems:[{id:"11576",title:"Malaria - Recent Advances, and New Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11576.jpg",hash:"5a01644fb0b4ce24c2f947913d154abe",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"April 26th 2022",isOpenForSubmission:!0,editors:[{id:"76041",title:"Prof.",name:"Pier Paolo",surname:"Piccaluga",slug:"pier-paolo-piccaluga",fullName:"Pier Paolo Piccaluga"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11577",title:"Tick-Borne Diseases - A Review and an Update of Knowledge on Infections in Human and Animal Population",coverURL:"https://cdn.intechopen.com/books/images_new/11577.jpg",hash:"3d72ae651ee2a04b2368bf798a3183ca",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"April 29th 2022",isOpenForSubmission:!0,editors:[{id:"51521",title:"Prof.",name:"Elisa",surname:"Pieragostini",slug:"elisa-pieragostini",fullName:"Elisa Pieragostini"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11570",title:"Influenza - New Approaches",coverURL:"https://cdn.intechopen.com/books/images_new/11570.jpg",hash:"157b379b9d7a4bf5e2cc7a742f155a44",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"May 10th 2022",isOpenForSubmission:!0,editors:[{id:"139889",title:"Dr.",name:"Seyyed Shamsadin",surname:"Athari",slug:"seyyed-shamsadin-athari",fullName:"Seyyed Shamsadin Athari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11569",title:"Bacterial Sexually Transmitted Infections - New Findings, Diagnosis, Treatment, and Prevention",coverURL:"https://cdn.intechopen.com/books/images_new/11569.jpg",hash:"069d6142ecb0d46d14920102d48c0e9d",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"May 31st 2022",isOpenForSubmission:!0,editors:[{id:"189561",title:"Dr.",name:"Mihaela Laura",surname:"Vica",slug:"mihaela-laura-vica",fullName:"Mihaela Laura Vica"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11568",title:"Staphylococcal Infections - Recent Advances and Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/11568.jpg",hash:"92c881664d1921c7f2d0fee34b78cd08",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"June 1st 2022",isOpenForSubmission:!0,editors:[{id:"59719",title:"Dr.",name:"Jaime",surname:"Bustos-Martínez",slug:"jaime-bustos-martinez",fullName:"Jaime Bustos-Martínez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:48,paginationItems:[{id:"81799",title:"Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases",doi:"10.5772/intechopen.104978",signatures:"Richa Rai",slug:"cross-talk-of-purinergic-and-immune-signaling-implication-in-inflammatory-and-pathogenic-diseases",totalDownloads:0,totalCrossrefCites:null,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81764",title:"Involvement of the Purinergic System in Cell Death in Models of Retinopathies",doi:"10.5772/intechopen.103935",signatures:"Douglas Penaforte Cruz, Marinna Garcia Repossi and Lucianne Fragel Madeira",slug:"involvement-of-the-purinergic-system-in-cell-death-in-models-of-retinopathies",totalDownloads:1,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81756",title:"Alteration of Cytokines Level and Oxidative Stress Parameters in COVID-19",doi:"10.5772/intechopen.104950",signatures:"Marija Petrusevska, Emilija Atanasovska, Dragica Zendelovska, Aleksandar Eftimov and Katerina Spasovska",slug:"alteration-of-cytokines-level-and-oxidative-stress-parameters-in-covid-19",totalDownloads:1,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Chemokines Updates",coverURL:"https://cdn.intechopen.com/books/images_new/11672.jpg",subseries:{id:"18",title:"Proteomics"}}},{id:"81681",title:"Immunomodulatory Effects of a M2-Conditioned Medium (PRS® CK STORM): Theory on the Possible Complex Mechanism of Action through Anti-Inflammatory Modulation of the TLR System and the Purinergic System",doi:"10.5772/intechopen.104486",signatures:"Juan Pedro Lapuente",slug:"immunomodulatory-effects-of-a-m2-conditioned-medium-prs-ck-storm-theory-on-the-possible-complex-mech",totalDownloads:5,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81647",title:"Diabetes and Epigenetics",doi:"10.5772/intechopen.104653",signatures:"Rasha A. Alhazzaa, Thomas Heinbockel and Antonei B. Csoka",slug:"diabetes-and-epigenetics",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"81580",title:"Graft-Versus-Host Disease: Pathogenesis and Treatment",doi:"10.5772/intechopen.104450",signatures:"Shin Mukai",slug:"graft-versus-host-disease-pathogenesis-and-treatment",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81533",title:"Prenylation of Natural Products: An Overview",doi:"10.5772/intechopen.104636",signatures:"Kantharaju Kamanna and Aravind Kamath",slug:"prenylation-of-natural-products-an-overview",totalDownloads:18,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Kantharaju",surname:"Kamanna"}],book:{title:"Modifications of Biomolecules",coverURL:"https://cdn.intechopen.com/books/images_new/11098.jpg",subseries:null}},{id:"81067",title:"Encapsulation of Essential Oils and Their Use in Food Applications",doi:"10.5772/intechopen.103147",signatures:"Hamdy A. Shaaban and Amr Farouk",slug:"encapsulation-of-essential-oils-and-their-use-in-food-applications",totalDownloads:44,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Essential Oils - Advances in Extractions and Biological Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",subseries:{id:"15",title:"Chemical Biology"}}},{id:"81099",title:"SK Channels and Heart Disease",doi:"10.5772/intechopen.104115",signatures:"Katherine Zhong, Shawn Kant, Frank Sellke and Jun Feng",slug:"sk-channels-and-heart-disease",totalDownloads:16,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"81188",title:"Structure- and Design-Based Difficulties in Recombinant Protein Purification in Bacterial Expression",doi:"10.5772/intechopen.103958",signatures:"Kubra Acikalin Coskun, Nazlıcan Yurekli, Elif Cansu Abay, Merve Tutar, Mervenur Al and Yusuf Tutar",slug:"structure-and-design-based-difficulties-in-recombinant-protein-purification-in-bacterial-expression",totalDownloads:20,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Yusuf",surname:"Tutar"},{name:"Nazlican",surname:"Yurekli"},{name:"Merve",surname:"Tutar"},{name:"Mervenur",surname:"Al"},{name:"Elif Cansu",surname:"Abay"},{name:"Kubra",surname:"Acikalin Coskun"}],book:{title:"Protein Detection",coverURL:"https://cdn.intechopen.com/books/images_new/10839.jpg",subseries:{id:"18",title:"Proteomics"}}}]},subseriesFiltersForOFChapters:[{caption:"Proteomics",value:18,count:3,group:"subseries"},{caption:"Metabolism",value:17,count:8,group:"subseries"},{caption:"Cell and Molecular Biology",value:14,count:17,group:"subseries"},{caption:"Chemical Biology",value:15,count:19,group:"subseries"}],publishedBooks:{paginationCount:8,paginationItems:[{type:"book",id:"10859",title:"Data Mining",subtitle:"Concepts and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/10859.jpg",slug:"data-mining-concepts-and-applications",publishedDate:"March 30th 2022",editedByType:"Edited by",bookSignature:"Ciza Thomas",hash:"63a4e514e537d3962cf53ef1c6b9d5eb",volumeInSeries:8,fullTitle:"Data Mining - Concepts and Applications",editors:[{id:"43680",title:"Prof.",name:"Ciza",middleName:null,surname:"Thomas",slug:"ciza-thomas",fullName:"Ciza Thomas",profilePictureURL:"https://mts.intechopen.com/storage/users/43680/images/system/43680.jpeg",institutionString:null,institution:{name:"Government of Kerala",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10651",title:"Machine Learning",subtitle:"Algorithms, Models and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/10651.jpg",slug:"machine-learning-algorithms-models-and-applications",publishedDate:"December 22nd 2021",editedByType:"Edited by",bookSignature:"Jaydip Sen",hash:"6208156401c496e0a4ca5ff4265324cc",volumeInSeries:7,fullTitle:"Machine Learning - Algorithms, Models and Applications",editors:[{id:"4519",title:"Prof.",name:"Jaydip",middleName:null,surname:"Sen",slug:"jaydip-sen",fullName:"Jaydip Sen",profilePictureURL:"https://mts.intechopen.com/storage/users/4519/images/system/4519.jpeg",institutionString:"Praxis Business School",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9869",title:"Self-Driving Vehicles and Enabling Technologies",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9869.jpg",slug:"self-driving-vehicles-and-enabling-technologies",publishedDate:"September 22nd 2021",editedByType:"Edited by",bookSignature:"Marian Găiceanu",hash:"fd451ca2e4785ef098e04b7d695a18d9",volumeInSeries:6,fullTitle:"Self-Driving Vehicles and Enabling Technologies",editors:[{id:"169608",title:"Prof.",name:"Marian",middleName:null,surname:"Găiceanu",slug:"marian-gaiceanu",fullName:"Marian Găiceanu",profilePictureURL:"https://mts.intechopen.com/storage/users/169608/images/system/169608.png",institutionString:'"Dunarea de Jos" University of Galati',institution:{name:'"Dunarea de Jos" University of Galati',institutionURL:null,country:{name:"Romania"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9958",title:"Artificial Intelligence",subtitle:"Latest Advances, New Paradigms and Novel Applications",coverURL:"https://cdn.intechopen.com/books/images_new/9958.jpg",slug:"artificial-intelligence-latest-advances-new-paradigms-and-novel-applications",publishedDate:"September 1st 2021",editedByType:"Edited by",bookSignature:"Eneko Osaba, Esther Villar, Jesús L. Lobo and Ibai Laña",hash:"39648fbfdaa11385097d62b1f13aad54",volumeInSeries:5,fullTitle:"Artificial Intelligence - Latest Advances, New Paradigms and Novel Applications",editors:[{id:"221364",title:"Dr.",name:"Eneko",middleName:null,surname:"Osaba",slug:"eneko-osaba",fullName:"Eneko Osaba",profilePictureURL:"https://mts.intechopen.com/storage/users/221364/images/system/221364.jpg",institutionString:"TECNALIA Research & Innovation",institution:{name:"Tecnalia",institutionURL:null,country:{name:"Spain"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9963",title:"Advances and Applications in Deep Learning",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9963.jpg",slug:"advances-and-applications-in-deep-learning",publishedDate:"December 9th 2020",editedByType:"Edited by",bookSignature:"Marco Antonio Aceves-Fernandez",hash:"0d51ba46f22e55cb89140f60d86a071e",volumeInSeries:4,fullTitle:"Advances and Applications in Deep Learning",editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez",profilePictureURL:"https://mts.intechopen.com/storage/users/24555/images/system/24555.jpg",institutionString:null,institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7656",title:"Fuzzy Logic",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7656.jpg",slug:"fuzzy-logic",publishedDate:"February 5th 2020",editedByType:"Edited by",bookSignature:"Constantin Volosencu",hash:"54f092d4ffe0abf5e4172a80025019bc",volumeInSeries:3,fullTitle:"Fuzzy Logic",editors:[{id:"1063",title:"Prof.",name:"Constantin",middleName:null,surname:"Volosencu",slug:"constantin-volosencu",fullName:"Constantin Volosencu",profilePictureURL:"https://mts.intechopen.com/storage/users/1063/images/system/1063.png",institutionString:"Polytechnic University of Timişoara",institution:{name:"Polytechnic University of Timişoara",institutionURL:null,country:{name:"Romania"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7726",title:"Swarm Intelligence",subtitle:"Recent Advances, New Perspectives and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/7726.jpg",slug:"swarm-intelligence-recent-advances-new-perspectives-and-applications",publishedDate:"December 4th 2019",editedByType:"Edited by",bookSignature:"Javier Del Ser, Esther Villar and Eneko Osaba",hash:"e7ea7e74ce7a7a8e5359629e07c68d31",volumeInSeries:2,fullTitle:"Swarm Intelligence - Recent Advances, New Perspectives and Applications",editors:[{id:"49813",title:"Dr.",name:"Javier",middleName:null,surname:"Del Ser",slug:"javier-del-ser",fullName:"Javier Del Ser",profilePictureURL:"https://mts.intechopen.com/storage/users/49813/images/system/49813.png",institutionString:"Tecnalia Research & Innovation",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7723",title:"Artificial Intelligence",subtitle:"Applications in Medicine and Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7723.jpg",slug:"artificial-intelligence-applications-in-medicine-and-biology",publishedDate:"July 31st 2019",editedByType:"Edited by",bookSignature:"Marco Antonio Aceves-Fernandez",hash:"a3852659e727f95c98c740ed98146011",volumeInSeries:1,fullTitle:"Artificial Intelligence - Applications in Medicine and Biology",editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez",profilePictureURL:"https://mts.intechopen.com/storage/users/24555/images/system/24555.jpg",institutionString:null,institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Evolutionary Computation",value:25,count:1},{group:"subseries",caption:"Machine Learning and Data Mining",value:26,count:3},{group:"subseries",caption:"Applied Intelligence",value:22,count:4}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:1},{group:"publicationYear",caption:"2021",value:2021,count:3},{group:"publicationYear",caption:"2020",value:2020,count:2},{group:"publicationYear",caption:"2019",value:2019,count:2}],authors:{paginationCount:25,paginationItems:[{id:"429683",title:"Dr.",name:"Bilal",middleName:null,surname:"Khalid",slug:"bilal-khalid",fullName:"Bilal Khalid",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/429683/images/system/429683.png",biography:"Dr. Bilal Khalid received a Ph.D. in Industrial Business Administration from KMITL Business School, Bangkok, in 2021, and a master’s in International Business Management from Stamford International University, Bangkok, in 2017. Dr. Khalid\\'s research interests include leadership and negotiations, digital transformations, gamification, eLearning, blockchain, Big Data, and management of information technology. Dr. Bilal Khalid also serves as an academic editor at Education Research International and a reviewer for international journals.",institutionString:"KMITL Business School",institution:{name:"King Mongkut's Institute of Technology Ladkrabang",country:{name:"Thailand"}}},{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038UqSfQAK/Profile_Picture_2022-05-13T10:39:03.jpg",biography:"Dr. Muhammad Mohiuddin is an Associate Professor of International Business at Laval University, Canada. He has taught at Thompson Rivers University, Canada; University of Paris-Est, France; Osnabruck University of Applied Science, Germany; and Shanghai Institute of Technology and Tianjin University of Technology, China. He has published research in Research Policy, Applied Economics, Review of Economic Philosophy, Strategic Change, International Journal of Logistics, Sustainability, Journal of Environmental Management, Journal of Global Information Management, Journal of Cleaner Production, M@N@GEMENT, and more. He is a member of CEDIMES Institut (France), Academy of International Business (AIB), Strategic Management Society (SMS), Academy of Management (AOM), Administrative Science Association of Canada (ASAC), and Canadian council of small business and entrepreneurship (CCSBE). He is currently the director of the Research Group on Contemporary Asia (GERAC) at Laval University. He is also co-managing editor of Transnational Corporations Review and a guest editor for Electronic Commerce Research and Journal of Internet Technology.",institutionString:null,institution:{name:"Université Laval",country:{name:"Canada"}}},{id:"189147",title:"Dr.",name:"Hailan",middleName:null,surname:"Salamun",slug:"hailan-salamun",fullName:"Hailan Salamun",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/189147/images/19274_n.jpeg",biography:"Hailan Salamun, (Dr.) was born in Selangor, Malaysia and graduated from Tunku Ampuan Jamaah Religious High School at Shah Alam. Obtained a degree from the International Islamic University (UIA), Gombak in the field of Islamic Revealed Knowledge and Heritage. Next, I furthered my studies to the professional level to obtain a Diploma in Education at UIA. After serving for several years in school, I furthered my studies to the Master of Dakwah and Leadership at Universiti Kebangsaan Malaysia (UKM), Bangi. I graduated with a Doctor of Philosophy in Principalship Leadership from the University of Malaya (UM) in 2010. I am currently a senior lecturer in the Department of Nationalism and Civilization, Center for Basic and Continuing Education, Universiti Malaysia Terengganu. Prior to that, I had served in several educational institutions such as schools, the Institute of Teacher Education (IPG), and also the University of Malaya. I am also actively involved in paper presentation, writing and publishing. My research interests are focused on leadership, education, society and Islamic civilization. This area of research requires a detailed understanding of Islamic studies and research studies in leadership. Another research interest that I have explored recently is the politics of the Malay community and also the leadership of the mosque.",institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"442081",title:"Dr.",name:"Audrey",middleName:null,surname:"Addy",slug:"audrey-addy",fullName:"Audrey Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Kwame Nkrumah University of Science and Technology",country:{name:"Ghana"}}},{id:"437993",title:"Mr.",name:"Job",middleName:null,surname:"Jackson",slug:"job-jackson",fullName:"Job Jackson",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Management College of Southern Africa",country:{name:"South Africa"}}},{id:"428495",title:"Prof.",name:"Asyraf",middleName:null,surname:"Ab Rahman",slug:"asyraf-ab-rahman",fullName:"Asyraf Ab Rahman",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"429650",title:"Dr.",name:"Jacqueline",middleName:null,surname:"Kareem",slug:"jacqueline-kareem",fullName:"Jacqueline Kareem",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Christ University",country:{name:"India"}}},{id:"421041",title:"Dr.",name:"Sunil",middleName:null,surname:"Kumar Ramdas",slug:"sunil-kumar-ramdas",fullName:"Sunil Kumar Ramdas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Jain University",country:{name:"India"}}},{id:"421833",title:"Mr.",name:"Eugene",middleName:null,surname:"Owusu-Acheampong",slug:"eugene-owusu-acheampong",fullName:"Eugene Owusu-Acheampong",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Ghana",country:{name:"Ghana"}}},{id:"239876",title:"Ph.D.",name:"Luciana",middleName:null,surname:"Mourão",slug:"luciana-mourao",fullName:"Luciana Mourão",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Salgado de Oliveira",country:{name:"Brazil"}}},{id:"421735",title:"Dr.",name:"elizabeth",middleName:null,surname:"addy",slug:"elizabeth-addy",fullName:"elizabeth addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"442083",title:"Dr.",name:"James",middleName:null,surname:"Addy",slug:"james-addy",fullName:"James Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437991",title:"Prof.",name:"Muhammad",middleName:null,surname:"Hoque",slug:"muhammad-hoque",fullName:"Muhammad Hoque",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421006",title:"Dr.",name:"Anna",middleName:null,surname:"Uster",slug:"anna-uster",fullName:"Anna Uster",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470243",title:"Dr.",name:"Md Samim",middleName:null,surname:"Al Azad",slug:"md-samim-al-azad",fullName:"Md Samim Al Azad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470244",title:"Dr.",name:"Slimane",middleName:null,surname:"Ed-dafali",slug:"slimane-ed-dafali",fullName:"Slimane Ed-dafali",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421011",title:"Dr.",name:"Afatakpa",middleName:null,surname:"Fortune",slug:"afatakpa-fortune",fullName:"Afatakpa Fortune",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"446057",title:"Mr.",name:"Okedare",middleName:null,surname:"David Olubukunmi",slug:"okedare-david-olubukunmi",fullName:"Okedare David Olubukunmi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421778",title:"Dr.",name:"Fatimah",middleName:"Saeed",surname:"AlAhmari",slug:"fatimah-alahmari",fullName:"Fatimah AlAhmari",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421024",title:"Prof.",name:"Harold Andrew",middleName:null,surname:"Patrick",slug:"harold-andrew-patrick",fullName:"Harold Andrew Patrick",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421065",title:"Ms.",name:"Euzália",middleName:null,surname:"do Rosário Botelho Tomé",slug:"euzalia-do-rosario-botelho-tome",fullName:"Euzália do Rosário Botelho Tomé",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421053",title:"Associate Prof.",name:"Ken",middleName:null,surname:"Kalala Ndalamba",slug:"ken-kalala-ndalamba",fullName:"Ken Kalala Ndalamba",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421826",title:"Dr.",name:"Inusah",middleName:null,surname:"Salifu",slug:"inusah-salifu",fullName:"Inusah Salifu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"420823",title:"Prof.",name:"Gardênia da Silva",middleName:null,surname:"Abbad",slug:"gardenia-da-silva-abbad",fullName:"Gardênia da Silva Abbad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437613",title:"MSc.",name:"Juliana",middleName:null,surname:"Legentil",slug:"juliana-legentil",fullName:"Juliana Legentil",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]}},subseries:{item:{id:"9",type:"subseries",title:"Biotechnology - Biosensors, Biomaterials and Tissue Engineering",keywords:"Biotechnology, Biosensors, Biomaterials, Tissue Engineering",scope:"The Biotechnology - Biosensors, Biomaterials and Tissue Engineering topic within the Biomedical Engineering Series aims to rapidly publish contributions on all aspects of biotechnology, biosensors, biomaterial and tissue engineering. We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics can include but are not limited to: Biotechnology such as biotechnological products and process engineering; Biotechnologically relevant enzymes and proteins; Bioenergy and biofuels; Applied genetics and molecular biotechnology; Genomics, transcriptomics, proteomics; Applied microbial and cell physiology; Environmental biotechnology; Methods and protocols. Moreover, topics in biosensor technology, like sensors that incorporate enzymes, antibodies, nucleic acids, whole cells, tissues and organelles, and other biological or biologically inspired components will be considered, and topics exploring transducers, including those based on electrochemical and optical piezoelectric, thermal, magnetic, and micromechanical elements. Chapters exploring biomaterial approaches such as polymer synthesis and characterization, drug and gene vector design, biocompatibility, immunology and toxicology, and self-assembly at the nanoscale, are welcome. Finally, the tissue engineering subcategory will support topics such as the fundamentals of stem cells and progenitor cells and their proliferation, differentiation, bioreactors for three-dimensional culture and studies of phenotypic changes, stem and progenitor cells, both short and long term, ex vivo and in vivo implantation both in preclinical models and also in clinical trials.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/9.jpg",hasOnlineFirst:!1,hasPublishedBooks:!0,annualVolume:11405,editor:{id:"126286",title:"Dr.",name:"Luis",middleName:"Jesús",surname:"Villarreal-Gómez",slug:"luis-villarreal-gomez",fullName:"Luis Villarreal-Gómez",profilePictureURL:"https://mts.intechopen.com/storage/users/126286/images/system/126286.jpg",biography:"Dr. Luis Villarreal is a research professor from the Facultad de Ciencias de la Ingeniería y Tecnología, Universidad Autónoma de Baja California, Tijuana, Baja California, México. Dr. Villarreal is the editor in chief and founder of the Revista de Ciencias Tecnológicas (RECIT) (https://recit.uabc.mx/) and is a member of several editorial and reviewer boards for numerous international journals. He has published more than thirty international papers and reviewed more than ninety-two manuscripts. His research interests include biomaterials, nanomaterials, bioengineering, biosensors, drug delivery systems, and tissue engineering.",institutionString:null,institution:{name:"Autonomous University of Baja California",institutionURL:null,country:{name:"Mexico"}}},editorTwo:null,editorThree:null,series:{id:"7",title:"Biomedical Engineering",doi:"10.5772/intechopen.71985",issn:"2631-5343"},editorialBoard:[{id:"35539",title:"Dr.",name:"Cecilia",middleName:null,surname:"Cristea",slug:"cecilia-cristea",fullName:"Cecilia Cristea",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYQ65QAG/Profile_Picture_1621007741527",institutionString:null,institution:{name:"Iuliu Hațieganu University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"40735",title:"Dr.",name:"Gil",middleName:"Alberto Batista",surname:"Gonçalves",slug:"gil-goncalves",fullName:"Gil Gonçalves",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYRLGQA4/Profile_Picture_1628492612759",institutionString:null,institution:{name:"University of Aveiro",institutionURL:null,country:{name:"Portugal"}}},{id:"211725",title:"Associate Prof.",name:"Johann F.",middleName:null,surname:"Osma",slug:"johann-f.-osma",fullName:"Johann F. Osma",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDv7QAG/Profile_Picture_1626602531691",institutionString:null,institution:{name:"Universidad de Los Andes",institutionURL:null,country:{name:"Colombia"}}},{id:"69697",title:"Dr.",name:"Mani T.",middleName:null,surname:"Valarmathi",slug:"mani-t.-valarmathi",fullName:"Mani T. Valarmathi",profilePictureURL:"https://mts.intechopen.com/storage/users/69697/images/system/69697.jpg",institutionString:"Religen Inc. | A Life Science Company, United States of America",institution:null},{id:"205081",title:"Dr.",name:"Marco",middleName:"Vinícius",surname:"Chaud",slug:"marco-chaud",fullName:"Marco Chaud",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDGeQAO/Profile_Picture_1622624307737",institutionString:null,institution:{name:"Universidade de Sorocaba",institutionURL:null,country:{name:"Brazil"}}}]},onlineFirstChapters:{paginationCount:9,paginationItems:[{id:"81493",title:"Rust Disease Classification Using Deep Learning Based Algorithm: The Case of Wheat",doi:"10.5772/intechopen.104426",signatures:"Shivani Sood, Harjeet Singh and Suruchi Jindal",slug:"rust-disease-classification-using-deep-learning-based-algorithm-the-case-of-wheat",totalDownloads:35,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"81428",title:"Observatory of Sustainable Development in Postgraduate Study Programs in Baja California",doi:"10.5772/intechopen.104641",signatures:"Rodolfo Martinez-Gutierrez, Maria Marcela Solis-Quinteros, Maria Esther Ibarra-Estrada and Angel Ernesto Jimenez-Bernardino",slug:"observatory-of-sustainable-development-in-postgraduate-study-programs-in-baja-california",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Globalization and Sustainability - Recent Advances, New Perspectives and Emerging Issues",coverURL:"https://cdn.intechopen.com/books/images_new/11476.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"81235",title:"Global Food System Transformation for Resilience",doi:"10.5772/intechopen.102749",signatures:"Jasper Okoro Godwin Elechi, Ikechukwu U. Nwiyi and Cornelius Smah Adamu",slug:"global-food-system-transformation-for-resilience",totalDownloads:30,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"80749",title:"Analysis of the Nexus Between Coping Strategies and Resilience to Food Insecurity Shocks: The Case of Rural Households in Boricha Woreda, Sidama National Regional State, Ethiopia",doi:"10.5772/intechopen.102613",signatures:"Adane Atara Debessa, Degefa Tolossa and Berhanu Denu",slug:"analysis-of-the-nexus-between-coping-strategies-and-resilience-to-food-insecurity-shocks-the-case-of",totalDownloads:45,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"80753",title:"Toward Safe Food Systems: Analyses of Mycotoxin Contaminants in Food and Preventive Strategies Thereof for Their Formation and Toxicity",doi:"10.5772/intechopen.101461",signatures:"Dikabo Mogopodi, Mesha Mbisana, Samuel Raditloko, Inonge Chibua and Banyaladzi Paphane",slug:"toward-safe-food-systems-analyses-of-mycotoxin-contaminants-in-food-and-preventive-strategies-thereo",totalDownloads:57,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"80388",title:"Social Resilience in Local Food Systems: A Foundation for Food Security during a Crisis",doi:"10.5772/intechopen.101998",signatures:"Tanya Zerbian, Mags Adams and Neil Wilson",slug:"social-resilience-in-local-food-systems-a-foundation-for-food-security-during-a-crisis",totalDownloads:52,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"80098",title:"Bundling Weather Index Insurance with Microfinance: Trekking the Long Road between Expectations and Reality. A Study on Sub-Saharan Africa",doi:"10.5772/intechopen.101742",signatures:"Dorcas Stella Shumba",slug:"bundling-weather-index-insurance-with-microfinance-trekking-the-long-road-between-expectations-and-r",totalDownloads:67,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"79696",title:"How to Build Food Safety Resilience in Commercial Restaurants?",doi:"10.5772/intechopen.101481",signatures:"Rayane Stephanie Gomes De Freitas and Elke Stedefeldt",slug:"how-to-build-food-safety-resilience-in-commercial-restaurants",totalDownloads:107,totalCrossrefCites:1,totalDimensionsCites:1,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}},{id:"79604",title:"Perspective Chapter: Food System Resilience - Towards a Joint Understanding and Implications for Policy",doi:"10.5772/intechopen.99899",signatures:"Bart de Steenhuijsen Piters, Emma Termeer, Deborah Bakker, Hubert Fonteijn and Herman Brouwer",slug:"perspective-chapter-food-system-resilience-towards-a-joint-understanding-and-implications-for-policy",totalDownloads:121,totalCrossrefCites:1,totalDimensionsCites:2,authors:null,book:{title:"Food Systems Resilience",coverURL:"https://cdn.intechopen.com/books/images_new/10897.jpg",subseries:{id:"91",title:"Sustainable Economy and Fair Society"}}}]},publishedBooks:{paginationCount:10,paginationItems:[{type:"book",id:"10799",title:"Phenolic Compounds",subtitle:"Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",coverURL:"https://cdn.intechopen.com/books/images_new/10799.jpg",slug:"phenolic-compounds-chemistry-synthesis-diversity-non-conventional-industrial-pharmaceutical-and-therapeutic-applications",publishedDate:"February 23rd 2022",editedByType:"Edited by",bookSignature:"Farid A. Badria",hash:"339199f254d2987ef3167eef74fb8a38",volumeInSeries:26,fullTitle:"Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",institutionString:"Mansoura University",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9753",title:"Terpenes and Terpenoids",subtitle:"Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/9753.jpg",slug:"terpenes-and-terpenoids-recent-advances",publishedDate:"July 28th 2021",editedByType:"Edited by",bookSignature:"Shagufta Perveen and Areej Mohammad Al-Taweel",hash:"575689df13c78bf0e6c1be40804cd010",volumeInSeries:21,fullTitle:"Terpenes and Terpenoids - Recent Advances",editors:[{id:"192992",title:"Prof.",name:"Shagufta",middleName:null,surname:"Perveen",slug:"shagufta-perveen",fullName:"Shagufta Perveen",profilePictureURL:"https://mts.intechopen.com/storage/users/192992/images/system/192992.png",institutionString:"King Saud University",institution:{name:"King Saud University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",slug:"oxidoreductase",publishedDate:"February 17th 2021",editedByType:"Edited by",bookSignature:"Mahmoud Ahmed Mansour",hash:"852e6f862c85fc3adecdbaf822e64e6e",volumeInSeries:19,fullTitle:"Oxidoreductase",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour",profilePictureURL:"https://mts.intechopen.com/storage/users/224662/images/system/224662.jpg",institutionString:"King Saud bin Abdulaziz University for Health Sciences",institution:{name:"King Saud bin Abdulaziz University for Health Sciences",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8094",title:"Aflatoxin B1 Occurrence, Detection and Toxicological Effects",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8094.jpg",slug:"aflatoxin-b1-occurrence-detection-and-toxicological-effects",publishedDate:"June 3rd 2020",editedByType:"Edited by",bookSignature:"Xi-Dai Long",hash:"44f4ad52d8a8cbb22ef3d505d6b18027",volumeInSeries:14,fullTitle:"Aflatoxin B1 Occurrence, Detection and Toxicological Effects",editors:[{id:"202142",title:"Prof.",name:"Xi-Dai",middleName:null,surname:"Long",slug:"xi-dai-long",fullName:"Xi-Dai Long",profilePictureURL:"https://mts.intechopen.com/storage/users/202142/images/system/202142.jpeg",institutionString:"Youjiang Medical University for Nationalities",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8004",title:"Nitrogen Fixation",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8004.jpg",slug:"nitrogen-fixation",publishedDate:"April 8th 2020",editedByType:"Edited by",bookSignature:"Everlon Cid Rigobelo and Ademar Pereira Serra",hash:"02f39c8365ba155d1c520184c2f26976",volumeInSeries:11,fullTitle:"Nitrogen Fixation",editors:[{id:"39553",title:"Prof.",name:"Everlon",middleName:"Cid",surname:"Rigobelo",slug:"everlon-rigobelo",fullName:"Everlon Rigobelo",profilePictureURL:"https://mts.intechopen.com/storage/users/39553/images/system/39553.jpg",institutionString:"São Paulo State University",institution:{name:"Sao Paulo State University",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8028",title:"Flavonoids",subtitle:"A Coloring Model for Cheering up Life",coverURL:"https://cdn.intechopen.com/books/images_new/8028.jpg",slug:"flavonoids-a-coloring-model-for-cheering-up-life",publishedDate:"March 11th 2020",editedByType:"Edited by",bookSignature:"Farid A. Badria and Anthony Ananga",hash:"6c33178a5c7d2b276d2c6af4255def64",volumeInSeries:10,fullTitle:"Flavonoids - A Coloring Model for Cheering up Life",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",institutionString:"Mansoura University",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8170",title:"Chemical Properties of Starch",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8170.jpg",slug:"chemical-properties-of-starch",publishedDate:"March 11th 2020",editedByType:"Edited by",bookSignature:"Martins Emeje",hash:"0aedfdb374631bb3a33870c4ed16559a",volumeInSeries:9,fullTitle:"Chemical Properties of Starch",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Emeje",slug:"martins-emeje",fullName:"Martins Emeje",profilePictureURL:"https://mts.intechopen.com/storage/users/94311/images/system/94311.jpeg",institutionString:"National Institute for Pharmaceutical Research and Development",institution:{name:"National Institute for Pharmaceutical Research and Development",institutionURL:null,country:{name:"Nigeria"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8019",title:"Alginates",subtitle:"Recent Uses of This Natural Polymer",coverURL:"https://cdn.intechopen.com/books/images_new/8019.jpg",slug:"alginates-recent-uses-of-this-natural-polymer",publishedDate:"February 5th 2020",editedByType:"Edited by",bookSignature:"Leonel Pereira",hash:"61ea5c1aef462684a3b2215631b7dbf2",volumeInSeries:7,fullTitle:"Alginates - Recent Uses of This Natural Polymer",editors:[{id:"279788",title:"Dr.",name:"Leonel",middleName:null,surname:"Pereira",slug:"leonel-pereira",fullName:"Leonel Pereira",profilePictureURL:"https://mts.intechopen.com/storage/users/279788/images/system/279788.jpg",institutionString:"University of Coimbra",institution:{name:"University of Coimbra",institutionURL:null,country:{name:"Portugal"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8504",title:"Pectins",subtitle:"Extraction, Purification, Characterization and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/8504.jpg",slug:"pectins-extraction-purification-characterization-and-applications",publishedDate:"January 22nd 2020",editedByType:"Edited by",bookSignature:"Martin Masuelli",hash:"ff1acef627b277c575a10b3259dd331b",volumeInSeries:6,fullTitle:"Pectins - Extraction, Purification, Characterization and Applications",editors:[{id:"99994",title:"Dr.",name:"Martin",middleName:"Alberto",surname:"Masuelli",slug:"martin-masuelli",fullName:"Martin Masuelli",profilePictureURL:"https://mts.intechopen.com/storage/users/99994/images/system/99994.jpg",institutionString:"National University of San Luis",institution:{name:"National University of San Luis",institutionURL:null,country:{name:"Argentina"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7953",title:"Bioluminescence",subtitle:"Analytical Applications and Basic Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7953.jpg",slug:"bioluminescence-analytical-applications-and-basic-biology",publishedDate:"September 25th 2019",editedByType:"Edited by",bookSignature:"Hirobumi Suzuki",hash:"3a8efa00b71abea11bf01973dc589979",volumeInSeries:4,fullTitle:"Bioluminescence - Analytical Applications and Basic Biology",editors:[{id:"185746",title:"Dr.",name:"Hirobumi",middleName:null,surname:"Suzuki",slug:"hirobumi-suzuki",fullName:"Hirobumi Suzuki",profilePictureURL:"https://mts.intechopen.com/storage/users/185746/images/system/185746.png",institutionString:"Kogakuin University",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.jpg",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:8,numberOfPublishedChapters:87,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:98,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:27,numberOfPublishedChapters:286,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:139,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:0,numberOfUpcomingTopics:2,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!1},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:105,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:9,numberOfPublishedChapters:101,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:11,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:0,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!1},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[{id:"4",title:"Fungal Infectious Diseases",scope:"Fungi are ubiquitous and there are almost no non-pathogenic fungi. Fungal infectious illness prevalence and prognosis are determined by the exposure between fungi and host, host immunological state, fungal virulence, and early and accurate diagnosis and treatment. \r\nPatients with both congenital and acquired immunodeficiency are more likely to be infected with opportunistic mycosis. Fungal infectious disease outbreaks are common during the post- disaster rebuilding era, which is characterised by high population density, migration, and poor health and medical conditions.\r\nSystemic or local fungal infection is mainly associated with the fungi directly inhaled or inoculated in the environment during the disaster. The most common fungal infection pathways are human to human (anthropophilic), animal to human (zoophilic), and environment to human (soilophile). Diseases are common as a result of widespread exposure to pathogenic fungus dispersed into the environment. \r\nFungi that are both common and emerging are intertwined. In Southeast Asia, for example, Talaromyces marneffei is an important pathogenic thermally dimorphic fungus that causes systemic mycosis. Widespread fungal infections with complicated and variable clinical manifestations, such as Candida auris infection resistant to several antifungal medicines, Covid-19 associated with Trichoderma, and terbinafine resistant dermatophytosis in India, are among the most serious disorders. \r\nInappropriate local or systemic use of glucocorticoids, as well as their immunosuppressive effects, may lead to changes in fungal infection spectrum and clinical characteristics. Hematogenous candidiasis is a worrisome issue that affects people all over the world, particularly ICU patients. CARD9 deficiency and fungal infection have been major issues in recent years. Invasive aspergillosis is associated with a significant death rate. Special attention should be given to endemic fungal infections, identification of important clinical fungal infections advanced in yeasts, filamentous fungal infections, skin mycobiome and fungal genomes, and immunity to fungal infections.\r\nIn addition, endemic fungal diseases or uncommon fungal infections caused by Mucor irregularis, dermatophytosis, Malassezia, cryptococcosis, chromoblastomycosis, coccidiosis, blastomycosis, histoplasmosis, sporotrichosis, and other fungi, should be monitored. \r\nThis topic includes the research progress on the etiology and pathogenesis of fungal infections, new methods of isolation and identification, rapid detection, drug sensitivity testing, new antifungal drugs, schemes and case series reports. It will provide significant opportunities and support for scientists, clinical doctors, mycologists, antifungal drug researchers, public health practitioners, and epidemiologists from all over the world to share new research, ideas and solutions to promote the development and progress of medical mycology.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/4.jpg",keywords:"Emerging Fungal Pathogens, Invasive Infections, Epidemiology, Cell Membrane, Fungal Virulence, Diagnosis, Treatment"},{id:"5",title:"Parasitic Infectious Diseases",scope:"Parasitic diseases have evolved alongside their human hosts. In many cases, these diseases have adapted so well that they have developed efficient resilience methods in the human host and can live in the host for years. Others, particularly some blood parasites, can cause very acute diseases and are responsible for millions of deaths yearly. Many parasitic diseases are classified as neglected tropical diseases because they have received minimal funding over recent years and, in many cases, are under-reported despite the critical role they play in morbidity and mortality among human and animal hosts. The current topic, Parasitic Infectious Diseases, in the Infectious Diseases Series aims to publish studies on the systematics, epidemiology, molecular biology, genomics, pathogenesis, genetics, and clinical significance of parasitic diseases from blood borne to intestinal parasites as well as zoonotic parasites. We hope to cover all aspects of parasitic diseases to provide current and relevant research data on these very important diseases. In the current atmosphere of the Coronavirus pandemic, communities around the world, particularly those in different underdeveloped areas, are faced with the growing challenges of the high burden of parasitic diseases. At the same time, they are faced with the Covid-19 pandemic leading to what some authors have called potential syndemics that might worsen the outcome of such infections. Therefore, it is important to conduct studies that examine parasitic infections in the context of the coronavirus pandemic for the benefit of all communities to help foster more informed decisions for the betterment of human and animal health.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/5.jpg",keywords:"Blood Borne Parasites, Intestinal Parasites, Protozoa, Helminths, Arthropods, Water Born Parasites, Epidemiology, Molecular Biology, Systematics, Genomics, Proteomics, Ecology"},{id:"6",title:"Viral Infectious Diseases",scope:"The Viral Infectious Diseases Book Series aims to provide a comprehensive overview of recent research trends and discoveries in various viral infectious diseases emerging around the globe. The emergence of any viral disease is hard to anticipate, which often contributes to death. A viral disease can be defined as an infectious disease that has recently appeared within a population or exists in nature with the rapid expansion of incident or geographic range. This series will focus on various crucial factors related to emerging viral infectious diseases, including epidemiology, pathogenesis, host immune response, clinical manifestations, diagnosis, treatment, and clinical recommendations for managing viral infectious diseases, highlighting the recent issues with future directions for effective therapeutic strategies.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/6.jpg",keywords:"Novel Viruses, Virus Transmission, Virus Evolution, Molecular Virology, Control and Prevention, Virus-host Interaction"}],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"14",title:"Artificial Intelligence",doi:"10.5772/intechopen.79920",issn:"2633-1403",scope:"Artificial Intelligence (AI) is a rapidly developing multidisciplinary research area that aims to solve increasingly complex problems. In today's highly integrated world, AI promises to become a robust and powerful means for obtaining solutions to previously unsolvable problems. This Series is intended for researchers and students alike interested in this fascinating field and its many applications.",coverUrl:"https://cdn.intechopen.com/series/covers/14.jpg",latestPublicationDate:"May 9th, 2022",hasOnlineFirst:!0,numberOfOpenTopics:6,numberOfPublishedChapters:86,numberOfPublishedBooks:8,editor:{id:"218714",title:"Prof.",name:"Andries",middleName:null,surname:"Engelbrecht",fullName:"Andries Engelbrecht",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRNR8QAO/Profile_Picture_1622640468300",biography:"Andries Engelbrecht received the Masters and PhD degrees in Computer Science from the University of Stellenbosch, South Africa, in 1994 and 1999 respectively. He is currently appointed as the Voigt Chair in Data Science in the Department of Industrial Engineering, with a joint appointment as Professor in the Computer Science Division, Stellenbosch University. Prior to his appointment at Stellenbosch University, he has been at the University of Pretoria, Department of Computer Science (1998-2018), where he was appointed as South Africa Research Chair in Artifical Intelligence (2007-2018), the head of the Department of Computer Science (2008-2017), and Director of the Institute for Big Data and Data Science (2017-2018). In addition to a number of research articles, he has written two books, Computational Intelligence: An Introduction and Fundamentals of Computational Swarm Intelligence.",institutionString:null,institution:{name:"Stellenbosch University",institutionURL:null,country:{name:"South Africa"}}},subseries:[{id:"22",title:"Applied Intelligence",keywords:"Machine Learning, Intelligence Algorithms, Data Science, Artificial Intelligence, Applications on Applied Intelligence",scope:"This field is the key in the current industrial revolution (Industry 4.0), where the new models and developments are based on the knowledge generation on applied intelligence. The motor of the society is the industry and the research of this topic has to be empowered in order to increase and improve the quality of our lives.",annualVolume:11418,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/22.jpg",editor:{id:"27170",title:"Prof.",name:"Carlos",middleName:"M.",surname:"Travieso-Gonzalez",fullName:"Carlos Travieso-Gonzalez",profilePictureURL:"https://mts.intechopen.com/storage/users/27170/images/system/27170.jpeg",institutionString:null,institution:{name:"University of Las Palmas de Gran Canaria",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"13633",title:"Prof.",name:"Abdelhamid",middleName:null,surname:"Mellouk",fullName:"Abdelhamid Mellouk",profilePictureURL:"https://mts.intechopen.com/storage/users/13633/images/1567_n.jpg",institutionString:null,institution:{name:"Paris 12 Val de Marne University",institutionURL:null,country:{name:"France"}}},{id:"109268",title:"Dr.",name:"Ali",middleName:null,surname:"Al-Ataby",fullName:"Ali Al-Ataby",profilePictureURL:"https://mts.intechopen.com/storage/users/109268/images/7410_n.jpg",institutionString:null,institution:{name:"University of Liverpool",institutionURL:null,country:{name:"United Kingdom"}}},{id:"3807",title:"Dr.",name:"Carmelo",middleName:"Jose Albanez",surname:"Bastos-Filho",fullName:"Carmelo Bastos-Filho",profilePictureURL:"https://mts.intechopen.com/storage/users/3807/images/624_n.jpg",institutionString:null,institution:{name:"Universidade de Pernambuco",institutionURL:null,country:{name:"Brazil"}}},{id:"38850",title:"Dr.",name:"Efren",middleName:null,surname:"Gorrostieta Hurtado",fullName:"Efren Gorrostieta Hurtado",profilePictureURL:"https://mts.intechopen.com/storage/users/38850/images/system/38850.jpg",institutionString:null,institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}},{id:"239041",title:"Prof.",name:"Yang",middleName:null,surname:"Yi",fullName:"Yang Yi",profilePictureURL:"https://mts.intechopen.com/storage/users/239041/images/system/239041.jpeg",institutionString:"Virginia Tech",institution:{name:"Virginia Tech",institutionURL:null,country:{name:"United States of America"}}}]},{id:"23",title:"Computational Neuroscience",keywords:"Single-Neuron Modeling, Sensory Processing, Motor Control, Memory and Synaptic Pasticity, Attention, Identification, Categorization, Discrimination, Learning, Development, Axonal Patterning and Guidance, Neural Architecture, Behaviours and Dynamics of Networks, Cognition and the Neuroscientific Basis of Consciousness",scope:"Computational neuroscience focuses on biologically realistic abstractions and models validated and solved through computational simulations to understand principles for the development, structure, physiology, and ability of the nervous system. This topic is dedicated to biologically plausible descriptions and computational models - at various abstraction levels - of neurons and neural systems. This includes, but is not limited to: single-neuron modeling, sensory processing, motor control, memory, and synaptic plasticity, attention, identification, categorization, discrimination, learning, development, axonal patterning, guidance, neural architecture, behaviors, and dynamics of networks, cognition and the neuroscientific basis of consciousness. Particularly interesting are models of various types of more compound functions and abilities, various and more general fundamental principles (e.g., regarding architecture, organization, learning, development, etc.) found at various spatial and temporal levels.",annualVolume:11419,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/23.jpg",editor:{id:"14004",title:"Dr.",name:"Magnus",middleName:null,surname:"Johnsson",fullName:"Magnus Johnsson",profilePictureURL:"https://mts.intechopen.com/storage/users/14004/images/system/14004.png",institutionString:null,institution:{name:"Malmö University",institutionURL:null,country:{name:"Sweden"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"13818",title:"Dr.",name:"Asim",middleName:null,surname:"Bhatti",fullName:"Asim Bhatti",profilePictureURL:"https://mts.intechopen.com/storage/users/13818/images/system/13818.jpg",institutionString:null,institution:{name:"Deakin University",institutionURL:null,country:{name:"Australia"}}},{id:"151889",title:"Dr.",name:"Joao Luis Garcia",middleName:null,surname:"Rosa",fullName:"Joao Luis Garcia Rosa",profilePictureURL:"https://mts.intechopen.com/storage/users/151889/images/4861_n.jpg",institutionString:null,institution:{name:"University of Sao Paulo",institutionURL:null,country:{name:"Brazil"}}},{id:"103779",title:"Prof.",name:"Yalcin",middleName:null,surname:"Isler",fullName:"Yalcin Isler",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRyQ8QAK/Profile_Picture_1628834958734",institutionString:null,institution:{name:"Izmir Kâtip Çelebi University",institutionURL:null,country:{name:"Turkey"}}}]},{id:"24",title:"Computer Vision",keywords:"Image Analysis, Scene Understanding, Biometrics, Deep Learning, Software Implementation, Hardware Implementation, Natural Images, Medical Images, Robotics, VR/AR",scope:"The scope of this topic is to disseminate the recent advances in the rapidly growing field of computer vision from both the theoretical and practical points of view. Novel computational algorithms for image analysis, scene understanding, biometrics, deep learning and their software or hardware implementations for natural and medical images, robotics, VR/AR, applications are some research directions relevant to this topic.",annualVolume:11420,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/24.jpg",editor:{id:"294154",title:"Prof.",name:"George",middleName:null,surname:"Papakostas",fullName:"George Papakostas",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002hYaGbQAK/Profile_Picture_1624519712088",institutionString:null,institution:{name:"International Hellenic University",institutionURL:null,country:{name:"Greece"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"1177",title:"Prof.",name:"Antonio",middleName:"J. R.",surname:"Neves",fullName:"Antonio Neves",profilePictureURL:"https://mts.intechopen.com/storage/users/1177/images/system/1177.jpg",institutionString:null,institution:{name:"University of Aveiro",institutionURL:null,country:{name:"Portugal"}}},{id:"220565",title:"Dr.",name:"Jucheng",middleName:null,surname:"Yang",fullName:"Jucheng Yang",profilePictureURL:"https://mts.intechopen.com/storage/users/220565/images/5988_n.jpg",institutionString:null,institution:{name:"Tianjin University of Technology",institutionURL:null,country:{name:"China"}}},{id:"29299",title:"Prof.",name:"Serestina",middleName:null,surname:"Viriri",fullName:"Serestina Viriri",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYOalQAG/Profile_Picture_1620817405517",institutionString:null,institution:{name:"University of KwaZulu-Natal",institutionURL:null,country:{name:"South Africa"}}},{id:"315933",title:"Dr.",name:"Yalın",middleName:null,surname:"Baştanlar",fullName:"Yalın Baştanlar",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00002qpr7hQAA/Profile_Picture_1621430127547",institutionString:null,institution:{name:"Izmir Institute of Technology",institutionURL:null,country:{name:"Turkey"}}}]},{id:"25",title:"Evolutionary Computation",keywords:"Genetic Algorithms, Genetic Programming, Evolutionary Programming, Evolution Strategies, Hybrid Algorithms, Bioinspired Metaheuristics, Ant Colony Optimization, Evolutionary Learning, Hyperparameter Optimization",scope:"Evolutionary computing is a paradigm that has grown dramatically in recent years. This group of bio-inspired metaheuristics solves multiple optimization problems by applying the metaphor of natural selection. It so far has solved problems such as resource allocation, routing, schedule planning, and engineering design. Moreover, in the field of machine learning, evolutionary computation has carved out a significant niche both in the generation of learning models and in the automatic design and optimization of hyperparameters in deep learning models. This collection aims to include quality volumes on various topics related to evolutionary algorithms and, alternatively, other metaheuristics of interest inspired by nature. For example, some of the issues of interest could be the following: Advances in evolutionary computation (Genetic algorithms, Genetic programming, Bio-inspired metaheuristics, Hybrid metaheuristics, Parallel ECs); Applications of evolutionary algorithms (Machine learning and Data Mining with EAs, Search-Based Software Engineering, Scheduling, and Planning Applications, Smart Transport Applications, Applications to Games, Image Analysis, Signal Processing and Pattern Recognition, Applications to Sustainability).",annualVolume:11421,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/25.jpg",editor:{id:"136112",title:"Dr.",name:"Sebastian",middleName:null,surname:"Ventura Soto",fullName:"Sebastian Ventura Soto",profilePictureURL:"https://mts.intechopen.com/storage/users/136112/images/system/136112.png",institutionString:null,institution:{name:"University of Córdoba",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"111683",title:"Prof.",name:"Elmer",middleName:"P.",surname:"Dadios",fullName:"Elmer Dadios",profilePictureURL:"https://mts.intechopen.com/storage/users/111683/images/system/111683.jpg",institutionString:"De La Salle University",institution:{name:"De La Salle University",institutionURL:null,country:{name:"Philippines"}}},{id:"106873",title:"Prof.",name:"Hongwei",middleName:null,surname:"Ge",fullName:"Hongwei Ge",profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institutionString:null,institution:{name:"Dalian University of Technology",institutionURL:null,country:{name:"China"}}},{id:"171056",title:"Dr.",name:"Sotirios",middleName:null,surname:"Goudos",fullName:"Sotirios Goudos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bS9IuQAK/Profile_Picture_1622623673666",institutionString:null,institution:{name:"Aristotle University of Thessaloniki",institutionURL:null,country:{name:"Greece"}}},{id:"15895",title:"Assistant Prof.",name:"Takashi",middleName:null,surname:"Kuremoto",fullName:"Takashi Kuremoto",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLrqQAG/Profile_Picture_1625656196038",institutionString:null,institution:{name:"Nippon Institute of Technology",institutionURL:null,country:{name:"Japan"}}},{id:"125844",title:"Prof.",name:"Wellington",middleName:"Pinheiro Dos",surname:"Santos",fullName:"Wellington Santos",profilePictureURL:"https://mts.intechopen.com/storage/users/125844/images/4878_n.jpg",institutionString:null,institution:{name:"Federal University of Pernambuco",institutionURL:null,country:{name:"Brazil"}}}]},{id:"26",title:"Machine Learning and Data Mining",keywords:"Intelligent Systems, Machine Learning, Data Science, Data Mining, Artificial Intelligence",scope:"The scope of machine learning and data mining is immense and is growing every day. It has become a massive part of our daily lives, making predictions based on experience, making this a fascinating area that solves problems that otherwise would not be possible or easy to solve. This topic aims to encompass algorithms that learn from experience (supervised and unsupervised), improve their performance over time and enable machines to make data-driven decisions. It is not limited to any particular applications, but contributions are encouraged from all disciplines.",annualVolume:11422,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/26.jpg",editor:{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",fullName:"Marco Antonio Aceves Fernandez",profilePictureURL:"https://mts.intechopen.com/storage/users/24555/images/system/24555.jpg",institutionString:null,institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"43680",title:"Prof.",name:"Ciza",middleName:null,surname:"Thomas",fullName:"Ciza Thomas",profilePictureURL:"https://mts.intechopen.com/storage/users/43680/images/system/43680.jpeg",institutionString:null,institution:{name:"Government of Kerala",institutionURL:null,country:{name:"India"}}},{id:"16614",title:"Prof.",name:"Juan Ignacio",middleName:null,surname:"Guerrero Alonso",fullName:"Juan Ignacio Guerrero Alonso",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6HB8QAM/Profile_Picture_1627901127555",institutionString:null,institution:{name:"University of Seville",institutionURL:null,country:{name:"Spain"}}},{id:"3095",title:"Prof.",name:"Kenji",middleName:null,surname:"Suzuki",fullName:"Kenji Suzuki",profilePictureURL:"https://mts.intechopen.com/storage/users/3095/images/1592_n.jpg",institutionString:null,institution:{name:"University of Chicago",institutionURL:null,country:{name:"United States of America"}}},{id:"214067",title:"Dr.",name:"W. David",middleName:null,surname:"Pan",fullName:"W. David Pan",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSEI9QAO/Profile_Picture_1623656213532",institutionString:null,institution:{name:"University of Alabama in Huntsville",institutionURL:null,country:{name:"United States of America"}}},{id:"72920",title:"Prof.",name:"Yves",middleName:"Philippe",surname:"Rybarczyk",fullName:"Yves Rybarczyk",profilePictureURL:"https://mts.intechopen.com/storage/users/72920/images/system/72920.jpeg",institutionString:"Dalarna University, Faculty of Data and Information Sciences",institution:{name:"Dalarna University",institutionURL:null,country:{name:"Sweden"}}}]},{id:"27",title:"Multi-Agent Systems",keywords:"Collaborative Intelligence, Learning, Distributed Control System, Swarm Robotics, Decision Science, Software Engineering",scope:"Multi-agent systems are recognised as a state of the art field in Artificial Intelligence studies, which is popular due to the usefulness in facilitation capabilities to handle real-world problem-solving in a distributed fashion. The area covers many techniques that offer solutions to emerging problems in robotics and enterprise-level software systems. Collaborative intelligence is highly and effectively achieved with multi-agent systems. Areas of application include swarms of robots, flocks of UAVs, collaborative software management. Given the level of technological enhancements, the popularity of machine learning in use has opened a new chapter in multi-agent studies alongside the practical challenges and long-lasting collaboration issues in the field. It has increased the urgency and the need for further studies in this field. We welcome chapters presenting research on the many applications of multi-agent studies including, but not limited to, the following key areas: machine learning for multi-agent systems; modeling swarms robots and flocks of UAVs with multi-agent systems; decision science and multi-agent systems; software engineering for and with multi-agent systems; tools and technologies of multi-agent systems.",annualVolume:11423,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/27.jpg",editor:{id:"148497",title:"Dr.",name:"Mehmet",middleName:"Emin",surname:"Aydin",fullName:"Mehmet Aydin",profilePictureURL:"https://mts.intechopen.com/storage/users/148497/images/system/148497.jpg",institutionString:null,institution:{name:"University of the West of England",institutionURL:null,country:{name:"United Kingdom"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"275140",title:"Dr.",name:"Dinh Hoa",middleName:null,surname:"Nguyen",fullName:"Dinh Hoa Nguyen",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRbnKQAS/Profile_Picture_1622204093453",institutionString:null,institution:{name:"Kyushu University",institutionURL:null,country:{name:"Japan"}}},{id:"20259",title:"Dr.",name:"Hongbin",middleName:null,surname:"Ma",fullName:"Hongbin Ma",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRhDJQA0/Profile_Picture_2022-05-02T08:25:21.jpg",institutionString:null,institution:{name:"Beijing Institute of Technology",institutionURL:null,country:{name:"China"}}},{id:"28640",title:"Prof.",name:"Yasushi",middleName:null,surname:"Kambayashi",fullName:"Yasushi Kambayashi",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYOQxQAO/Profile_Picture_1625660525470",institutionString:null,institution:{name:"Nippon Institute of Technology",institutionURL:null,country:{name:"Japan"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"profile.detail",path:"/profiles/18378",hash:"",query:{},params:{id:"18378"},fullPath:"/profiles/18378",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()